Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADAT3	TAD3	ENSG00000213638	"Adenosine deaminase tRNA specific 3"		19	1905399-1913447	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 9.1;Gastric mucus-secreting cells: 8.2;Squamous epithelial cells: 13.7;Suprabasal keratinocytes: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 13.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058899	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA058899: AB_2683847"	"unprognostic (1.79e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.43e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.55e-3)"	3.3	4.6	1.6	0.8	3.1	0.7	3.1	2.8	2.6	4.2	1.2	7.7	7.5	3.5	0.2	10.6	3.7	0.2	2.8	1.1	1.4	7.9	5.4	3.7	0.5	5.6	3.1	3.1	6.3	0.1	3.3	0.2	4.0	6.4	0.7	0.0	8.1	0.4	1.9	13.9	6.6	0.1	3.1	6.1	4.7	2.9	3.3	0.1	4.5	0.2	0.3	2.8	5.3	6.1	4.9	1.2	0.7	1.0	0.4	0.0	5.9	1.7	0.3	0.6	0.9	1.9	1.5	2.8	0.7	0.2	0.3	3.1	0.2	0.2	0.0	6.9	12.5	0.7	3.7	2.5	0.2	1.3	8.8	0.0	0.2	0.8	0.0	0.1	0.6	0.8	8.1	1.5	0.4	1.0	2.3	4.2	6.5	0.2	8.4	7.6	1.1	4.8	0.7	1.2	2.6	6.4	2.1	5.0	2.5	0.3	3.9	1.0	1.6	0.6	2.8	2.4	3.7	2.7	2.6	2.5	0.5	1.3	1.6	0.2	1.2	0.0	1.3	0.7	1.4	0.9	2.0	2.3	1.7	2.5	1.4	2.3	0.3	4.1	1.1	13.2	2.6	0.8	1.6	3.1	2.8	2.6	1.1	1.4	5.6	3.1	4.0	3.1	3.3	6.1	1.1	0.0	1.5	0.0	2.9	6.1	1.0	1.0	9.1	0.0	4.0	1.8	0.6	1.5	0.5	0.0	0.0	1.8	5.5	4.1	1.9	1.5	0.1	6.3	1.2	1.4	1.2	0.4	0.0	0.7	2.4	1.6	8.2	3.1	0.0	0.5	2.2	0.8	1.8	0.0	0.0	1.1	0.0	1.4	3.1	0.6	0.0	2.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	4.3	0.7	6.4	0.3	4.2	4.0	2.3	0.0	0.0	0.8	1.2	0.8	3.1	13.7	11.1	4.5	3.6	0.8	1.7	1.2
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662160-67681224	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 73.0;esophagus: 152.2;skin 1: 123.0;vagina: 41.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 26.2;Endometrial ciliated cells: 12.6;Glandular and luminal cells: 28.1;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 14.8;Syncytiotrophoblasts: 14.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 71.9;SK-BR-3: 70.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045132	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.3	0.0	0.1	0.1	0.0	0.2	73.0	0.0	0.0	14.4	0.0	0.1	0.1	0.8	6.8	152.2	4.6	0.3	0.1	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.3	5.2	0.1	3.2	0.0	3.3	0.1	0.5	17.3	4.8	0.3	123.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	2.4	0.0	0.0	21.1	8.3	41.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	7.9	0.0	0.0	0.1	0.0	1.3	3.5	3.3	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.9	6.8	0.0	0.1	9.0	0.0	0.0	0.0	1.9	0.0	13.0	0.0	0.1	0.0	70.7	0.1	0.4	15.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	1.7	1.2	4.9	1.2	0.0	26.2	7.2	0.4	0.0	7.3	5.5	0.0	10.6	0.2	0.0	1.9	1.1	0.0	12.6	2.6	0.2	0.0	0.0	0.1	0.2	10.6	0.2	0.0	28.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	53.3	14.8	14.6	0.2	0.0	0.0	7.6
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996049-7010754	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 34.6;esophagus: 49.4;vagina: 105.7"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 25.5;HEL: 40.4"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		49000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	1.0	1.5	0.9	3.2	1.5	4.7	0.3	0.1	1.4	34.6	0.6	0.4	1.8	2.2	0.0	49.4	1.2	3.1	1.4	0.4	0.4	0.5	0.2	1.1	3.9	1.3	0.7	1.3	1.9	0.0	0.1	1.1	1.0	0.8	0.1	3.1	20.2	0.0	1.6	21.7	2.0	0.2	0.1	3.3	1.1	1.3	1.2	0.0	1.9	0.1	3.8	1.5	105.7	3.4	25.5	4.2	1.9	1.4	0.0	0.0	1.7	1.6	0.0	0.0	0.0	3.7	0.9	1.3	0.9	0.0	1.4	3.2	0.0	0.1	0.0	2.8	3.2	40.4	6.8	2.8	0.1	0.4	6.5	0.0	0.1	0.0	0.0	2.4	0.0	2.8	2.7	1.4	0.0	0.3	0.5	0.9	1.3	0.2	0.8	1.4	0.8	0.7	0.0	3.2	0.1	0.9	0.7	0.8	0.4	2.4	1.5	1.1	4.6	2.2	1.2	2.1	1.1	0.8	0.3	0.7	1.2	3.0	1.0	2.1	0.9	1.8	0.7	0.4	0.5	1.1	0.5	0.7	0.7	0.6	0.2	0.3	4.5	0.7	0.4	1.3	0.3	13.6	0.9	1.5	0.1	1.4	0.4	0.4	1.3	0.7	1.0	0.1	1.2	3.4	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	17.3	0.0	1.0	0.8	0.0	0.0	2.5	2.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.5	1.1	0.0	0.1	0.1	0.0	2.0
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase type B"	O15296	17	8039034-8049134	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 111.7;prostate: 73.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 75.8;Basal respiratory cells: 22.0;Kupffer cells: 42.2;monocytes: 87.9;Prostatic glandular cells: 25.6;Squamous epithelial cells: 44.4"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.9;myeloid DC: 4.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 4.3;monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.7;HSkMC: 16.6;hTCEpi: 35.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	2.2	1.7	0.7	1.3	0.7	0.4	111.7	0.6	2.5	12.0	0.5	2.3	0.1	1.1	0.9	39.1	1.6	0.7	0.7	0.7	0.8	0.5	0.4	24.5	2.9	1.8	0.9	0.7	1.4	0.2	0.5	1.2	1.6	73.1	0.3	0.3	3.7	0.1	0.3	36.9	3.7	0.1	0.9	3.8	4.4	0.5	0.9	0.7	1.9	0.1	7.6	1.7	33.4	1.9	0.1	0.0	0.0	0.1	0.5	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	16.6	35.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.9	0.7	0.7	0.6	2.5	0.7	0.8	1.8	0.9	1.6	0.9	0.9	1.9	1.4	0.0	75.8	0.0	0.3	3.1	0.6	22.0	7.4	0.0	19.8	12.3	0.3	1.5	8.2	0.0	0.0	0.2	0.2	0.2	0.0	0.1	1.3	0.0	0.8	0.4	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.2	1.3	0.0	0.7	0.3	4.2	0.0	0.0	0.0	2.0	42.2	1.1	0.8	0.0	15.4	5.4	0.0	87.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	25.6	0.0	0.0	2.2	0.0	0.0	0.1	1.3	0.6	0.8	44.4	1.1	0.8	0.0	0.0	0.0	2.2
ALS2CL	"DKFZp686I0110, FLJ36525, RN49018"	ENSG00000178038	"ALS2 C-terminal like"	Q60I27	3	46668995-46693704	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.5;kidney: 30.7;skin 1: 32.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Gastric mucus-secreting cells: 41.3;Respiratory ciliated cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 31.6;HaCaT: 17.1;HBEC3-KT: 33.1;hTCEpi: 20.9;RT4: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB046465, HPA048301"	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB046465: AB_10638285, HPA048301: AB_2680346"	"unprognostic (6.38e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-3)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.60e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.45e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.14e-3)"	4.7	2.2	0.8	1.6	0.9	0.8	5.1	1.8	2.0	10.1	0.5	5.6	3.5	2.2	0.1	37.5	4.4	2.7	10.1	0.6	0.8	30.7	7.2	10.8	1.7	1.5	0.6	1.8	5.8	0.5	4.3	1.3	1.4	4.5	1.0	0.0	11.0	2.2	5.3	32.3	4.7	0.8	0.5	6.5	3.5	0.8	0.6	1.1	15.6	1.9	1.4	4.8	19.5	0.6	9.8	2.2	0.0	0.0	0.0	0.0	0.1	0.7	1.1	0.0	0.3	0.1	31.6	0.0	8.9	0.8	0.5	17.1	0.0	33.1	0.1	0.1	0.0	0.8	3.7	0.0	0.3	0.0	0.0	0.0	20.9	0.0	3.2	0.2	0.9	2.0	0.0	0.2	0.0	0.9	0.0	0.1	0.3	4.7	1.9	0.1	0.0	12.0	7.7	15.8	0.3	0.2	12.6	9.7	0.0	0.5	2.2	0.2	6.6	0.1	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.9	1.8	2.0	0.6	0.8	1.5	0.6	1.4	0.5	0.6	0.6	17.5	73.7	15.3	2.3	0.5	15.2	8.4	21.8	12.0	0.3	4.7	5.5	10.2	18.6	29.9	11.0	0.0	1.5	0.1	29.0	0.0	10.1	0.6	5.1	1.8	13.1	0.0	0.0	8.0	13.5	7.3	4.5	41.3	5.5	1.3	0.1	7.1	7.6	2.7	0.0	2.9	6.4	24.4	0.3	4.1	0.2	0.3	1.4	1.8	10.3	0.8	0.1	0.0	0.0	0.3	26.3	12.0	0.0	0.1	17.7	5.9	0.4	46.9	0.1	19.7	5.6	8.5	1.3	2.7	22.3	16.3	2.1	1.3	0.3	11.8	27.7
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2185.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 174.7"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		19000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	975.6	370.5	49.0	461.9	50.5	151.7	708.5	49.6	96.9	806.3	95.6	631.2	502.0	296.2	267.2	2185.3	388.4	453.9	393.0	47.6	79.4	358.3	185.5	878.3	200.7	90.0	83.6	187.0	324.3	344.0	163.9	650.4	84.9	399.3	606.1	30.2	933.4	386.4	304.8	1140.8	487.5	425.4	73.3	301.6	379.0	116.1	120.9	188.7	351.2	205.8	541.1	842.2	1256.7	80.1	4183.3	4421.4	223.6	105.5	2962.4	4744.2	971.0	4703.6	2968.4	2868.4	2534.9	2083.5	1903.6	10.0	3907.2	5983.6	2185.1	4304.9	992.9	8695.5	3113.5	846.8	103.9	78.2	1918.7	882.7	1782.0	4.5	59.9	2324.4	2278.6	2013.2	4335.0	3477.2	5455.0	58.4	320.9	447.9	6271.8	468.4	18.5	239.1	508.2	3444.1	3283.5	48.9	1198.8	226.6	5172.4	2410.7	295.1	171.9	1774.5	424.8	1942.8	2305.1	922.7	173.6	6336.8	2534.1	3406.8	8668.0	4807.4	172.6	616.3	83.8	2449.2	47.9	5206.0	4429.7	2762.3	355.0	603.8	2401.9	668.5	657.9	686.4	701.7	4018.8	412.1	77.0	313.9	73.6	287.1	2686.5	609.4	1681.4	3754.4	49.0	50.5	49.6	96.9	47.6	79.4	90.0	83.6	84.9	73.3	120.9	80.1	673.9	2141.0	414.8	0.3	101.3	2512.2	3396.9	5755.6	246.4	2.5	395.9	337.4	28.2	773.5	3086.6	560.9	0.0	1874.5	135.9	933.6	13.7	3941.4	93.0	855.9	457.1	772.0	103.4	38.7	0.2	2411.4	2714.4	1076.7	328.7	1376.3	105.7	97.5	474.0	64.2	1537.2	0.0	1.3	689.0	1668.2	429.6	1992.1	126.6	771.1	715.1	1417.6	15.9	1284.0	19.4	138.0	1.5	0.1	5217.8	920.9	638.7	144.5	4575.5	845.8	51.8	2446.8	8.1	184.1	437.7	831.1	13.0	29.3	789.7	2325.1	1150.1	224.1	8.6	749.9	4326.1
ANXA8	ANX8	ENSG00000265190	"Annexin A8"	P13928	10	47460162-47484158	"Predicted intracellular proteins"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.6;skin 1: 266.2;vagina: 110.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 99.3;Astrocytes: 38.8;Club cells: 40.7;Excitatory neurons: 47.8;Fibroblasts: 34.5;Inhibitory neurons: 41.0;Microglial cells: 35.6;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 48.1;Squamous epithelial cells: 63.6"	"Group enriched"	"Detected in many"	4	"cervical cancer: 14.3;head and neck cancer: 16.1;lung cancer: 4.3;urothelial cancer: 11.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 394.3;HBEC3-KT: 622.3;hTCEpi: 357.6;hTERT-HME1: 134.2;RT4: 159.6"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (8.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.55e-15)"	"unprognostic (1.04e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	73.3	0.7	0.5	0.1	0.5	0.7	11.7	0.7	1.1	49.6	0.6	0.5	0.0	0.1	1.0	217.6	3.7	0.4	4.4	0.6	0.3	0.0	1.8	13.1	0.0	1.0	0.8	1.3	0.3	0.0	0.3	30.9	0.8	12.4	0.1	0.0	47.3	9.8	0.4	266.2	0.2	0.0	0.6	0.2	0.4	0.8	1.5	4.8	0.2	0.2	46.6	66.4	110.7	0.9	123.4	16.2	0.0	0.0	0.0	0.0	33.7	2.3	0.3	0.0	0.0	8.7	35.0	0.0	2.5	1.0	1.8	394.3	0.0	622.3	0.0	27.9	0.0	0.0	39.6	0.0	26.2	0.0	1.3	0.2	357.6	0.2	134.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.2	0.1	4.0	0.0	0.0	0.5	0.0	0.0	159.6	0.0	0.0	56.4	16.4	0.3	8.7	0.1	3.5	0.0	0.0	39.5	0.7	2.4	0.2	0.1	0.2	4.4	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.5	0.7	1.1	0.6	0.3	1.0	0.8	0.8	0.6	1.5	0.9	0.1	99.3	7.3	38.8	0.0	1.1	10.3	1.6	2.8	0.0	4.9	3.4	2.6	7.2	40.7	3.7	0.0	14.7	0.1	1.0	0.0	3.1	0.6	2.1	0.0	0.5	0.0	0.0	47.8	0.4	6.7	34.5	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.0	41.0	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	35.6	0.1	0.0	0.0	50.8	48.1	17.3	0.0	0.0	0.0	8.5	1.5	0.0	14.2	0.0	0.0	0.0	0.6	0.2	1.4	63.6	2.0	6.2	0.3	0.1	0.2	17.2
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441156-33447596	"Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1526.1;skin 1: 581.9;urinary bladder: 688.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4"	"Group enriched"	"Detected in all"	5	"cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 5.3;medulla oblongata: 16.0;pons: 21.0"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 181.7;T-reg: 205.4"	"Lineage enriched"	"Detected in many"	18	"T-cells: 205.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	10.9	2.1	1.5	16.8	0.4	19.7	36.6	2.4	3.4	173.3	1.4	10.3	73.4	10.9	2.9	1526.1	25.4	9.4	31.5	5.3	0.4	131.7	118.6	114.0	16.1	16.0	1.6	12.1	43.1	2.0	2.8	6.0	21.0	85.6	10.1	1.7	399.7	36.8	5.3	581.9	100.5	3.2	0.2	110.1	35.9	2.8	0.8	233.9	2.3	26.7	172.5	688.6	529.9	0.9	0.6	38.6	1.9	0.0	67.7	12.2	1.0	0.3	0.9	0.9	1.1	20.5	12.0	0.5	9.1	0.0	0.5	127.1	6.2	0.7	0.2	61.6	6.0	4.3	213.2	1.9	0.4	1.3	1.3	1.9	6.5	0.5	0.2	0.2	0.5	130.7	67.4	58.8	6.9	29.1	60.4	23.0	5.3	88.6	0.7	0.9	94.3	10.8	1.3	216.6	1.7	4.7	32.3	149.7	0.1	8.0	0.9	10.6	1.2	0.0	1.0	0.4	0.4	151.2	213.6	14.5	0.5	0.4	0.2	1.6	0.5	0.1	20.2	0.4	181.7	11.3	171.9	52.8	0.3	3.0	97.3	47.1	2.3	3.0	0.5	11.1	205.4	43.0	1.5	0.4	2.4	3.4	5.3	0.4	16.0	1.6	21.0	0.2	0.8	0.9	9.2	38.5	249.9	0.0	42.4	1923.3	982.0	381.4	811.0	9.7	56.8	27.8	3.4	157.3	436.3	1609.3	2.1	0.9	21.6	2.7	0.0	37.4	2.2	82.3	21.4	37.1	8.3	71.4	0.3	48.9	2.0	27.5	16.3	96.2	20.8	0.2	16.4	137.3	2.2	0.0	0.1	104.0	315.3	3.5	122.9	0.6	33.2	15.3	158.3	0.0	1.6	0.4	4.1	0.5	0.2	28.5	8.1	1.2	246.9	1430.8	343.1	31.9	546.0	0.5	0.0	10.2	35.8	0.7	1.9	2189.3	2485.4	50.2	73.4	1.6	7.3	2455.4
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325898-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		760000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	74.4	82.9	61.6	39.7	63.3	40.4	63.2	60.1	71.9	69.8	71.9	80.7	92.8	60.1	80.9	124.6	75.5	53.3	121.7	78.7	73.9	65.9	77.4	62.2	41.9	64.6	67.7	81.5	63.8	65.4	62.1	54.3	71.7	56.9	78.2	33.0	66.6	55.5	48.0	84.5	84.9	57.2	60.8	52.7	99.1	42.4	68.4	39.2	78.8	47.1	44.9	61.6	74.9	62.9	265.3	144.3	155.1	73.6	144.2	242.4	133.5	185.5	216.1	185.5	184.4	164.4	301.7	92.3	270.5	226.7	273.8	110.6	208.0	270.8	221.5	46.7	186.4	49.7	99.9	137.1	156.1	59.2	63.7	227.6	149.1	237.8	252.0	220.0	310.8	75.9	125.9	105.6	289.8	398.6	99.4	78.5	150.5	295.3	326.1	58.1	107.8	113.9	142.0	162.7	161.7	138.3	180.9	260.2	255.9	264.2	130.2	88.4	239.3	239.0	211.0	424.7	302.1	39.6	80.0	130.7	206.6	130.1	320.2	111.7	49.9	88.8	24.2	80.8	19.3	30.8	23.1	31.5	43.0	28.8	30.0	22.6	63.7	30.7	86.1	31.9	33.5	26.9	61.6	63.3	60.1	71.9	78.7	73.9	64.6	67.7	71.7	60.8	68.4	62.9	124.3	51.3	55.5	20.9	45.2	41.4	139.5	249.1	54.7	38.0	107.2	131.6	46.7	95.8	130.1	58.8	18.8	189.6	27.3	196.2	135.0	213.6	32.1	55.0	43.7	96.4	74.2	68.8	31.6	276.9	345.8	70.6	140.2	57.4	13.3	141.4	135.0	75.8	84.6	33.7	28.0	209.4	132.2	77.5	26.1	24.6	66.8	56.0	80.0	26.2	68.6	79.8	42.2	19.1	28.4	442.5	191.6	67.4	52.4	151.5	295.7	155.5	102.2	40.1	184.1	59.1	188.4	171.6	130.0	88.9	47.9	129.7	29.8	87.7	166.3	280.7
BDKRB1	"B1BKR, BKR1, bradyb1"	ENSG00000100739	"Bradykinin receptor B1"	P46663	14	96256210-96268967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 23.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 40.8;Basal squamous epithelial cells: 41.5;Fibroblasts: 17.0;Squamous epithelial cells: 22.5;Suprabasal keratinocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.0;fHDF/TERT166: 18.8;HHSteC: 29.2;hTEC/SVTERT24-B: 29.2;U-2197: 27.9;U-87 MG: 90.1"	"Low region specificity"	"Detected in single"							HPA002935	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA002935: AB_1078274"	"unprognostic (6.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.96e-6)"	"unprognostic (2.33e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.66e-2)"	10.7	0.2	0.4	5.2	0.7	0.0	1.2	1.3	0.9	6.9	0.3	4.2	1.8	0.9	0.6	13.4	5.1	14.1	1.6	0.5	0.3	8.3	0.2	1.3	0.1	0.5	0.4	0.4	6.5	0.0	0.2	0.7	0.5	1.5	2.7	0.2	1.9	0.2	0.1	3.3	3.6	6.0	0.3	0.1	4.5	2.3	0.4	0.1	1.1	0.5	0.4	23.4	7.4	0.6	0.5	1.4	0.0	1.2	2.9	9.9	0.1	2.3	32.0	3.1	0.5	0.0	0.6	0.0	0.1	18.8	1.4	2.4	0.0	0.4	5.0	0.3	0.1	0.0	2.7	0.0	29.2	0.0	0.1	1.0	2.4	29.2	0.6	0.2	0.0	0.0	0.0	0.1	4.2	0.4	0.0	0.0	0.0	1.7	0.2	0.0	7.2	0.2	0.2	0.1	0.7	0.0	8.2	2.4	0.0	0.3	0.0	0.0	0.0	9.5	0.6	27.9	1.8	4.6	9.3	0.0	90.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	1.3	0.9	0.5	0.3	0.5	0.4	0.5	0.3	0.4	0.6	1.4	0.0	0.5	0.0	0.0	40.8	2.9	9.0	41.5	1.7	0.0	0.3	0.8	0.0	3.2	0.0	0.0	0.3	0.0	5.5	7.9	2.3	1.1	0.9	3.7	5.0	0.0	0.0	0.4	1.2	1.4	17.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	8.2	0.0	6.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.3	4.9	0.4	0.0	1.6	2.3	0.1	3.3	0.1	0.0	1.6	2.5	0.9	1.3	22.5	17.2	1.5	0.2	0.0	0.4	2.8
BHLHE40	"BHLHB2, Clast5, DEC1, SHARP2, STRA13"	ENSG00000134107	"Basic helix-loop-helix family member e40"	O14503	3	4979437-4985323	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 386.7;granulocytes: 439.2;Squamous epithelial cells: 517.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 101.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 488.2;Karpas-707: 228.4;U-87 MG: 218.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028922	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA028922: AB_2672828"	"unprognostic (8.64e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (5.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.03e-3)"	154.1	99.0	38.5	52.9	38.4	188.2	200.0	36.1	48.7	141.6	41.4	67.9	30.8	67.6	34.6	353.2	61.5	100.4	153.4	38.1	32.8	151.4	187.9	112.1	52.4	52.0	47.5	76.0	79.8	67.5	92.6	72.2	39.3	98.1	47.4	118.3	117.3	32.5	251.7	207.2	42.6	65.2	40.5	26.9	43.5	14.1	49.6	40.6	82.7	46.8	50.7	172.1	272.3	37.0	40.4	53.4	0.1	14.7	30.8	23.8	78.6	7.5	19.7	7.7	30.2	3.4	39.7	0.2	19.6	14.2	118.9	31.5	6.6	108.0	13.2	488.2	4.7	9.8	39.6	11.9	29.7	25.5	192.8	55.1	63.3	88.9	25.4	53.4	30.0	1.7	53.9	228.4	20.3	28.4	3.9	10.8	2.9	45.6	87.1	0.7	17.6	23.0	74.4	7.9	0.8	1.7	132.6	34.2	40.0	45.9	78.6	38.8	39.7	30.4	29.3	28.9	50.0	175.9	82.8	1.6	218.0	19.8	15.3	101.4	9.7	54.5	24.7	4.9	24.9	7.7	13.1	16.6	15.2	4.5	2.9	10.1	14.3	54.9	0.5	19.9	0.9	11.9	38.5	38.4	36.1	48.7	38.1	32.8	52.0	47.5	39.3	40.5	49.6	37.0	172.5	67.3	191.3	32.3	24.9	165.4	112.8	330.5	373.3	15.4	136.6	74.7	65.0	40.0	297.7	46.0	0.0	32.0	159.8	52.9	11.7	75.2	0.3	210.2	69.6	161.6	10.7	2.5	36.6	72.5	89.3	102.6	68.3	386.7	439.2	0.5	75.0	56.5	38.3	10.1	4.5	32.6	136.3	52.1	354.0	1.7	7.2	117.9	108.5	27.2	42.9	95.1	44.3	11.1	3.3	138.8	37.9	3.8	38.0	61.1	8.8	23.1	102.1	11.5	6.6	55.3	94.4	0.2	0.4	517.2	262.0	158.4	97.8	0.3	24.4	129.4
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036321-151047720	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 128.5;skin 1: 181.4;vagina: 69.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 17.2;Squamous epithelial cells: 42.7;Suprabasal keratinocytes: 57.1;Urothelial cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"T-47d: 46.1"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.6;cerebellum: 2.4"	"Not detected"	"Not detected"			HPA019946			Uncertain	Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA019946: AB_2732424"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (6.81e-2)"	0.4	0.3	0.9	0.4	1.0	0.6	15.6	3.0	1.3	25.1	0.7	0.4	0.3	0.3	0.2	128.5	2.7	0.3	0.7	0.9	1.0	2.9	1.2	9.4	0.6	1.5	1.0	0.6	0.4	1.1	0.6	0.5	1.1	12.5	0.2	0.8	22.9	4.7	1.6	181.4	0.5	0.1	0.7	1.1	1.4	4.3	1.0	0.7	7.4	0.1	10.1	9.7	69.7	1.1	0.4	0.4	0.6	0.6	0.4	0.4	0.7	0.3	0.0	0.3	0.2	1.5	0.4	0.7	0.7	0.0	0.1	1.5	0.9	0.2	0.6	1.1	1.0	1.2	0.8	0.2	0.1	0.6	0.6	0.0	3.1	0.2	0.3	1.0	0.0	1.1	0.6	0.5	0.3	2.0	0.7	1.2	0.5	1.0	0.4	0.3	0.3	0.4	0.6	0.4	1.3	0.6	0.5	0.9	0.3	2.2	46.1	0.4	1.1	0.7	0.5	0.2	0.1	1.7	1.3	3.9	0.1	0.3	0.8	0.5	0.1	0.1	0.3	0.1	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.9	1.0	3.0	1.3	0.9	1.0	1.5	1.0	1.1	0.7	1.0	1.1	0.4	16.0	17.2	0.0	0.3	15.3	6.1	3.9	12.5	0.4	14.2	6.1	0.3	0.0	11.0	11.0	0.0	1.6	1.2	0.3	0.0	0.0	7.6	1.1	1.3	0.8	0.0	0.0	1.1	0.0	0.4	0.9	0.0	1.1	0.0	0.4	2.5	0.1	0.3	0.0	1.2	0.3	2.0	0.6	5.5	1.3	0.9	1.9	3.6	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.6	5.5	0.8	0.3	12.8	1.5	0.0	0.9	1.2	0.9	0.3	42.7	57.1	2.6	1.3	0.2	0.4	24.4
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40769980-40772449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.0;skin 1: 17.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.6;Club cells: 5.0;Glandular and luminal cells: 6.3;Ionocytes: 6.1;Prostatic glandular cells: 5.5;Squamous epithelial cells: 4.7;Urothelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.7;SK-BR-3: 5.7"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in all"			HPA044636	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.8	1.3	0.7	1.5	1.0	1.7	2.3	4.4	1.5	3.5	0.0	2.0	1.9	1.7	0.1	26.0	2.1	1.3	1.4	0.7	0.2	2.0	4.0	1.8	2.1	0.7	0.5	2.5	2.0	0.1	2.1	0.4	0.8	2.4	0.1	2.4	8.3	0.1	2.0	17.1	2.6	0.0	0.1	2.3	1.9	0.6	0.8	0.7	2.0	0.1	5.0	1.8	6.9	1.2	0.5	0.4	1.6	2.0	0.6	0.1	0.4	0.7	0.1	0.0	0.2	1.9	2.2	1.0	1.8	0.0	1.3	4.1	0.7	0.0	0.0	1.5	1.6	1.0	4.4	0.6	0.0	0.9	1.2	0.2	0.8	0.0	0.1	1.8	0.6	0.7	0.9	1.2	0.0	0.5	1.3	1.6	0.7	2.8	0.8	1.4	0.3	0.5	17.7	1.5	3.6	0.8	0.6	5.7	0.2	0.6	2.0	1.3	0.8	2.0	0.9	1.8	0.6	1.4	1.0	0.9	0.6	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.4	1.5	0.7	0.2	0.7	0.5	0.8	0.1	0.8	1.2	0.2	0.0	0.0	0.3	0.3	0.0	3.6	2.1	0.6	0.3	1.7	0.6	0.7	0.0	5.0	0.0	0.0	0.1	0.2	0.1	0.0	0.5	0.0	1.6	0.9	0.3	0.0	0.0	0.1	0.2	0.0	0.2	0.0	6.3	0.0	0.1	0.0	0.8	0.2	3.3	0.1	0.1	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.1	0.0	0.0	5.5	0.3	0.3	1.3	0.5	0.0	0.0	0.3	0.0	0.0	4.7	1.0	0.0	0.2	0.0	0.3	11.6
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304164-38305006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 515.3;skin 1: 331.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"myeloid DC: 22.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 22.2"	"Cell line enhanced"	"Detected in many"		"A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8"	"Not detected"	"Not detected"							"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	43.1	5.0	2.8	17.6	3.1	3.6	25.5	2.9	4.4	82.4	2.9	187.5	186.7	6.1	0.6	515.3	91.5	49.5	32.9	2.3	2.6	28.2	1.3	91.3	0.9	3.1	3.0	4.6	8.9	0.5	12.7	7.9	3.4	26.2	104.1	0.1	123.3	18.3	3.9	331.1	189.5	4.0	2.5	10.7	151.5	1.5	3.8	4.1	18.9	4.3	30.8	102.2	224.3	2.5	745.5	1228.0	0.0	0.6	0.0	0.0	1.2	1.0	0.0	0.0	0.0	77.1	767.1	0.0	394.2	0.0	0.7	300.1	0.0	744.6	0.0	0.4	0.5	0.4	244.2	20.0	5.4	0.0	0.2	0.0	799.2	0.3	493.3	3.3	10.2	0.9	0.4	0.5	0.8	220.4	0.1	1.9	0.4	678.3	659.8	0.2	0.2	2.8	469.5	255.2	0.8	0.8	416.6	340.8	0.8	1.6	103.7	2.3	141.6	0.5	201.9	0.7	2.8	0.7	2.4	3.7	0.1	0.2	0.2	2.1	0.6	2.2	0.2	0.0	0.4	0.1	0.5	0.1	22.2	1.4	0.7	0.3	1.0	0.4	0.1	1.8	0.0	18.2	2.8	3.1	2.9	4.4	2.3	2.6	3.1	3.0	3.4	2.5	3.8	2.5	29.1	535.2	172.9	0.0	5.4	225.3	28.4	508.7	436.5	0.0	32.5	25.5	2.4	267.4	418.0	55.2	0.0	8.6	1.7	2060.3	1.9	207.7	0.7	144.3	26.0	18.4	76.1	3.6	0.1	753.8	1.3	44.7	353.7	273.2	38.2	3.7	3.6	0.4	1.3	0.0	0.0	842.0	99.7	1.4	15.1	5.1	4.1	32.9	1.8	0.0	4.9	0.0	0.0	0.0	0.0	2590.4	1697.3	0.0	5.7	35.7	1756.4	51.7	212.5	0.0	0.0	0.4	14.3	1.8	1.9	629.0	348.4	3.1	7.9	0.0	691.9	188.4
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566684-55567687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.7;skin 1: 102.4"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 87.8;Basal squamous epithelial cells: 117.3;Squamous epithelial cells: 108.6;Suprabasal keratinocytes: 149.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.8;intermediate monocyte: 1.0"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 1.0"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 223.0"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.4	0.0	0.4	0.1	0.7	0.6	6.6	0.9	0.5	14.3	0.4	0.0	0.0	0.1	0.2	85.7	0.8	0.0	0.1	0.5	0.6	0.0	0.1	0.2	0.0	1.5	0.9	0.1	0.1	0.0	0.1	0.3	1.6	4.2	0.0	0.1	16.8	0.1	0.7	102.4	0.1	0.0	1.1	0.1	0.1	0.0	1.1	0.2	0.3	0.0	18.6	18.1	33.5	1.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	23.0	0.0	1.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.7	0.8	0.0	223.0	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	1.1	0.1	7.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	1.2	0.0	0.1	3.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.7	0.9	0.5	0.5	0.6	1.5	0.9	1.6	1.1	1.1	1.5	0.6	0.0	0.5	0.0	0.0	87.8	10.0	13.7	117.3	0.0	0.2	0.3	0.0	0.0	11.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.8	7.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.5	0.7	0.0	0.0	108.6	149.3	2.3	0.2	0.1	0.0	15.4
CARD14	"BIMP2, CARMA2, PSORS2"	ENSG00000141527	"Caspase recruitment domain family member 14"	Q9BXL6	17	80169992-80209331	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.5;skin 1: 14.4;vagina: 7.3"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 8.2;Microglial cells: 6.5;Oligodendrocytes: 11.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 5.2;SK-BR-3: 6.9;T-47d: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023388			Supported	Aggresome,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	Aggresome	"HPA023388: AB_1846020"	"unprognostic (9.79e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-8)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-1)"	0.3	1.1	0.3	0.6	0.3	0.2	2.6	0.1	0.4	4.9	0.1	0.4	1.1	0.3	0.3	13.5	0.6	0.4	0.2	0.3	0.3	0.6	0.3	0.6	0.6	0.5	0.3	0.4	0.4	0.0	0.5	0.2	0.4	2.5	0.0	0.3	3.3	0.0	0.4	14.4	0.8	0.0	0.1	1.5	0.5	1.2	0.4	0.0	0.5	0.0	1.6	1.0	7.3	0.4	1.7	0.4	0.3	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.8	0.6	0.0	1.9	0.2	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	5.2	0.0	0.0	0.1	1.0	0.1	0.0	1.1	0.4	0.0	1.6	0.4	0.1	0.0	6.9	0.8	0.4	10.4	0.0	0.4	0.1	0.3	0.3	0.0	2.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.4	0.3	0.3	0.5	0.3	0.4	0.1	0.4	0.4	0.3	0.0	1.1	1.6	0.1	1.8	4.0	2.1	0.0	0.6	4.5	2.2	0.9	2.8	2.0	0.0	0.0	0.2	0.2	0.1	0.0	0.6	0.7	1.3	0.2	0.9	0.0	0.0	0.9	2.2	0.4	0.5	0.0	1.5	0.0	0.4	0.7	0.0	0.8	0.0	0.8	0.1	0.0	8.2	0.8	0.1	0.3	0.6	1.8	6.5	0.1	1.4	0.0	1.0	11.6	1.8	0.1	0.4	0.1	3.2	0.9	0.3	3.6	0.8	0.0	0.2	0.3	1.3	0.4	5.0	3.0	1.5	0.3	0.7	0.5	3.6
CCDC120	JM11	ENSG00000147144	"Coiled-coil domain containing 120"	Q96HB5	X	49053572-49069857	"Cancer-related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 29.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.9;BEWO: 28.6;HaCaT: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000561			Uncertain	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA000561: AB_2244190"	"unprognostic (1.65e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.34e-3)"	3.1	2.6	5.2	2.1	5.0	2.3	4.4	7.6	6.4	10.6	4.5	5.2	8.7	4.4	5.7	35.9	5.0	2.5	1.8	5.0	4.8	9.1	6.6	4.3	2.0	3.9	4.0	6.3	8.0	3.8	9.3	4.0	3.9	7.7	2.2	2.0	12.0	4.0	0.7	29.3	7.4	1.6	3.0	3.8	6.8	3.4	4.9	2.9	6.0	0.5	3.9	5.3	16.1	3.5	20.9	2.8	4.5	0.2	0.0	0.0	28.6	0.7	1.0	1.5	2.4	6.9	8.7	0.8	3.2	1.2	3.4	19.5	3.4	11.7	0.1	5.4	6.6	2.0	5.0	2.4	1.5	0.1	3.4	2.5	9.0	1.9	0.5	3.1	2.5	5.4	2.9	0.2	0.0	17.5	7.5	0.5	5.1	9.8	0.1	6.6	3.3	2.0	8.8	11.0	6.0	4.7	3.6	7.2	2.2	6.1	17.7	2.8	1.2	0.1	5.2	0.2	0.2	6.6	4.8	0.1	0.2	0.1	0.9	1.1	0.2	0.5	0.3	0.0	0.2	0.2	0.4	0.3	0.0	0.6	0.4	0.3	1.0	0.4	0.1	0.6	0.1	0.1	5.2	5.0	7.6	6.4	5.0	4.8	3.9	4.0	3.9	3.0	4.9	3.5	1.7	6.4	3.1	2.0	2.5	5.1	3.5	7.1	4.0	6.8	8.2	5.6	1.3	4.3	6.0	12.9	4.2	12.7	2.2	5.6	0.0	5.1	0.1	8.5	2.2	2.7	6.0	1.7	4.8	6.5	3.2	2.9	9.7	11.5	0.0	4.9	2.5	2.5	2.3	10.1	6.2	6.2	2.0	1.2	1.5	0.5	2.1	0.9	0.0	2.8	0.4	3.3	2.1	2.5	0.7	14.4	8.3	1.2	1.5	6.3	9.0	3.1	5.0	6.8	0.0	2.6	1.5	1.4	2.4	9.0	9.2	16.8	2.3	2.3	4.6	11.4
CD164L2		ENSG00000174950	"CD164 molecule like 2"	Q6UWJ8	1	27379176-27383333	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 19.9;fallopian tube: 30.0;salivary gland: 13.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 28.5;Endometrial ciliated cells: 53.6;Respiratory ciliated cells: 146.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.2;CAPAN-2: 4.1;HaCaT: 1.9;HBEC3-KT: 2.2;hTCEpi: 2.8;SK-BR-3: 2.6;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062915	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane"	"HPA062915: AB_2684903"	"unprognostic (8.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.64e-5)"		"unprognostic (7.81e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.91e-6)"	"unprognostic (1.33e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.71e-2)"	0.1	0.1	0.3	0.0	0.3	0.0	2.5	0.2	0.4	4.9	1.0	0.2	0.0	0.3	0.5	19.9	30.0	0.1	0.0	0.4	0.3	0.9	0.2	5.1	0.0	2.0	1.5	0.0	0.8	0.8	3.4	0.0	0.6	4.1	0.2	0.0	13.5	0.3	0.0	11.1	0.1	0.0	0.8	0.0	0.7	0.5	0.2	0.9	0.4	0.0	1.8	0.0	9.3	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.1	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	2.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.4	0.3	2.0	1.5	0.6	0.8	0.2	0.4	0.2	0.0	3.7	0.0	0.2	2.9	9.6	12.9	28.5	0.0	5.7	14.4	0.9	0.0	10.1	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.2	53.6	0.5	1.5	0.0	0.0	0.2	0.2	0.1	0.5	0.0	1.0	0.0	0.0	1.1	0.0	0.1	0.0	0.3	0.5	12.2	0.0	0.4	1.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.2	3.4	0.0	0.1	146.1	0.0	0.0	0.1	2.8	0.1	1.0	9.3	2.8	0.0	0.4	0.0	0.5	4.4
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CD82	"IA4, KAI1, R2, ST6, TSPAN27"	ENSG00000085117	"CD82 molecule"	P27701	11	44564427-44620358	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 280.3;Proximal enterocytes: 220.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 536.4"	"Group enriched"	"Detected in all"	6	"B-cells: 310.1;granulocytes: 536.4;T-cells: 173.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 463.8;U-87 MG: 323.3"	"Region enhanced"	"Detected in all"		"white matter: 210.9"	"Low region specificity"	"Detected in all"			"CAB002508, HPA028900, HPA061418"	Supported		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510"	"unprognostic (5.31e-2)"	"unprognostic (4.62e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.30e-2)"	39.2	9.1	47.7	57.3	80.5	140.9	36.6	45.2	48.8	38.8	48.5	24.7	74.1	9.1	31.9	130.9	54.0	39.6	25.6	41.9	51.7	26.1	36.9	87.3	68.5	58.5	74.3	14.9	31.3	7.8	7.5	41.0	49.8	27.5	17.2	4.2	81.1	72.1	23.1	84.2	81.6	16.6	39.6	47.3	62.8	4.5	79.0	45.0	22.4	20.0	82.6	47.6	66.1	67.2	30.0	5.2	35.1	7.2	24.0	98.4	1.2	16.9	132.9	29.4	78.5	2.0	19.6	30.9	20.8	8.1	61.1	118.8	4.6	88.4	59.6	145.4	2.7	220.9	9.3	0.6	21.3	58.8	463.8	142.1	99.2	128.3	62.1	68.4	49.7	26.9	1.6	9.4	247.3	25.0	46.7	97.7	1.1	103.2	2.4	1.5	190.0	43.9	16.8	36.1	1.2	2.0	13.0	162.6	23.0	4.2	161.2	51.3	33.9	94.4	12.5	1.8	179.0	3.6	0.4	0.9	323.3	32.5	56.0	369.9	59.3	110.7	29.9	33.0	51.4	310.1	150.7	70.3	14.9	211.9	51.1	23.1	536.4	50.1	25.0	44.5	173.1	65.9	47.7	80.5	45.2	48.8	41.9	51.7	58.5	74.3	49.8	39.6	79.0	67.2	43.6	48.1	38.8	9.4	112.8	55.1	108.1	149.0	107.6	2.4	68.1	54.7	7.7	58.6	143.8	158.2	2.1	1.3	14.9	17.4	11.7	79.7	2.0	23.1	5.0	41.0	13.2	92.9	0.3	66.7	1.1	29.1	58.6	25.2	280.3	0.7	59.6	32.5	64.3	1.7	0.6	36.8	63.1	26.6	18.2	2.0	40.4	52.3	64.0	3.7	11.0	35.7	0.0	54.3	22.4	86.7	50.3	8.2	16.0	59.1	220.6	2.5	73.0	2.7	13.1	109.0	46.0	2.1	5.9	161.3	67.2	1.4	46.3	0.6	43.1	142.8
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 55.1;skin 1: 64.0;vagina: 30.3"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 65.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.1	0.0	0.1	0.0	0.2	0.2	3.3	0.3	0.2	15.1	0.0	0.0	0.0	0.0	0.5	55.1	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.6	0.0	0.1	8.4	0.1	0.6	64.0	0.1	0.0	0.0	0.1	0.1	18.3	0.2	0.4	0.1	0.0	16.0	0.3	30.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	1.3	0.0	18.9	5.0	3.9	39.3	0.4	0.1	0.3	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.5	0.2	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.1	17.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	2.0	1.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	28.2	0.7	48.3	50.2	0.0	0.1	0.0	0.0	6.0
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin subunit beta 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 3.2;skin 1: 3.9"	"Group enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 16.5;Syncytiotrophoblasts: 58.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HaCaT: 3.1;hTCEpi: 3.2;U-251 MG: 7.5"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	1.1	0.2	0.0	0.1	0.1	0.1	2.4	0.6	0.0	0.1	0.2	0.1	0.2	0.0	0.6	0.0	0.1	0.3	0.1	0.7	0.0	1.5	0.4	0.1	3.2	0.0	0.0	1.1	0.4	2.2	3.9	0.0	0.0	0.1	0.1	0.0	1.1	0.1	0.2	0.2	0.1	0.0	1.1	1.8	0.1	2.2	0.3	0.1	1.0	0.0	0.0	2.7	0.3	0.0	0.6	0.8	0.5	1.8	0.0	0.1	0.5	1.2	3.1	0.0	2.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	3.2	0.2	0.4	1.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	1.0	0.0	0.0	1.1	0.6	0.1	0.0	1.5	1.5	0.0	7.5	0.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.6	0.1	0.6	1.8	0.0	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.0	58.7	0.0	0.0	0.0	0.1
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424171-86456553	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 117.5;skin 1: 88.7;vagina: 53.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 47.4;Basal respiratory cells: 57.5;Basal squamous epithelial cells: 39.9;Club cells: 37.1;Early spermatids: 30.2;Squamous epithelial cells: 167.1;Suprabasal keratinocytes: 54.8;Urothelial cells: 52.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 146.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 210.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		96000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.8	0.1	0.2	0.1	0.6	0.0	4.6	0.4	0.5	22.8	0.1	0.6	0.2	0.0	0.5	117.5	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.7	0.4	2.4	0.7	0.0	13.2	0.2	0.2	88.7	0.8	0.0	0.4	0.0	0.1	0.6	0.3	1.0	0.0	0.0	26.0	21.2	53.1	1.0	0.0	0.0	0.0	0.0	0.6	3.0	38.9	1.7	2.7	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	0.0	33.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	210.8	1.0	10.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.9	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.5	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.7	0.0	47.4	13.1	57.5	39.9	0.0	7.7	2.8	0.4	0.0	37.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.3	4.1	0.0	3.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.5	2.1	0.3	0.0	8.0	0.0	0.0	0.0	0.6	0.2	0.0	167.1	54.8	0.1	0.5	0.0	0.1	52.9
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"		6	106360717-106572017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"esophagus: 61.9;placenta: 72.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.2"	"Low region specificity"	"Detected in many"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	17.0	1.2	0.6	21.9	0.5	24.1	17.3	0.7	0.8	6.8	40.3	25.0	25.4	2.4	6.2	61.9	6.7	8.1	1.0	1.9	0.4	15.3	11.8	9.8	20.4	0.8	0.7	2.3	4.9	5.8	0.4	72.0	0.6	25.2	19.2	0.8	9.3	5.4	1.1	42.1	23.7	4.8	0.5	12.6	10.3	5.1	1.5	9.7	2.6	1.2	33.5	19.0	14.0	0.4	34.7	0.2	0.0	0.1	25.5	93.7	9.9	4.9	33.5	10.8	10.0	2.4	11.5	54.0	2.3	21.7	14.6	54.5	0.2	124.1	5.3	74.0	2.3	0.0	1.5	16.9	12.1	33.4	0.2	44.9	66.7	19.7	95.8	0.1	46.5	41.9	1.7	7.3	28.5	3.5	9.7	10.7	0.4	0.2	21.2	16.4	0.4	0.4	14.9	80.0	2.2	0.2	20.3	31.9	0.3	3.0	16.4	24.3	13.5	11.6	1.5	0.2	34.4	5.7	4.7	57.7	56.0	39.3	26.3	0.3	3.4	0.4	7.4	3.6	10.1	6.6	9.8	8.5	8.6	2.9	5.8	5.7	2.4	4.8	4.1	1.0	9.9	4.0	0.6	0.5	0.7	0.8	1.9	0.4	0.8	0.7	0.6	0.5	1.5	0.4	13.4	12.8	11.9	0.0	24.2	0.0	0.0	0.0	0.0	0.0	31.2	14.1	0.0	0.0	13.0	33.1	0.0	219.4	153.6	0.0	3.9	10.9	0.0	20.2	2.7	4.4	0.0	0.0	0.0	12.5	15.3	2.5	0.0	31.6	1.3	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	26.4	0.0	0.0	89.9	0.0	0.0	15.0	8.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	600.1	76.7	0.1	0.0	0.0
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.2;skin 1: 20.3;vagina: 20.6"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 11.4;BEWO: 23.2;CACO-2: 39.3;CAPAN-2: 25.7;HaCaT: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	10.2	0.0	2.6	6.5	0.0	0.8	48.2	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.0	0.0	0.4	1.9	0.0	6.1	0.0	0.0	20.3	5.9	0.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	4.2	8.4	20.6	0.0	11.4	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.1	0.1	39.3	25.7	0.3	7.7	0.0	0.1	9.7	0.1	6.9	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	1.9	6.3	0.0	0.0	0.0	0.2	0.4	2.5	0.4	0.0	0.0	4.5	0.0	1.7	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	1.8	0.0	6.7	0.9	0.0	1.9	2.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	1.4	4.4	0.1	0.0	2.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.6	1.2	0.0	0.0	0.0
CWH43	"CWH43-C, FLJ21511, PGAP2IP"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986275-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.0;prostate: 42.8;skin 1: 25.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"		"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	6.0	0.0	16.9	0.4	0.6	0.4	21.0	14.5	0.0	0.0	0.0	0.0	9.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	42.8	15.6	0.0	3.0	7.7	0.0	25.5	0.0	0.8	0.1	0.0	9.6	0.0	0.1	0.1	10.2	0.0	1.5	2.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.9	0.1	0.8	0.0	0.0	0.6	0.1	0.6	0.0	2.3	7.3	0.0	0.0	0.0	10.4	1.9	0.0	0.2	41.3	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.7	21.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.4	0.0	0.0	7.6	0.0	2.9	29.5	0.0	0.0	0.0	0.5	0.0	0.5	3.2	9.1	0.0	0.2	0.0	15.0	0.3
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 90.9;HBEC3-KT: 70.1;RT4: 93.5;T-47d: 103.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		4400000	"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	26.5	50.4	24.1	5.3	49.5	0.4	54.6	47.9	20.2	55.2	4.8	57.7	12.3	23.4	4.5	150.1	46.2	11.4	42.1	17.5	40.7	96.8	6.3	33.7	1.2	68.7	47.3	41.5	99.7	19.7	67.9	4.2	57.9	70.2	10.7	4.5	131.7	13.8	40.5	121.1	47.3	1.1	38.8	11.5	71.1	16.5	46.3	7.0	85.9	4.3	3.0	45.0	88.4	58.9	58.2	18.5	26.0	5.4	1.7	2.4	16.2	1.4	0.4	0.8	0.1	25.2	29.8	0.5	30.9	5.1	26.8	90.9	5.7	70.1	0.3	32.0	9.9	0.2	18.7	6.7	5.0	0.0	1.2	3.3	35.4	0.4	0.5	16.1	2.0	1.4	17.3	0.7	4.0	36.5	2.0	0.1	4.5	31.8	3.8	3.9	19.5	2.2	13.1	93.5	4.7	2.5	5.4	41.4	19.4	8.6	103.0	0.6	4.3	12.8	11.7	1.2	13.6	0.8	0.1	2.6	8.4	0.0	11.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	24.1	49.5	47.9	20.2	17.5	40.7	68.7	47.3	57.9	38.8	46.3	58.9	1.9	35.3	24.6	54.5	3.8	53.0	68.3	125.5	67.2	7.4	77.0	57.9	18.0	37.1	79.8	90.1	0.0	63.6	1.5	109.7	5.9	125.5	15.1	58.5	6.5	4.1	46.2	2.7	1.2	76.2	26.0	7.4	63.7	58.4	1.3	29.5	2.2	0.6	6.1	6.7	7.5	69.8	109.9	0.8	5.4	30.1	8.4	2.5	16.0	9.4	13.1	139.9	1.0	60.3	73.8	71.5	78.2	5.3	0.8	68.1	77.3	5.4	104.2	8.0	6.6	10.5	11.9	1.5	6.8	81.8	51.9	46.5	1.9	4.1	67.1	88.4
DEFB103B		ENSG00000177243	"Defensin beta 103B"	P81534	8	7428888-7430348	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP5	HVH3	ENSG00000138166	"Dual specificity phosphatase 5"	Q16690	10	110497907-110511533	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 175.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 409.1;Langerhans cells: 298.4;Plasma cells: 412.2;Urothelial cells: 1063.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 10.3;plasmacytoid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 408.0;Karpas-707: 161.2;U-266/70: 227.8"	"Region enhanced"	"Detected in all"		"cerebellum: 60.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 45.4"							NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.25e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (8.30e-6)"	"unprognostic (1.70e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	38.8	37.6	8.5	26.8	8.6	38.5	26.6	26.1	17.3	39.4	13.3	22.3	12.2	19.7	2.0	115.5	12.7	51.4	34.1	17.9	12.4	26.4	25.6	23.2	12.8	7.7	9.3	7.6	8.0	6.7	20.0	48.3	7.4	17.7	26.3	9.8	23.4	12.5	2.7	16.9	19.5	21.1	8.3	28.4	26.5	20.1	10.7	14.9	18.8	3.7	32.5	175.7	37.9	7.9	22.0	14.6	3.0	7.3	11.1	46.5	10.6	50.9	114.6	26.8	32.2	9.4	28.9	2.6	9.4	12.4	56.9	7.0	2.8	26.7	43.2	62.8	1.8	12.1	2.6	5.8	41.8	3.2	15.1	17.9	35.9	85.7	408.0	11.8	17.1	1.2	2.1	161.2	81.4	5.9	0.9	9.2	9.6	2.1	22.2	0.2	6.3	38.8	92.0	42.3	1.6	4.0	3.3	8.0	17.4	25.6	4.5	3.8	26.5	9.0	6.2	21.7	24.7	227.8	44.7	6.2	34.9	16.4	6.4	0.5	0.2	0.0	3.5	2.2	1.3	0.2	1.8	1.0	0.9	0.0	0.1	1.0	0.2	0.0	10.3	14.5	0.1	0.6	8.5	8.6	26.1	17.3	17.9	12.4	7.7	9.3	7.4	8.3	10.7	7.9	150.7	3.2	7.8	0.3	71.2	66.0	409.1	91.4	30.7	9.0	72.7	77.0	33.5	11.5	78.3	35.0	6.2	44.0	97.7	63.5	5.9	29.1	1.5	50.6	32.2	90.8	48.9	0.4	4.4	4.8	11.2	42.7	39.3	196.6	3.8	5.5	158.5	4.1	10.7	0.0	2.2	12.8	22.4	16.6	298.4	3.3	1.5	91.5	158.3	1.0	46.9	2.3	4.1	1.0	0.0	49.1	93.2	0.7	412.2	127.0	44.4	0.6	27.3	12.6	0.0	25.8	37.3	1.2	19.8	61.8	101.9	137.4	122.0	3.3	9.2	1063.2
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484683	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.1;esophagus: 20.8;vagina: 32.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 239.7;Basal respiratory cells: 137.3;Club cells: 146.1;Collecting duct cells: 69.9;Prostatic glandular cells: 62.5;Proximal enterocytes: 91.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.8;EFO-21: 35.9;HeLa: 13.0;SCLC-21H: 16.8;SK-BR-3: 41.2;U-2 OS: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.3	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	26.1	1.0	1.9	3.9	3.1	4.7	20.8	1.6	0.2	1.4	0.1	0.0	7.4	1.2	3.7	0.0	0.1	0.1	0.1	2.4	0.0	2.1	0.0	0.1	7.5	0.9	0.2	8.0	0.5	0.2	15.0	17.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.0	0.3	2.4	32.7	0.1	0.2	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	13.8	0.0	35.9	0.0	0.0	1.7	0.0	0.1	0.0	4.2	0.0	0.0	13.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.8	0.4	0.0	0.0	1.3	8.4	9.4	0.9	16.8	0.0	0.3	41.2	0.0	0.9	0.8	0.0	0.0	0.0	15.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	6.4	1.5	0.0	0.0	30.3	239.7	137.3	8.6	0.1	2.5	1.3	0.7	2.8	146.1	69.9	0.0	0.2	0.1	23.3	0.0	8.8	0.0	36.9	0.5	0.6	1.8	0.0	0.0	1.0	0.0	1.8	3.1	6.5	0.0	0.3	0.0	0.2	0.0	0.0	0.0	4.2	38.7	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.9	2.7	0.0	0.1	62.5	91.7	1.6	20.9	0.0	0.0	0.4	3.5	0.0	0.2	2.4	29.1	0.0	0.7	0.8	8.2	45.2
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572824-7579006	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		4100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	500.5	373.3	110.2	296.5	113.4	416.2	354.2	118.1	129.6	287.0	116.7	260.6	199.7	290.3	196.6	566.2	307.9	229.5	229.7	112.7	123.9	274.2	328.3	339.0	286.3	128.9	119.1	302.8	360.5	150.4	190.2	301.9	125.9	219.2	289.5	118.5	268.6	168.7	281.2	375.5	228.9	316.6	122.9	291.4	313.2	159.8	131.2	309.3	171.4	122.4	385.2	506.9	321.6	131.5	1048.3	1396.3	914.1	833.9	802.7	931.9	852.4	977.9	1104.0	1770.4	1356.8	1420.1	457.7	1428.7	735.7	1032.2	774.7	907.6	1962.5	1505.4	1890.2	468.1	1454.0	799.3	854.7	1597.9	1226.2	826.4	771.9	1244.8	763.3	1491.8	1510.3	1055.1	1351.6	784.4	831.1	284.9	1294.2	1092.6	865.0	704.8	789.1	1068.6	952.6	802.1	691.1	682.2	1249.8	939.1	481.2	934.2	883.0	585.6	1273.8	679.4	651.5	625.1	976.1	930.2	649.9	603.8	2010.9	276.0	425.7	921.2	1000.8	999.3	1045.7	318.5	1639.1	408.1	463.4	1377.5	755.2	469.1	493.1	497.9	1905.9	412.2	477.7	488.1	157.1	658.5	1076.3	727.7	682.0	2945.6	110.2	113.4	118.1	129.6	112.7	123.9	128.9	119.1	125.9	122.9	131.2	131.5	212.3	115.4	239.6	0.0	139.7	1342.5	678.5	1913.6	173.0	113.5	191.0	183.4	6.8	104.4	799.6	73.5	116.7	345.6	185.8	100.5	152.6	295.4	32.4	120.7	171.6	286.1	116.1	139.6	0.0	231.4	370.5	299.2	129.5	165.0	149.1	237.5	154.2	63.8	212.1	106.0	0.0	117.3	767.0	160.4	1330.1	42.0	160.9	206.7	725.7	0.0	133.3	120.7	119.4	0.0	0.0	313.9	123.3	109.1	134.7	342.8	151.8	174.0	446.1	119.4	151.2	374.4	871.4	71.5	102.8	154.0	1233.4	636.9	224.2	197.1	135.9	474.6
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ETS transcription factor ELK3"	P41970	12	96194375-96269824	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 170.7;Endothelial cells: 148.0;Hepatic stellate cells: 160.6;Respiratory ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	37.1	14.4	5.4	34.2	6.1	18.4	28.4	14.4	5.8	28.0	11.7	15.6	9.2	35.2	9.3	38.1	16.9	30.2	23.9	4.7	7.2	14.0	10.8	27.5	38.0	9.1	7.9	10.2	9.0	11.6	5.8	27.0	7.9	13.1	13.9	2.9	15.3	15.3	11.2	12.5	13.5	37.9	7.0	41.8	14.8	8.6	8.3	19.7	21.8	22.2	37.5	29.2	24.5	6.6	50.3	29.5	29.7	15.8	73.7	137.3	7.6	62.3	118.5	48.6	37.3	1.7	36.6	8.0	20.9	70.4	36.4	17.6	3.3	99.8	85.0	21.7	11.4	2.5	12.2	11.2	22.3	24.2	5.7	81.3	18.4	100.4	75.4	98.5	117.8	6.0	6.0	32.3	166.4	7.6	4.8	16.4	36.3	7.1	38.8	39.7	49.8	9.1	41.7	13.0	1.4	31.4	20.5	9.1	32.0	44.7	5.0	13.3	73.2	132.4	52.2	82.5	54.8	61.7	55.0	1.8	47.0	28.2	94.1	7.1	23.5	0.5	11.1	13.0	42.5	23.2	25.7	15.0	17.7	19.0	15.4	11.4	7.4	20.1	12.1	7.1	45.4	12.8	5.4	6.1	14.4	5.8	4.7	7.2	9.1	7.9	7.9	7.0	8.3	6.6	170.7	6.4	22.3	3.9	22.3	32.6	44.6	15.0	10.8	0.7	7.1	8.1	6.6	2.8	39.4	5.5	4.2	1.2	27.5	2.1	5.9	21.8	1.0	49.0	19.7	148.0	1.2	12.4	4.2	15.6	3.9	35.2	3.1	44.0	17.1	1.3	160.6	4.3	24.5	0.0	1.9	3.4	2.0	32.0	39.7	2.5	11.5	31.4	12.4	39.4	23.6	5.8	9.2	5.5	5.3	56.8	3.4	10.5	29.5	45.7	0.5	0.7	103.1	0.6	13.1	27.7	19.9	0.2	12.6	24.4	27.0	1.1	32.6	10.6	3.0	79.0
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 230.6"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	56.8	9.7	15.5	12.4	15.5	0.7	49.5	14.8	17.1	51.0	18.6	48.0	15.5	25.9	45.5	152.1	35.5	17.7	64.1	13.6	15.6	20.3	83.2	230.6	5.7	16.1	16.8	54.9	13.7	32.8	13.3	23.0	16.0	38.8	34.1	2.0	39.2	17.3	22.5	140.6	28.3	22.3	15.2	16.0	39.1	7.2	18.8	5.3	27.7	25.4	32.8	39.6	72.9	15.7	28.7	39.1	15.9	18.9	35.0	30.0	31.3	40.0	36.8	23.9	35.7	128.5	98.2	0.2	12.6	48.4	17.2	123.9	41.1	49.8	31.3	0.1	26.1	0.1	76.6	72.1	6.1	0.2	0.4	18.4	13.1	31.9	3.2	5.4	10.1	0.1	9.6	2.6	66.9	268.1	0.4	0.6	18.3	46.4	9.5	7.5	18.2	61.7	5.5	182.0	22.0	25.0	49.6	256.2	15.2	45.2	156.6	6.2	5.7	75.5	32.2	25.6	22.7	0.8	1.0	0.2	33.2	0.5	75.7	1.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.1	0.3	0.3	0.3	0.2	0.1	15.5	15.5	14.8	17.1	13.6	15.6	16.1	16.8	16.0	15.2	18.8	15.7	239.7	4163.5	368.4	13.1	3.1	356.9	137.9	172.2	111.0	2.3	105.0	94.0	53.1	100.1	255.8	42.3	0.0	74.2	3.1	119.5	0.0	3.8	8.0	78.8	30.9	183.9	104.9	0.0	0.7	67.0	17.8	152.7	46.4	51.9	36.7	68.7	161.0	235.1	10.1	0.0	0.6	207.8	81.4	19.6	136.5	9.3	190.7	17.0	87.2	41.2	33.6	5.7	0.0	22.6	0.6	32.9	158.4	276.1	1.6	86.0	21.0	0.2	142.8	2.2	52.6	256.3	129.3	5.7	12.9	319.5	1174.3	48.0	9.3	73.3	178.5	221.4
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.9;skin 1: 76.5;vagina: 36.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.5;Club cells: 19.3;Squamous epithelial cells: 30.7;Suprabasal keratinocytes: 43.3;Urothelial cells: 23.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	19	"dendritic cells: 1.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;NTERA-2: 2.3;OE19: 8.4;SuSa: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.5	0.3	0.8	0.2	0.8	0.2	1.5	0.6	0.9	14.7	0.7	0.2	0.2	0.4	0.3	68.9	1.7	1.3	0.5	0.7	0.9	3.3	0.3	1.7	0.1	0.9	0.8	0.7	0.2	3.0	1.8	0.4	0.8	1.5	0.2	0.2	7.6	0.9	0.4	76.5	0.3	0.4	0.8	2.6	0.8	2.1	0.9	1.7	0.4	0.1	26.7	8.6	36.6	0.8	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	2.3	8.4	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.2	0.8	0.8	0.6	0.9	0.7	0.9	0.9	0.8	0.8	0.8	0.9	0.8	0.2	0.0	1.1	0.0	0.2	7.0	2.6	15.5	0.0	0.4	0.9	0.6	0.5	5.7	19.3	5.5	0.0	1.6	0.0	0.1	1.9	0.5	0.2	0.7	0.4	0.6	0.0	0.0	0.1	0.0	3.4	0.6	0.0	1.7	0.0	0.4	1.1	0.0	0.6	0.0	0.1	0.1	2.0	3.2	1.4	0.0	0.0	1.5	0.0	0.0	0.6	2.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.6	0.2	0.0	3.3	0.0	0.0	0.8	2.5	4.6	2.1	30.7	43.3	2.6	0.2	0.2	0.1	23.3
EPS8L1	"DRC3, FLJ20258, MGC23164, MGC4642"	ENSG00000131037	"EPS8 like 1"	Q8TE68	19	55072020-55087923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 124.3;skin 1: 59.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 104.1;Gastric mucus-secreting cells: 108.1;Paneth cells: 110.2;Syncytiotrophoblasts: 428.0;Urothelial cells: 189.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 17.6;BEWO: 58.8;SK-BR-3: 19.6;T-47d: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041851, HPA043545"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA041851: AB_2677706, HPA043545: AB_2678544"	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (7.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.63e-1)"	4.5	0.2	0.0	0.9	0.1	0.1	4.0	0.0	0.1	24.0	0.0	3.5	2.3	1.5	0.0	124.3	14.8	0.9	0.6	0.1	0.0	25.1	0.7	3.9	0.0	0.1	0.1	0.5	5.6	2.1	2.1	5.4	0.1	9.2	0.6	0.0	20.4	2.5	0.5	59.7	2.0	0.0	0.0	0.6	27.0	0.6	0.2	0.1	17.4	0.0	1.6	2.7	37.1	0.2	17.6	0.7	0.6	0.4	0.0	0.0	58.8	1.5	0.1	0.0	0.1	7.6	13.7	0.3	3.4	0.0	0.1	9.7	0.4	2.1	0.0	0.3	1.6	1.3	0.6	0.5	0.2	2.6	10.8	0.0	3.6	0.0	0.0	0.0	0.0	1.2	6.2	0.1	0.0	8.0	0.9	2.6	0.8	12.7	0.0	0.1	0.0	5.4	2.7	3.6	0.2	3.8	1.0	19.6	0.8	0.6	28.9	3.2	1.3	0.0	0.7	0.0	0.0	2.4	3.1	1.6	3.3	0.9	2.0	1.1	0.2	2.3	0.3	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	4.0	9.6	6.1	0.3	0.8	2.0	28.4	39.5	8.6	0.0	16.3	15.1	2.6	8.6	92.2	31.3	0.0	55.1	4.0	104.1	13.7	20.4	1.6	29.1	6.3	10.7	3.0	0.0	0.1	10.2	26.8	4.7	108.1	41.7	10.2	5.4	10.0	0.1	8.9	0.0	0.1	39.0	24.4	1.9	3.4	4.5	1.2	2.6	21.4	0.0	5.2	0.2	6.2	0.0	0.1	94.5	110.2	0.7	1.0	48.7	12.7	1.1	53.6	0.6	26.3	0.5	21.6	1.6	3.6	6.6	4.0	428.0	2.8	0.3	22.1	189.4
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027306	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 281.2;skin 1: 147.4;vagina: 101.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.7;Squamous epithelial cells: 94.1;Suprabasal keratinocytes: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 59.8;MCF7: 40.4;RT4: 87.8;SK-BR-3: 43.2;T-47d: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Cytosol	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	1.3	0.3	0.6	1.0	0.6	2.5	2.6	1.1	1.0	47.5	0.8	8.9	11.0	1.5	1.7	281.2	2.1	1.7	0.2	0.6	0.3	17.0	0.3	9.4	0.6	2.8	1.3	0.3	4.0	3.4	1.5	0.3	2.8	8.0	1.5	0.6	42.3	1.8	1.4	147.4	9.1	1.0	0.5	0.3	5.2	0.8	0.6	0.4	10.7	0.1	7.9	12.7	101.9	1.5	28.1	23.4	0.0	0.3	0.2	0.0	9.6	0.2	0.0	0.0	0.0	2.6	16.7	0.0	0.1	0.0	0.0	59.8	0.1	7.8	0.1	0.1	0.2	0.7	19.4	17.4	0.0	0.2	4.2	0.2	12.3	0.2	0.0	0.0	0.0	3.7	0.1	1.1	0.0	40.4	1.0	3.6	0.1	11.9	10.5	11.5	0.1	0.4	16.7	87.8	1.1	0.0	11.4	43.2	0.0	0.2	54.1	0.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.6	0.6	1.1	1.0	0.6	0.3	2.8	1.3	2.8	0.5	0.6	1.5	0.2	19.2	19.5	0.0	0.0	11.7	4.7	10.5	26.7	0.3	5.1	2.9	3.7	4.3	16.5	5.5	0.0	0.2	0.2	10.8	1.9	4.4	0.0	4.3	0.6	0.3	20.4	1.3	0.3	0.5	0.2	0.5	12.8	8.9	12.6	0.2	0.0	0.0	0.0	0.0	0.1	5.7	2.0	0.6	2.1	0.1	0.9	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.1	8.4	7.4	1.9	1.2	4.6	19.3	3.4	13.1	0.1	0.0	0.7	0.7	0.1	1.2	94.1	25.9	0.0	0.4	0.4	15.5	12.9
FAM25C	bA164N7.4	ENSG00000276430	"Family with sequence similarity 25 member C"	B3EWG5	10	47995322-47999791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 14.8;esophagus: 30.1;salivary gland: 15.4;skin 1: 43.6;vagina: 13.4"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 1.3;Basal respiratory cells: 3.0;Suprabasal keratinocytes: 3.1"	"Cancer enriched"	"Detected in single"	5	"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 10.7"									HPA044808	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA044808: AB_2679096"		"unprognostic (2.93e-1)"				"unprognostic (2.21e-1)"												0.1	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.1	14.8	0.0	0.3	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	43.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.4	0.0	13.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	3.1	0.0	0.0	0.0	0.0	0.0
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292425	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 33.3;skin 1: 42.3;vagina: 15.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 27.9;Basal squamous epithelial cells: 17.6;Early spermatids: 11.8;Squamous epithelial cells: 26.1;Suprabasal keratinocytes: 64.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 9.9;head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 28: Keratinocytes - Keratinization"			"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.2	5.3	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.2	0.0	0.1	42.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.1	0.6	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	27.9	1.1	0.0	17.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	6.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.3	1.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	26.1	64.2	0.0	0.0	0.0	0.1	1.9
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.4;urinary bladder: 84.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 51.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	56.4	11.2	1.2	7.7	1.3	26.8	10.5	2.2	4.3	6.0	1.0	7.4	1.0	3.5	0.1	48.9	8.5	29.6	11.9	1.6	1.7	12.6	5.6	16.7	0.3	1.9	1.4	1.7	12.9	0.5	4.8	2.7	2.1	6.4	1.9	0.6	11.0	0.8	4.1	25.2	5.5	4.7	1.0	1.7	21.0	0.9	1.9	2.7	5.3	0.3	2.1	84.3	13.8	1.0	324.3	43.8	5.4	20.4	45.7	44.4	45.0	288.5	257.2	239.7	131.7	14.2	252.6	0.5	65.1	199.7	379.6	60.6	19.6	227.4	210.8	9.7	0.7	20.6	4.5	34.9	57.0	13.3	6.9	18.8	23.1	191.1	297.1	117.9	80.4	0.2	48.8	1.7	320.9	12.3	0.3	26.5	21.5	27.0	829.4	1.5	25.7	1.3	116.7	20.4	0.4	0.5	18.2	0.8	229.0	13.0	1.0	12.1	200.6	282.5	62.7	520.1	423.8	0.3	1.4	0.9	389.7	4.9	1123.6	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.2	0.1	3.4	0.0	0.2	0.0	0.5	0.0	0.3	0.4	0.0	0.5	1.2	1.3	2.2	4.3	1.6	1.7	1.9	1.4	2.1	1.0	1.9	1.0	15.2	6.4	4.4	0.3	2.0	338.0	398.5	56.2	281.1	0.0	27.6	12.2	1.0	4.3	26.2	0.0	0.0	1.3	4.3	11.8	0.0	25.1	0.3	24.4	12.2	30.1	11.3	0.8	0.1	3.5	4.3	45.8	74.9	56.3	9.5	0.3	6.1	0.4	1.9	0.0	0.1	6.8	10.2	1.0	46.6	0.0	0.3	15.5	44.4	1.0	1.1	0.1	0.0	0.5	0.2	39.0	11.1	0.0	6.2	196.9	1.2	0.2	10.7	0.0	0.0	32.4	26.1	0.4	0.7	210.4	339.5	17.6	6.8	0.1	4.2	456.4
FRMD6	"C14orf31, EX1, MGC17921, willin"	ENSG00000139926	"FERM domain containing 6"	Q96NE9	14	51489100-51730727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 160.6;Early spermatids: 219.1;Late spermatids: 473.0;Suprabasal keratinocytes: 137.5;Urothelial cells: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 351.1;fHDF/TERT166: 765.6;U-138 MG: 290.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001297	Uncertain	Supported	Approved	Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA001297: AB_1078913"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.05e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.28e-4)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.20e-2)"	12.1	13.4	5.2	9.5	5.2	1.2	27.1	12.6	6.7	28.1	8.4	16.0	5.2	53.6	11.3	59.8	13.4	33.0	7.3	6.4	4.5	4.2	10.4	8.6	5.5	5.7	8.1	25.9	5.0	2.4	3.4	14.1	4.9	27.7	10.8	1.5	21.5	30.7	7.4	43.2	7.5	46.8	5.4	12.0	7.2	31.0	5.8	12.6	6.6	6.8	12.7	31.5	30.1	5.6	71.4	14.1	20.1	42.1	40.1	67.6	8.8	351.1	163.2	169.5	146.0	51.9	16.4	1.9	10.6	765.6	47.6	82.8	5.7	113.8	200.3	1.1	8.6	0.3	7.6	2.2	46.8	0.2	4.2	58.8	40.9	152.0	200.5	77.8	52.6	3.7	0.7	24.6	181.8	12.2	7.1	0.2	3.9	0.2	27.4	0.8	79.1	0.7	33.4	113.7	4.1	44.9	27.8	3.9	31.3	37.7	3.0	1.0	242.6	290.7	97.6	73.3	73.5	18.9	17.3	0.2	19.3	0.3	114.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.0	0.1	5.2	5.2	12.6	6.7	6.4	4.5	5.7	8.1	4.9	5.4	5.8	5.6	6.9	3.2	1.5	34.6	0.8	111.4	160.6	42.4	41.5	0.4	40.5	49.4	2.9	8.6	11.6	0.0	0.0	40.1	1.5	0.0	0.0	16.9	219.1	2.0	41.1	14.4	0.0	2.5	45.2	2.9	4.8	57.8	1.1	3.6	1.3	0.9	9.3	4.2	3.8	0.0	22.5	0.3	10.2	0.3	21.1	473.0	17.7	1.5	32.0	68.4	0.7	8.2	0.0	74.9	5.9	64.0	0.0	22.2	3.7	52.0	0.1	0.4	2.7	0.5	6.6	24.5	28.0	10.2	9.8	115.7	137.5	39.0	3.3	0.9	0.1	130.7
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.7;skin 1: 9.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	0.7	0.1	0.7	0.1	0.6	0.0	0.8	1.2	0.6	6.5	0.2	0.3	0.1	2.8	0.9	16.7	1.4	1.6	0.2	0.6	0.6	0.6	0.0	0.8	0.4	1.2	1.0	2.9	0.1	0.0	0.9	2.3	1.1	2.9	0.2	0.4	4.2	1.5	1.0	9.4	0.4	0.4	0.7	0.0	0.4	0.1	2.7	0.3	1.0	0.8	0.7	2.6	6.8	1.1	0.0	0.0	5.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	1.2	0.6	0.6	0.6	1.2	1.0	1.1	0.7	2.7	1.1	0.4	0.0	0.5	0.0	0.0	8.4	4.7	0.1	12.5	0.1	0.6	0.8	0.6	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	2.1	2.1	0.0	0.0	0.0	0.2	0.6	8.4	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	13.1	9.3	0.0	0.4	25.5	8.5	0.8	0.1	0.0	0.0	1.8
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"esophagus: 101.0;skin 1: 95.1;vagina: 35.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 48.6;Basal prostatic cells: 38.0;Basal respiratory cells: 49.6;Squamous epithelial cells: 63.8;Suprabasal keratinocytes: 83.5;Urothelial cells: 66.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 36.7;head and neck cancer: 57.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 29.1;HaCaT: 90.8;HBEC3-KT: 40.7;hTCEpi: 147.4;RT4: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.2	0.1	1.0	0.0	1.0	0.0	3.9	0.6	1.3	12.8	0.0	0.1	0.0	0.1	3.4	101.0	0.6	3.4	0.1	1.4	0.3	0.1	0.4	0.3	0.0	0.4	0.4	0.1	1.1	0.0	0.8	0.6	0.5	5.2	0.1	0.0	13.9	3.1	0.3	95.1	0.2	0.0	0.6	0.1	0.1	2.3	0.7	1.4	0.9	0.1	12.6	7.1	35.0	0.9	29.1	0.3	0.1	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	2.2	0.0	1.2	0.0	0.3	90.8	0.0	40.7	0.0	0.1	0.0	7.0	0.9	0.0	0.0	0.0	0.0	0.1	147.4	0.0	23.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	50.9	0.1	0.0	3.6	1.5	0.0	0.4	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.3	1.4	0.3	0.4	0.4	0.5	0.6	0.7	0.9	0.0	0.0	1.1	0.3	0.0	48.6	38.0	49.6	12.5	0.0	2.8	1.9	0.5	0.0	17.2	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	4.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.5	0.0	0.0	12.4	0.0	0.0	0.0	1.4	0.0	0.0	63.8	83.5	0.4	0.2	0.0	0.3	66.2
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316820	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 32.8;vagina: 23.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.1	0.8	10.0	2.9	0.0	0.0	0.0	3.2	35.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.6	0.0	4.3	0.0	0.0	13.7	5.5	0.1	32.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.5	0.0	0.0	12.4	13.2	23.8	0.4	110.8	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.2	0.0	40.8	0.0	0.0	0.0	0.6	90.6	0.0	116.7	1.1	0.0	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	152.8	0.1	62.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	6.1	0.0	0.0	0.0	3.8	46.7	0.0	0.0	19.0	0.5	0.0	3.1	0.4	0.1	0.0	0.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	1.0	0.0	59.3	139.2	150.0	46.7	0.0	2.8	1.8	0.1	0.0	49.9	3.7	0.0	59.0	0.4	0.0	0.0	1.2	0.7	3.3	0.0	1.5	0.0	0.0	1.1	0.7	8.7	1.1	0.0	2.4	1.3	0.0	0.0	0.0	4.2	0.0	0.4	0.0	28.5	0.0	3.6	0.1	0.0	0.6	10.6	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	0.0	0.0	60.6	0.0	0.1	19.6	0.0	0.0	0.0	4.1	0.0	0.0	52.7	68.2	205.0	0.9	0.0	0.0	211.4
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.6;skin 1: 87.7;vagina: 66.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Cytotrophoblasts: 61.9;Extravillous trophoblasts: 80.5;Suprabasal keratinocytes: 132.7;Syncytiotrophoblasts: 184.6;Urothelial cells: 104.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 212.3;RT4: 41.4;SK-BR-3: 112.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	4.5	1.3	2.2	1.2	2.3	8.7	39.8	0.8	2.8	31.0	1.0	1.5	1.2	1.0	7.3	119.6	2.2	3.0	2.5	2.7	2.5	4.0	12.2	5.0	1.0	0.8	1.5	0.4	4.2	29.0	3.6	26.7	0.9	11.4	1.0	11.4	44.7	7.3	1.1	87.7	0.7	0.7	0.6	0.8	3.7	3.2	4.3	0.9	2.9	0.4	26.1	13.9	66.9	1.7	10.9	0.2	1.2	3.0	0.4	0.5	212.3	1.0	1.5	0.7	1.2	0.9	7.5	1.4	0.4	0.1	1.5	6.5	13.0	1.4	3.1	3.2	5.9	0.3	2.3	4.3	0.3	0.7	1.2	0.4	5.5	6.0	0.0	0.0	1.1	2.3	2.2	4.1	0.0	14.3	2.2	1.7	0.8	3.5	2.5	0.9	1.0	1.9	1.4	41.4	2.4	1.6	2.0	112.3	2.7	17.4	13.7	0.4	1.2	0.6	2.6	3.3	1.3	2.7	1.7	1.5	0.6	1.7	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	1.7	2.2	2.3	0.8	2.8	2.7	2.5	0.8	1.5	0.9	0.6	4.3	1.7	2.2	3.2	8.1	3.9	1.2	40.0	23.1	10.7	2.8	25.5	37.1	19.9	2.1	1.5	31.1	20.2	62.6	61.9	1.3	1.2	0.0	2.9	6.4	4.5	1.3	4.2	3.5	0.0	14.6	9.1	80.5	5.4	3.1	9.6	10.2	0.4	2.5	7.7	7.7	11.8	6.0	0.8	4.1	1.0	15.7	3.0	0.0	10.6	21.4	1.9	1.0	1.1	0.0	4.0	1.0	5.7	0.1	0.4	1.0	31.5	0.1	2.4	18.6	11.5	0.0	3.0	3.7	9.6	5.1	35.2	132.7	184.6	2.1	0.1	1.2	104.6
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319357-24364482	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 120.8;skin 1: 53.5;vagina: 47.7"	"Group enriched"	"Detected in some"	5	"Squamous epithelial cells: 113.5;Suprabasal keratinocytes: 99.3;Urothelial cells: 78.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 13.3;head and neck cancer: 16.1;urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 46.1;HaCaT: 36.6;MCF7: 58.5;OE19: 21.2;RT4: 64.8;SuSa: 33.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.2	0.1	0.4	0.3	0.4	0.1	1.9	1.4	0.6	23.3	0.1	0.1	0.6	0.1	1.6	120.8	0.6	0.7	0.0	0.3	1.3	0.2	0.3	0.1	0.0	3.8	4.6	0.0	0.2	0.9	0.2	1.4	3.4	1.5	0.2	0.1	16.7	1.6	0.1	53.5	0.3	0.0	2.3	0.0	0.5	2.3	0.8	1.0	0.0	0.0	25.1	34.7	47.7	1.9	1.2	2.7	1.0	0.0	0.0	0.0	46.1	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	36.6	0.1	3.3	0.0	1.2	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	14.2	0.2	2.7	0.0	0.0	0.0	0.2	0.1	0.0	58.5	0.0	0.2	2.4	21.2	0.0	0.0	0.0	0.2	4.6	64.8	0.3	0.0	0.2	6.3	0.0	33.3	4.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.4	0.6	0.3	1.3	3.8	4.6	3.4	2.3	0.8	1.9	0.0	0.0	0.6	0.0	0.0	14.4	13.2	5.2	8.6	0.0	1.1	0.3	0.5	0.0	6.4	1.8	0.0	4.1	0.0	0.9	0.0	0.4	0.5	3.8	0.1	0.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.1	2.0	0.3	2.1	0.3	0.0	0.3	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.1	0.2	0.0	3.3	0.0	0.0	0.0	0.3	2.6	0.0	113.5	99.3	18.5	0.0	0.0	0.1	78.4
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786624	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 33.1;lymphoid tissue: 12.8;skin 1: 25.5;vagina: 11.4"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 46.5;Basal squamous epithelial cells: 37.5;Squamous epithelial cells: 29.5;Suprabasal keratinocytes: 53.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.8;head and neck cancer: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 3.7;hTCEpi: 1.8;HUVEC TERT2: 2.0;TIME: 5.8"					"Low region specificity"	"Detected in many"			"HPA023670, HPA024767, HPA026317"	Supported		Approved	Mitochondria		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.1	33.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	5.4	0.0	0.0	25.5	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.4	11.4	0.1	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.0	1.0	0.0	46.5	0.9	7.4	37.5	0.0	1.5	0.9	3.6	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.1	0.0	3.9	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.1	29.5	53.1	0.0	0.1	0.0	0.0	2.8
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105653-69118719	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.5;urinary bladder: 92.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 162.3;Basal prostatic cells: 51.6;Basal respiratory cells: 107.1;Suprabasal keratinocytes: 158.6;Urothelial cells: 115.5"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 52.5;PC-3: 270.5;RT4: 111.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA031554, CAB033850"	Supported		Approved	Microtubules		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"	Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.8	0.5	0.9	0.7	1.2	0.9	7.5	1.3	1.3	4.6	0.9	5.3	2.9	0.9	1.1	33.5	1.2	4.8	0.7	0.6	1.1	1.1	1.3	20.1	0.4	1.0	1.3	1.4	1.3	0.4	1.7	3.4	1.1	3.7	3.1	0.8	5.4	1.5	1.2	9.7	2.2	0.6	0.4	0.8	12.8	3.5	1.0	0.5	5.9	0.9	2.8	92.8	10.3	1.0	3.5	17.1	1.0	0.9	0.3	0.4	6.6	1.1	0.4	1.0	0.4	3.4	9.0	0.7	2.0	0.4	4.0	52.5	2.9	31.5	1.0	0.2	1.3	0.0	0.2	0.6	0.1	0.3	0.9	0.5	8.6	1.0	3.0	4.0	0.7	0.6	0.1	0.4	0.3	1.8	1.2	0.7	15.5	18.7	270.5	2.0	0.1	0.2	28.3	111.6	19.2	0.8	1.8	0.1	0.3	3.1	0.6	0.8	0.3	0.9	0.9	29.9	1.8	1.0	0.9	0.2	1.0	0.0	0.6	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.9	1.2	1.3	1.3	0.6	1.1	1.0	1.3	1.1	0.4	1.0	1.0	4.2	0.0	30.8	0.7	0.2	162.3	51.6	107.1	8.6	1.1	1.6	6.1	1.4	0.0	12.2	0.0	2.1	1.0	0.1	16.4	0.0	4.5	10.2	0.7	0.3	2.4	0.0	0.4	1.0	3.6	0.9	1.1	5.1	2.7	0.0	0.4	1.1	0.2	0.3	0.0	2.1	0.7	2.0	0.0	6.5	22.7	1.2	0.5	3.6	0.0	0.0	0.1	0.0	0.5	0.8	2.4	0.2	0.4	0.6	18.4	0.1	0.7	3.0	1.0	0.0	0.9	1.9	0.5	0.7	25.6	158.6	0.3	1.1	0.1	2.2	115.5
HBEGF	"DTR, DTS, HEGFL"	ENSG00000113070	"Heparin binding EGF like growth factor"	Q99075	5	140332843-140346603	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 128.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 818.1;Squamous epithelial cells: 281.8;Urothelial cells: 548.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 1.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 61.2;JURKAT: 81.5;TIME: 68.9;U-698: 93.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053243	Uncertain				"Secreted to blood"	NA	NA	118000		"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA053243: AB_2682086"	"unprognostic (3.64e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.44e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	69.5	11.6	11.6	32.3	13.9	36.4	28.7	13.5	14.4	13.1	11.6	19.7	4.6	12.1	2.3	42.3	14.3	56.6	36.3	11.5	12.9	12.8	9.6	44.9	3.2	14.9	13.7	5.2	6.6	5.6	13.1	16.0	14.1	12.8	15.5	12.1	12.0	4.8	28.0	20.1	14.3	36.6	14.7	6.3	31.4	5.4	13.6	4.8	15.9	20.1	4.6	128.6	18.9	16.7	23.2	1.6	3.4	8.1	1.6	0.6	2.7	21.8	8.5	40.5	33.2	13.0	24.4	0.3	16.9	5.4	14.1	7.1	4.2	37.0	61.2	1.3	3.8	0.5	4.9	1.8	1.2	1.5	1.0	0.9	45.7	44.4	17.8	12.0	20.5	81.5	0.2	3.6	8.7	1.6	2.0	10.8	2.9	9.2	6.0	4.0	13.1	0.7	25.0	3.0	1.2	1.3	6.4	0.8	7.8	22.8	1.4	5.9	68.9	23.1	19.5	7.4	49.5	0.5	1.8	93.6	29.1	11.0	30.3	0.0	0.3	0.0	0.0	2.2	0.0	0.3	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.2	11.6	13.9	13.5	14.4	11.5	12.9	14.9	13.7	14.1	14.7	13.6	16.7	186.2	221.2	69.3	1.3	5.7	214.6	818.1	161.9	95.6	2.8	37.9	77.8	80.8	24.3	58.0	11.0	0.0	2.5	5.4	199.2	0.0	37.6	0.5	23.6	22.9	94.7	88.3	0.0	2.1	10.7	1.8	35.2	62.7	74.0	21.5	0.6	22.5	3.4	73.2	5.0	2.9	105.1	18.3	39.7	36.2	0.7	0.3	210.2	32.0	4.7	2.1	7.4	0.0	1.0	8.8	89.5	130.6	0.7	3.1	153.2	181.9	1.0	16.4	1.0	0.0	50.5	33.1	2.0	7.4	281.8	125.2	2.6	12.7	1.0	97.7	548.7
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;skin 1: 30.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 84.7;Basal respiratory cells: 52.0;Basal squamous epithelial cells: 120.1;Ionocytes: 87.5;Langerhans cells: 124.0;Suprabasal keratinocytes: 106.1"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.9"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 176.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 176.7"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 118.4"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	22.2	0.3	0.1	9.8	0.2	22.1	7.6	0.1	5.9	8.9	0.2	0.7	0.9	0.2	0.3	40.8	0.7	0.8	0.9	0.3	0.1	3.9	2.9	11.9	0.6	0.1	0.1	0.1	0.2	5.5	0.3	4.5	1.2	3.4	0.3	0.2	14.2	14.7	0.2	30.2	1.0	0.3	0.1	25.9	1.5	2.7	0.2	10.5	0.5	1.9	10.2	6.9	14.0	0.1	4.5	0.4	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	118.4	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.1	3.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.5	0.2	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	38.7	2.5	2.6	0.0	5.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	176.7	0.0	23.9	0.0	0.0	1.4	0.1	0.2	0.1	5.9	0.3	0.1	0.1	0.1	1.2	0.1	0.2	0.1	0.4	0.0	4.3	0.0	0.5	94.4	84.7	52.0	120.1	0.5	3.4	1.1	0.1	0.0	40.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	24.9	0.4	0.2	1.2	0.0	0.0	0.0	0.0	26.3	2.4	0.0	0.3	2.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	87.5	4.1	124.0	2.7	0.0	17.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	8.5	0.1	0.0	0.1	1.4	0.0	0.1	47.2	106.1	2.6	1.5	0.0	0.0	32.5
HEBP2	"C6orf34, SOUL"	ENSG00000051620	"Heme binding protein 2"	Q9Y5Z4	6	138403531-138422197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 678.8;Urothelial cells: 1174.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 219.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016928	Approved					NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA016928: AB_1850572"	"unprognostic (8.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.76e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.07e-4)"	168.1	34.4	13.9	15.0	11.2	31.8	147.3	13.8	13.8	50.6	14.8	51.7	21.9	35.2	28.0	131.1	30.4	12.8	78.5	11.2	15.8	42.4	72.3	26.4	7.0	14.1	17.4	27.8	37.2	14.6	27.2	13.3	14.8	52.7	19.2	10.1	72.2	10.5	132.8	80.4	32.7	13.3	13.4	17.6	54.3	7.5	22.9	8.6	27.0	33.5	12.3	51.5	81.5	12.5	42.8	8.6	13.6	45.4	42.5	17.1	88.2	45.7	12.8	6.0	9.9	23.2	28.3	1.3	74.0	24.0	29.0	40.0	13.2	22.7	3.4	31.0	60.8	17.4	8.7	42.9	24.8	27.4	0.1	20.8	25.8	6.5	22.6	32.2	23.7	31.5	40.7	23.4	10.5	34.9	9.0	83.7	17.7	22.2	33.1	29.1	20.5	26.1	26.5	31.8	31.0	5.7	47.5	85.5	29.4	21.0	27.6	219.5	28.9	14.5	40.8	18.7	46.1	36.5	31.5	17.2	25.2	41.6	9.4	5.6	7.9	5.6	1.5	8.2	2.0	5.0	4.3	2.5	7.4	2.9	2.0	1.7	14.6	1.9	5.0	4.6	6.4	2.3	13.9	11.2	13.8	13.8	11.2	15.8	14.1	17.4	14.8	13.4	22.9	12.5	106.3	19.2	31.6	5.9	48.7	117.5	387.1	73.4	71.7	28.6	274.7	262.4	160.8	190.1	98.1	121.4	14.6	273.3	49.2	231.9	295.4	304.3	4.5	167.0	104.2	91.7	102.2	38.3	1.1	578.1	408.5	70.7	72.9	229.9	45.1	38.4	74.6	547.6	93.6	18.5	1.0	169.4	79.3	84.7	58.5	10.9	67.7	70.9	58.7	8.4	98.3	90.5	51.5	3.5	1.8	678.8	224.6	66.5	68.2	510.0	115.2	353.0	72.7	38.9	59.2	78.4	89.0	11.7	58.2	201.2	204.9	291.3	59.9	29.2	141.8	1174.8
HES1	"bHLHb39, FLJ20408, HES-1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136148-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 850.6;Muller glia cells: 1146.0;Paneth cells: 1137.2;Undifferentiated cells: 882.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"eosinophil: 15.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.1;OE19: 95.8;SK-BR-3: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA066929: AB_2732753"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.04e-5)"	64.2	32.2	13.6	7.9	14.9	0.9	87.0	12.5	15.0	66.0	11.8	44.1	31.2	22.5	9.0	127.8	22.4	17.7	65.6	14.7	16.8	87.3	68.7	47.1	7.0	15.3	17.4	25.3	34.8	22.6	42.7	27.5	13.5	90.1	35.7	66.5	79.9	31.5	69.9	184.5	23.9	9.8	13.5	23.4	42.1	12.8	14.5	11.9	93.2	22.4	11.8	59.8	136.6	11.6	9.3	2.6	20.8	27.1	6.1	0.0	5.2	4.3	12.2	0.9	0.5	36.4	26.1	1.3	74.6	1.6	12.6	51.4	3.9	24.2	0.3	7.7	44.0	33.1	3.5	9.4	0.1	0.2	30.1	2.2	94.1	0.8	10.9	14.3	28.6	1.7	16.1	1.2	0.0	43.9	47.5	45.7	19.4	95.8	17.8	0.1	1.5	1.0	28.0	71.2	1.2	1.6	21.0	78.9	38.9	23.6	22.2	2.6	22.3	2.3	21.8	0.3	31.3	0.2	0.1	0.2	1.6	0.1	43.7	0.0	0.0	15.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	13.6	14.9	12.5	15.0	14.7	16.8	15.3	17.4	13.5	13.5	14.5	11.6	684.0	25.6	96.0	70.2	54.2	122.9	498.5	736.7	159.4	15.9	352.0	164.1	128.8	517.6	355.1	196.8	16.7	41.1	4.7	696.8	189.8	268.9	2.2	231.9	37.6	401.8	160.1	19.2	1.2	199.1	6.0	274.1	105.0	257.4	303.4	16.1	850.6	163.1	24.4	10.1	0.4	579.7	213.6	95.3	76.2	8.7	58.7	74.6	80.0	5.6	22.8	1146.0	0.0	4.5	0.1	227.1	1137.2	18.8	5.0	231.1	297.5	126.6	190.2	54.9	164.3	76.8	291.7	1.2	13.2	367.8	296.5	209.2	24.1	31.4	882.7	358.1
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.7;skin 1: 16.9;vagina: 18.8"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 48.9;Late spermatids: 45.3;Paneth cells: 33.0;Squamous epithelial cells: 58.5;Syncytiotrophoblasts: 99.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 17.0;head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 19.7;HaCaT: 37.6;HBEC3-KT: 32.3;hTCEpi: 18.3;PC-3: 13.4;TIME: 55.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039462	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA039462: AB_10673533"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.1	0.0	0.2	0.8	0.2	0.4	0.8	0.4	0.4	9.8	0.2	6.1	0.3	0.3	0.6	33.7	2.6	0.1	0.1	0.3	0.2	1.1	0.1	1.1	0.1	0.3	0.2	0.1	0.0	0.3	0.2	6.7	0.4	1.6	4.6	1.2	3.7	0.1	0.1	16.9	1.3	0.3	0.1	0.1	0.1	2.9	0.2	0.3	0.0	0.1	1.7	0.3	18.8	0.7	1.8	0.6	0.0	0.2	0.3	0.1	19.7	0.0	0.0	0.1	0.0	0.5	0.3	0.1	3.5	0.2	0.2	37.6	1.0	32.3	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.2	0.1	18.3	0.1	0.7	0.0	9.8	0.0	0.3	0.3	0.1	2.9	0.1	1.6	0.0	2.0	13.4	0.1	0.0	0.2	0.3	0.5	0.2	0.0	1.9	10.3	0.3	1.9	1.4	0.7	55.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	1.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.1	0.2	0.7	0.4	9.6	3.9	0.0	0.4	6.5	8.7	10.5	8.0	1.8	2.0	1.5	9.1	0.0	12.7	1.8	4.2	3.6	0.4	17.3	0.0	1.1	19.4	10.3	1.2	1.5	3.0	0.0	0.0	0.0	4.6	1.1	0.0	9.9	1.3	0.2	1.4	0.2	0.9	0.0	0.0	48.9	6.1	0.6	4.8	45.3	0.3	1.2	1.8	0.0	0.1	1.0	1.0	0.0	0.0	0.5	33.0	0.7	0.3	10.9	9.2	6.6	16.8	6.1	0.0	1.4	0.9	5.8	4.8	58.5	19.6	99.3	0.8	0.1	13.1	23.2
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 164.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.8;Club cells: 140.2;Extravillous trophoblasts: 246.8;Ionocytes: 311.3;Syncytiotrophoblasts: 241.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 72.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 67.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 116.1"	"Low region specificity"	"Detected in all"							HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	101.1	8.1	14.9	6.9	19.8	20.2	59.9	22.6	18.7	59.1	12.8	23.5	5.7	11.1	7.5	164.3	10.9	8.8	56.9	15.9	18.9	40.2	38.8	50.3	5.9	26.5	26.8	45.5	12.4	4.4	13.8	36.2	22.3	14.8	7.3	43.3	23.6	7.0	6.0	50.6	8.0	8.2	21.1	8.8	19.0	17.1	25.4	7.6	14.5	5.5	7.4	38.3	86.1	21.0	30.0	61.3	34.1	37.6	45.5	16.9	62.5	11.0	13.4	22.6	24.6	15.0	26.5	21.2	8.3	16.5	22.9	19.6	19.4	23.3	28.6	11.3	17.3	12.2	13.9	14.1	10.2	19.8	16.7	28.0	19.7	17.8	11.8	23.0	18.8	32.5	18.2	8.1	22.6	37.2	60.9	36.8	41.2	22.3	26.7	45.5	15.5	31.0	12.5	44.8	32.3	29.1	17.0	116.1	21.8	30.5	95.6	18.4	13.3	28.6	13.9	21.4	13.5	8.2	6.3	25.7	51.7	30.1	25.0	23.4	6.6	67.8	4.5	7.5	6.3	17.6	5.5	5.3	6.8	17.6	5.4	5.3	2.6	13.9	5.9	11.9	4.0	4.1	14.9	19.8	22.6	18.7	15.9	18.9	26.5	26.8	22.3	21.1	25.4	21.0	22.6	9.6	5.5	0.0	9.3	64.2	14.8	170.8	9.1	6.5	11.1	13.8	4.1	2.8	140.2	1.8	18.8	114.3	5.0	10.0	0.0	27.5	0.5	23.6	49.1	30.9	13.1	12.6	0.0	8.9	246.8	44.0	6.6	38.6	18.9	85.6	11.0	3.3	27.6	26.9	0.0	11.2	311.3	4.4	89.2	2.4	30.4	14.8	37.4	0.0	13.7	15.8	3.1	0.0	0.0	35.5	4.5	24.5	6.4	27.1	2.4	9.6	98.9	23.2	6.6	7.0	43.4	7.8	17.3	10.0	52.0	241.1	9.7	16.2	14.9	122.4
HOXA1	"HOX1, HOX1F"	ENSG00000105991	"Homeobox A1"		7	27092993-27096000	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"urinary bladder: 5.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 7.4;Enteroendocrine cells: 3.0;Kupffer cells: 3.2;Squamous epithelial cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 4.5;NK-cell: 4.8;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	6	"monocytes: 7.0;NK-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.1"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Region enhanced"	"Detected in some"		"spinal cord: 2.6"							NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (7.39e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.17e-1)"	0.6	0.5	0.0	0.7	0.0	0.3	0.6	0.0	0.0	0.4	0.0	1.1	0.3	0.4	1.9	2.9	0.8	0.3	0.0	0.0	0.0	0.9	0.2	0.3	1.3	1.1	0.0	1.6	0.0	1.1	0.0	0.1	0.5	0.5	1.0	0.0	0.0	0.4	0.2	2.2	1.1	0.3	0.7	1.2	0.7	0.1	0.0	0.7	0.1	0.0	1.1	5.3	0.5	0.7	6.3	2.6	0.2	3.4	0.0	0.0	5.6	0.8	3.5	2.2	2.6	13.8	3.8	4.2	7.9	2.1	8.5	13.2	4.6	3.7	1.6	0.3	13.9	5.5	0.2	0.1	0.7	4.8	14.1	2.4	3.8	2.6	5.5	0.0	3.5	4.2	6.1	0.0	4.7	0.1	0.0	7.7	0.0	2.4	0.6	5.2	1.6	0.0	7.6	6.0	0.4	0.0	3.0	0.0	3.8	4.4	0.0	2.2	2.7	0.5	5.4	4.1	1.1	0.0	0.0	2.0	2.1	8.1	5.8	0.7	0.2	0.5	0.8	4.5	0.8	0.3	0.9	0.8	0.8	0.0	0.3	0.8	0.2	4.8	7.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.7	0.0	0.7	0.9	0.0	0.0	0.0	0.2	2.3	1.4	0.3	7.4	0.0	0.6	1.8	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.2	0.4	0.8	3.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	2.5	0.1	2.2	0.0	0.1	0.0	0.0	2.1	0.0	3.2	0.4	0.0	0.0	1.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.1	0.3	0.0	1.3	0.2	1.2	0.9	1.2	0.0	0.0	0.3	1.5	0.1	0.8	5.8	1.1	0.0	1.4	0.3	0.9	2.1
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 256.5;WM-115: 239.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.5	1.8	0.9	1.3	1.8	0.3	8.5	1.8	3.9	6.1	1.4	6.5	7.7	2.9	5.7	23.2	2.0	3.2	9.1	1.1	3.0	11.4	0.5	8.4	0.5	2.0	3.5	0.4	2.6	2.1	2.4	11.1	2.3	5.6	5.8	7.5	9.1	5.7	1.6	18.2	8.8	2.9	4.7	0.4	8.7	4.1	4.9	10.9	8.3	1.5	5.3	5.0	10.9	2.9	22.3	36.9	28.2	7.2	6.4	13.4	75.5	0.1	1.0	2.9	1.0	21.5	12.4	0.0	11.4	0.3	15.8	60.7	12.6	30.4	1.3	256.5	9.3	12.1	13.7	0.6	0.0	1.2	22.2	1.7	23.1	0.2	5.2	5.3	0.2	4.1	3.7	0.2	0.6	78.0	0.9	0.8	17.8	13.4	0.9	9.1	34.6	0.1	21.6	27.5	16.4	50.0	8.9	84.7	55.1	53.9	28.7	1.5	0.1	4.9	16.4	0.2	23.0	0.3	1.3	0.1	2.2	0.7	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	1.8	3.9	1.1	3.0	2.0	3.5	2.3	4.7	4.9	2.9	3.5	16.0	36.0	1.0	0.0	19.6	8.6	23.2	23.9	29.3	17.1	10.8	16.1	7.2	9.1	14.7	0.0	13.7	0.1	29.3	3.9	14.0	2.1	8.3	2.1	3.3	3.0	0.0	11.8	1.9	27.3	7.8	16.8	14.4	1.3	7.3	1.8	0.6	2.1	6.7	18.8	5.0	2.0	1.3	11.1	2.2	1.2	0.5	8.8	0.0	3.1	11.3	0.0	1.5	0.4	16.4	7.3	0.0	0.0	10.2	15.4	11.4	11.3	0.8	0.0	26.4	2.8	0.5	3.8	30.6	27.7	13.3	0.4	3.5	9.3	11.4
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143253-112164096	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.5;skin 1: 149.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	Yes	196000	16000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	19.9	6.1	5.3	18.2	5.4	31.6	12.6	5.9	8.6	38.0	7.0	34.1	22.0	2.4	3.3	124.5	8.0	23.0	3.0	5.3	6.0	23.8	9.1	23.0	67.8	7.5	6.2	1.9	17.9	1.3	2.9	6.7	7.4	6.1	29.1	6.9	15.0	3.0	6.0	149.6	22.0	3.6	6.7	29.3	13.4	1.9	5.7	8.0	3.7	2.1	25.7	25.3	77.0	11.3	117.9	40.0	0.0	0.4	0.0	0.0	0.7	2.0	0.0	0.0	0.1	22.4	182.3	0.1	25.7	0.3	3.2	167.0	0.0	125.8	0.0	0.3	1.2	17.5	35.6	9.9	3.9	9.3	32.6	0.2	188.5	0.3	43.5	0.2	0.1	0.1	0.5	0.3	1.6	0.2	0.2	0.9	0.2	31.9	110.2	0.1	0.1	0.4	79.9	24.8	0.1	0.0	78.4	52.1	0.5	1.0	31.0	25.4	0.3	0.4	208.9	1.2	35.9	0.4	0.3	0.6	0.2	67.1	0.2	6.8	8.7	16.0	0.1	10.9	0.0	0.7	0.1	0.0	25.8	0.7	0.0	0.5	9.5	19.6	6.3	5.6	0.0	2.5	5.3	5.4	5.9	8.6	5.3	6.0	7.5	6.2	7.4	6.7	5.7	11.3	1.0	173.1	38.4	0.7	6.0	122.9	33.5	186.4	215.1	2.6	4.6	7.7	1.0	41.5	66.1	9.2	0.0	2.3	10.8	109.9	80.3	24.7	2.4	94.9	1.4	4.6	14.5	26.3	3.8	143.0	3.7	18.8	20.9	32.5	101.2	2.8	8.2	1.9	68.4	0.0	4.6	30.1	57.0	241.0	37.3	1.9	0.0	123.8	3.6	61.8	38.8	2.7	6.2	2.0	1.1	161.4	104.6	4.5	4.6	23.6	67.5	22.3	69.6	39.1	6.6	0.6	3.9	1.5	1.3	152.6	111.2	1.8	9.6	0.3	47.8	90.5
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773925-112784493	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.3;testis: 10.4;urinary bladder: 26.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.6;Club cells: 9.8;Endometrial ciliated cells: 11.5;Glandular and luminal cells: 29.4;Macrophages: 30.6;Squamous epithelial cells: 9.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 447.6;hTCEpi: 216.2;hTERT-HME1: 283.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	10800			"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"				"unprognostic (3.41e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.5	0.0	0.3	1.3	0.4	1.0	0.4	0.5	0.4	4.8	0.2	0.3	0.1	2.5	0.8	13.3	0.1	2.3	0.0	0.4	0.5	0.0	0.0	2.3	0.3	0.9	0.8	0.0	0.0	0.4	0.2	1.5	1.0	0.1	0.2	0.1	1.2	0.4	0.0	0.8	0.1	0.0	0.7	0.3	0.1	10.4	0.5	0.3	0.2	0.0	8.7	26.0	1.3	1.2	12.5	0.0	0.5	0.0	0.1	0.0	0.2	0.4	13.5	0.0	0.2	0.5	0.8	0.0	52.5	0.0	65.9	3.6	0.0	447.6	1.7	0.1	0.1	0.1	0.7	0.2	1.0	0.2	0.1	0.0	216.2	3.8	283.4	3.4	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.2	0.2	0.5	0.0	0.0	0.0	0.1	55.0	0.1	0.0	1.6	0.0	0.0	0.6	0.0	0.1	1.7	1.3	0.6	0.3	0.3	0.0	0.1	0.2	5.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.4	0.4	0.5	0.9	0.8	1.0	0.7	0.5	1.2	0.9	6.4	1.1	0.0	2.2	1.5	0.7	22.6	1.2	0.0	0.5	0.3	0.2	0.0	9.8	0.0	0.0	0.3	0.3	0.6	0.0	4.6	8.3	11.5	2.8	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.0	29.4	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.0	0.0	4.8	3.8	0.0	30.6	0.0	5.6	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.4	0.3	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	0.1	9.4	1.0	0.0	0.4	0.1	0.2	2.4
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985658	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 14.3;lymphoid tissue: 39.4;skin 1: 31.3"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 136.0;Club cells: 36.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;HaCaT: 1.0"	"Not detected"	"Not detected"							HPA068168			Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		11000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA068168: "	"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	3.9	0.2	0.0	31.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	39.4	0.8	3.6	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	136.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.7	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.0	0.0	1.3	0.2	0.0	1.7	13.2	0.0	0.0	0.0	0.0	7.8
INKA1	"C3orf54, FAM212A"	ENSG00000185614	"Inka box actin regulator 1"		3	49803261-49805030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skin 1: 24.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4"	"Group enriched"	"Detected in many"	7	"B-cells: 65.9;granulocytes: 59.6"	"Cell line enhanced"	"Detected in many"		"HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9"	"Low region specificity"	"Detected in all"							HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	5.1	2.3	4.8	2.0	5.0	3.5	4.1	5.2	7.6	6.2	2.8	3.2	0.8	4.7	1.4	19.7	2.8	1.5	5.2	5.3	5.5	5.8	1.1	5.4	4.1	6.2	5.3	2.2	1.3	0.5	2.1	3.1	5.7	6.4	0.5	0.2	4.9	2.1	11.7	24.1	4.3	1.8	5.8	6.7	2.4	2.9	6.5	1.6	2.1	2.3	3.9	5.5	10.3	7.0	1.3	1.1	1.5	1.1	1.8	4.1	0.0	3.0	1.9	1.4	1.7	0.1	0.0	14.9	0.4	2.2	1.5	8.7	0.5	10.4	0.1	2.6	0.0	68.5	0.7	0.2	2.6	10.4	45.1	5.4	14.5	2.9	2.6	0.9	6.1	1.0	4.7	1.2	1.2	0.6	0.9	38.5	1.1	0.0	5.8	13.9	0.8	3.3	0.1	16.9	0.8	5.3	2.7	0.5	1.5	0.4	0.3	42.1	3.8	7.3	0.9	3.4	1.3	1.7	1.7	1.2	3.2	34.9	1.8	59.6	2.4	11.6	1.3	5.9	0.3	65.9	1.5	1.8	0.7	64.4	2.2	3.6	1.3	0.0	8.5	9.3	1.6	6.4	4.8	5.0	5.2	7.6	5.3	5.5	6.2	5.3	5.7	5.8	6.5	7.0	19.9	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.7	0.0	0.5	1.6	8.4	0.0	0.0	0.0	1.2	0.7	3.0	0.0	0.1	0.0	0.1	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613183-92670131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 31.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.4	6.9	5.2	4.5	5.7	8.5	6.4	7.5	6.4	9.1	3.9	4.1	3.2	5.2	4.8	31.6	5.4	4.6	7.8	6.9	4.7	4.4	5.3	4.7	5.7	5.5	5.1	5.4	3.6	8.5	8.1	5.5	5.7	4.2	4.4	5.7	8.8	2.8	7.6	29.8	4.2	5.4	5.0	5.4	4.6	11.6	5.6	5.9	4.6	6.1	8.7	5.7	15.5	5.6	19.3	10.1	9.2	8.0	11.1	8.2	30.4	13.5	8.5	13.6	7.8	6.3	7.4	11.9	6.6	18.9	12.0	27.1	16.4	18.9	11.3	14.9	10.4	9.8	21.9	9.9	7.8	16.7	11.2	8.1	18.4	16.3	12.7	12.4	10.3	9.8	13.5	14.1	13.6	26.3	9.6	7.7	15.8	21.2	14.9	8.5	9.8	4.9	8.0	11.5	19.1	11.2	10.9	44.9	7.8	8.9	10.6	4.2	19.7	10.0	11.3	28.2	14.4	13.0	16.2	6.5	13.0	7.5	9.9	0.0	1.4	3.4	3.6	1.8	4.1	2.4	3.0	3.1	2.1	2.2	2.3	2.6	2.1	0.8	1.9	2.3	4.6	1.9	5.2	5.7	7.5	6.4	6.9	4.7	5.5	5.1	5.7	5.0	5.6	5.6	6.8	3.2	3.4	10.1	4.8	25.4	6.4	7.6	16.5	7.5	6.0	4.7	0.4	1.5	5.1	1.8	6.2	10.8	4.6	5.0	5.9	6.2	11.0	8.3	5.3	6.8	6.7	6.1	23.8	8.0	13.8	4.1	7.1	10.2	0.0	3.6	10.0	3.1	5.1	15.2	23.7	3.5	6.1	7.5	4.6	33.7	3.1	5.3	3.6	7.5	2.8	4.9	8.2	20.6	23.3	9.1	1.4	3.0	6.0	6.4	2.6	3.6	2.6	4.6	6.6	3.9	3.5	20.0	19.4	25.5	29.5	22.8	6.0	4.4	3.7	10.5
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388242-90502239	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		1500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	57.3	31.1	14.4	69.3	30.0	69.7	51.6	19.8	20.5	62.0	26.9	67.1	32.3	72.2	21.3	75.6	45.1	55.0	22.9	17.0	21.5	35.6	18.8	74.2	58.9	29.0	24.6	39.6	30.1	49.7	12.1	79.8	28.1	36.2	66.9	7.1	72.2	38.0	15.0	64.9	37.9	81.3	16.5	57.7	52.6	13.0	27.9	65.4	64.3	25.4	63.4	63.5	31.4	63.4	148.9	81.5	39.8	46.6	99.3	128.4	229.6	139.7	127.0	124.7	132.4	93.6	150.5	82.7	66.2	231.5	111.4	259.2	80.6	153.5	149.5	106.4	56.6	55.5	145.8	34.3	120.2	102.9	113.6	76.2	139.5	147.2	206.5	152.7	172.8	53.0	49.0	112.8	192.3	76.5	55.4	30.8	51.6	235.8	45.6	67.5	106.5	72.1	126.9	233.8	49.5	37.3	195.1	96.9	100.7	162.8	85.1	86.5	224.2	141.1	73.4	120.4	145.6	43.3	67.0	82.4	128.3	98.5	77.5	30.6	27.5	20.0	21.8	25.2	19.3	12.6	13.5	18.9	23.3	12.5	7.9	14.0	89.9	27.6	31.0	13.8	16.1	16.9	14.4	30.0	19.8	20.5	17.0	21.5	29.0	24.6	28.1	16.5	27.9	63.4	180.9	266.0	286.3	36.2	129.2	103.0	124.9	87.7	72.8	4.6	115.1	88.4	18.0	54.3	167.2	77.3	16.7	89.7	215.3	204.5	7.9	95.9	8.8	133.8	127.9	135.7	60.7	46.7	39.7	98.7	159.4	116.5	91.7	242.0	209.3	130.2	95.3	11.6	149.0	1.7	24.4	121.1	63.1	407.5	175.1	13.2	47.8	261.6	71.2	60.9	272.2	13.5	200.8	9.5	316.0	128.1	112.1	48.2	137.3	98.6	72.7	19.6	134.2	30.2	78.9	108.8	131.0	18.9	32.6	99.3	113.4	95.6	176.8	56.0	152.0	151.5
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785617-209806175	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 95.4;skin 1: 114.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 387.2;Basal prostatic cells: 253.9;Basal squamous epithelial cells: 217.9;Squamous epithelial cells: 251.9;Suprabasal keratinocytes: 552.4;Urothelial cells: 290.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 10.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 61.9;HaCaT: 210.7;HBEC3-KT: 80.5;hTCEpi: 170.1;hTERT-HME1: 82.2;RT4: 78.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.6	11.4	1.6	3.2	1.5	2.8	35.9	10.9	1.8	21.6	5.2	27.1	26.9	5.9	49.3	95.4	21.7	10.8	29.7	1.7	1.4	17.0	33.3	8.8	0.9	1.9	2.9	1.9	19.7	26.4	6.5	20.4	1.9	32.4	31.5	2.4	39.0	26.4	0.5	114.0	25.0	2.0	2.1	2.1	24.8	2.9	2.3	20.3	17.1	2.7	23.0	40.5	46.8	1.2	61.9	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.5	0.1	0.3	13.6	20.7	0.0	0.1	0.1	0.0	210.7	0.0	80.5	0.0	0.0	1.3	0.1	0.2	0.0	0.2	0.0	0.2	0.1	170.1	0.1	82.2	0.0	3.7	0.0	0.1	0.2	0.0	8.3	0.0	0.3	1.2	17.0	0.2	0.0	0.0	0.3	7.7	78.8	18.7	6.1	1.4	34.1	1.9	3.8	24.1	0.3	0.0	0.0	0.1	0.0	0.3	0.8	15.8	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.6	1.5	10.9	1.8	1.7	1.4	1.9	2.9	1.9	2.1	2.3	1.2	1.9	16.0	10.4	0.3	1.0	387.2	253.9	154.0	217.9	0.1	47.2	33.3	26.0	32.9	70.4	35.0	0.0	94.2	1.3	95.5	27.4	36.7	1.1	120.2	9.5	6.0	59.9	0.4	0.0	19.2	25.4	4.5	53.0	121.7	2.5	0.0	1.1	35.9	8.3	0.0	0.1	74.9	38.7	1.0	30.1	0.7	0.6	2.3	35.6	1.9	1.0	6.5	0.0	0.0	0.0	49.2	43.8	0.0	2.5	153.9	49.5	11.9	82.1	0.6	0.0	0.4	7.4	8.2	3.7	251.9	552.4	161.6	2.5	0.7	44.5	290.3
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.8;heart muscle: 14.3;skin 1: 22.5;vagina: 12.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 1.2;pons: 1.5"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	3.2	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	14.3	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.9	0.0	1.2	9.9	0.0	0.0	9.5	0.0	0.6	22.5	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	16.3	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	8.3	1.1	0.1	0.1	4.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.8	0.7	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	48.6	2.8	0.1	50.7	0.0	1.4	15.6	6.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.1	26.5	20.2	3.7	0.0	0.0	0.0	1.7
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		43000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.4	12.8	2.4	4.9	6.7	0.4	7.8	4.4	3.7	5.0	0.9	6.1	7.7	4.9	7.4	11.0	2.6	9.0	1.1	2.4	4.2	9.8	0.5	12.5	0.9	4.8	4.9	1.0	1.6	9.3	1.2	4.8	5.4	6.6	5.9	2.4	10.4	11.1	0.5	17.1	7.7	2.4	3.3	6.8	7.5	0.4	4.8	4.3	2.3	0.7	4.6	15.6	8.0	12.9	60.4	15.4	1.3	0.8	3.9	7.1	4.5	60.2	91.4	2.2	3.6	29.0	41.8	0.1	9.8	25.4	33.5	92.5	4.9	67.1	8.5	0.0	4.4	4.3	3.7	17.5	13.3	0.7	1.3	2.9	11.4	59.2	10.5	83.2	83.5	3.1	0.1	0.2	1.6	11.4	0.6	0.1	3.7	15.7	29.6	0.0	0.4	0.1	18.9	32.0	0.6	3.2	3.2	4.1	6.1	2.3	9.6	0.2	71.2	10.8	6.3	1.7	12.1	0.0	0.1	0.1	64.0	0.0	48.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.7	4.4	3.7	2.4	4.2	4.8	4.9	5.4	3.3	4.8	12.9	7.4	57.7	13.7	9.1	0.6	151.0	406.2	141.3	56.9	2.7	24.4	39.0	1.3	15.7	133.2	53.3	4.2	1.9	0.9	23.2	9.8	144.0	0.1	20.3	5.0	39.0	13.8	0.0	0.5	169.3	2.2	11.6	13.3	90.6	1.3	45.4	5.3	0.2	0.3	0.0	0.9	37.8	20.3	0.0	6.1	0.2	1.2	2.5	12.4	14.0	1.1	14.7	0.0	0.0	370.9	558.7	20.3	0.0	2.6	299.3	20.6	3.8	103.6	4.3	0.0	4.4	12.1	0.0	1.3	57.0	37.2	0.4	5.8	23.7	30.9	363.9
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717112-40740860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 96.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 151.4;Glandular and luminal cells: 139.3;Squamous epithelial cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	45.3	13.9	11.2	10.8	9.6	3.5	29.4	9.4	10.7	32.6	11.6	16.8	11.7	18.6	4.7	96.7	25.0	23.0	19.3	10.0	10.7	18.8	17.7	41.8	6.0	15.0	11.5	12.9	22.8	10.3	22.0	10.3	11.6	27.1	6.8	5.5	31.1	10.5	18.4	51.0	16.9	16.3	10.8	14.5	26.3	6.0	15.2	8.7	17.2	8.9	13.9	22.4	42.0	9.3	12.9	12.0	7.3	11.5	32.2	27.8	11.6	7.5	15.7	7.6	6.7	17.3	13.1	3.5	8.5	9.7	5.7	13.3	7.3	32.6	3.1	6.7	7.5	2.7	4.5	12.3	31.8	3.0	3.6	38.8	46.4	7.2	26.5	10.3	18.9	5.0	10.6	6.1	7.5	15.7	4.4	4.5	3.7	29.4	5.4	4.7	3.6	4.9	12.0	21.5	5.2	6.5	7.6	30.5	7.2	8.4	14.1	7.6	12.2	4.9	7.3	3.3	5.1	3.5	0.9	3.7	7.6	3.1	5.4	0.9	0.7	0.4	0.8	0.3	0.3	0.3	0.6	0.4	0.3	0.7	0.4	0.5	0.3	0.2	0.5	0.5	0.6	0.4	11.2	9.6	9.4	10.7	10.0	10.7	15.0	11.5	11.6	10.8	15.2	9.3	75.4	86.6	35.2	6.5	2.7	60.4	72.4	17.4	39.9	10.0	88.4	44.4	4.1	7.2	29.7	3.7	0.0	7.7	2.8	57.7	1.9	13.9	2.1	67.5	23.2	26.4	16.7	3.2	7.4	12.3	5.5	20.1	151.4	139.3	3.8	4.3	25.7	6.8	2.9	5.0	6.0	27.2	2.0	7.8	9.6	2.2	11.8	6.8	19.6	6.5	3.1	3.7	3.1	9.0	3.5	23.2	50.8	7.5	1.2	65.3	28.7	4.4	29.4	6.2	0.0	7.1	10.1	1.9	2.0	160.8	53.4	16.8	5.2	4.6	18.0	98.6
IVL		ENSG00000163207	Involucrin	P07476	1	152908546-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 162.3;esophagus: 298.3;salivary gland: 94.5;skin 1: 160.9;vagina: 235.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3"					"Not detected"	"Not detected"			"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		4700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	162.3	0.0	0.0	0.0	0.0	18.2	298.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	94.5	0.1	0.4	160.9	0.1	0.0	0.0	0.1	0.2	0.1	0.0	3.5	0.1	0.0	36.9	17.4	235.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	292.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0	86.3	0.0	0.2	3.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.1	3.5	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	0.0	30.8	71.0	0.0	0.1	0.0	0.0	13.3
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 128.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 128.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	22.0	12.1	16.3	22.9	16.6	16.3	20.8	25.0	20.8	22.5	22.4	19.9	15.9	20.7	19.0	39.9	16.8	15.9	13.4	15.8	14.9	17.0	17.6	18.4	17.6	15.0	13.8	14.4	14.0	14.5	12.1	32.4	16.0	16.9	21.2	31.2	14.6	13.6	13.2	31.4	15.7	25.4	12.9	18.6	17.7	18.0	18.2	15.2	12.5	13.0	20.3	17.8	27.7	25.3	37.1	31.5	49.7	33.4	39.5	39.0	37.0	49.6	30.0	38.7	38.4	17.8	19.9	17.6	31.2	32.2	54.5	47.5	24.9	28.5	45.8	36.9	12.6	31.8	34.6	21.6	27.0	33.9	33.1	23.6	40.8	26.1	51.3	39.7	70.6	45.4	34.3	36.7	53.1	17.6	21.4	27.4	35.8	47.4	25.0	32.3	30.3	16.1	35.9	49.5	28.1	24.8	30.1	21.9	14.7	49.2	27.0	38.8	40.4	51.9	26.7	46.8	39.7	21.5	32.5	37.1	46.5	35.7	38.9	62.8	18.2	29.7	18.4	17.3	23.3	23.9	19.6	18.8	20.7	25.6	21.5	19.2	128.5	13.2	11.5	28.4	17.9	12.0	16.3	16.6	25.0	20.8	15.8	14.9	15.0	13.8	16.0	12.9	18.2	25.3	59.7	38.5	25.2	83.9	41.7	41.3	65.2	60.5	34.7	57.0	42.1	43.1	12.8	24.3	51.6	25.8	52.1	58.6	42.3	30.6	33.2	59.1	75.4	40.5	53.3	47.0	23.9	39.8	104.3	54.5	86.2	38.8	39.3	50.8	44.9	68.7	37.9	20.8	39.1	67.3	96.7	35.6	52.9	27.6	48.8	59.2	31.7	36.2	32.0	64.6	49.9	53.1	27.8	86.0	114.4	105.3	37.4	33.1	41.1	116.8	21.4	41.6	49.6	44.7	59.2	52.2	45.3	47.8	44.3	45.0	54.3	179.5	39.7	31.6	39.1	132.6
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319845-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 151.3;Urothelial cells: 131.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.4;granulocytes: 26.2;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.6;HMC-1: 40.3;T-47d: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.9	2.4	2.9	7.5	2.4	3.9	5.6	3.0	3.3	29.9	2.7	15.4	4.6	24.0	1.5	30.5	15.7	4.5	6.7	2.7	2.2	3.1	3.0	9.4	5.6	2.9	2.3	9.5	12.5	0.6	1.9	7.0	2.9	6.2	9.4	0.8	14.5	2.4	1.5	19.1	6.8	14.3	2.1	15.6	9.5	2.1	2.8	2.5	1.4	0.7	7.9	13.3	18.2	3.7	9.2	3.3	0.5	0.5	5.1	3.3	0.7	7.8	3.8	2.0	2.7	2.6	9.8	0.6	3.5	11.2	2.1	11.7	4.2	17.7	1.3	0.4	0.3	37.6	1.9	0.4	4.7	2.7	40.3	0.8	15.6	2.5	4.8	10.5	5.3	5.8	0.5	2.8	5.7	20.2	2.4	2.3	0.4	19.4	2.1	3.9	0.5	2.7	7.1	0.8	0.5	0.8	0.8	0.8	0.3	1.8	22.8	10.5	5.8	0.5	4.4	4.1	0.4	1.0	0.2	1.0	0.6	13.4	0.3	26.2	6.9	15.8	1.4	6.2	1.2	1.4	2.0	1.9	11.4	1.1	1.7	1.2	5.0	0.6	7.2	3.1	2.6	2.3	2.9	2.4	3.0	3.3	2.7	2.2	2.9	2.3	2.9	2.1	2.8	3.7	8.7	0.0	10.5	0.0	16.0	43.1	50.6	20.6	20.5	3.3	61.2	32.9	12.1	17.2	15.1	7.3	6.2	2.0	18.5	62.4	0.0	19.1	2.8	32.5	58.8	28.3	12.6	17.9	1.1	47.7	4.0	19.2	28.1	84.8	22.2	72.7	151.3	4.3	39.2	0.0	1.7	64.5	2.0	75.7	61.5	1.2	25.7	47.0	5.4	2.8	62.1	1.2	11.3	0.0	0.9	67.2	39.2	20.3	45.6	41.1	37.6	0.4	7.7	5.9	26.3	3.1	9.3	14.8	3.3	48.0	67.2	2.5	14.8	1.5	26.7	131.5
KCTD11	"C17orf36, KCASH1, REN"	ENSG00000213859	"Potassium channel tetramerization domain containing 11"	Q693B1	17	7351889-7354944	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Ubl conjugation pathway"	"Developmental protein, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 32.2;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 9.6;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 53.6;hTCEpi: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052035	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA052035: AB_2681704"	"unprognostic (1.98e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (6.78e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	10.5	7.3	5.6	6.1	6.2	1.0	8.2	6.3	6.0	31.6	6.4	8.5	5.8	11.4	7.9	40.1	9.2	7.5	6.4	5.6	5.9	8.0	6.2	8.1	6.0	7.1	6.0	7.8	7.8	9.1	6.5	7.4	6.2	8.8	5.6	3.4	15.6	9.8	5.3	35.1	8.5	7.8	6.1	8.7	8.5	3.4	7.4	3.0	9.9	3.9	10.3	28.6	35.5	6.5	18.2	7.7	5.6	4.0	23.5	13.6	5.1	10.9	19.3	12.5	10.6	6.6	8.1	2.3	6.1	20.2	11.8	32.3	0.7	53.6	10.9	10.4	2.1	0.2	4.0	0.8	11.7	0.3	10.2	10.7	38.1	13.8	7.6	25.7	3.8	1.9	2.4	3.0	9.7	8.1	1.5	2.5	1.5	8.5	3.3	1.9	5.1	2.3	13.3	7.1	0.3	2.4	8.1	8.4	1.2	6.9	11.5	1.0	7.6	10.3	8.2	7.0	6.2	2.1	0.9	0.8	12.1	5.1	7.4	9.6	2.6	1.6	1.4	3.5	0.4	1.0	0.7	0.6	1.5	0.7	0.3	1.0	0.4	1.0	2.9	0.1	0.1	1.9	5.6	6.2	6.3	6.0	5.6	5.9	7.1	6.0	6.2	6.1	7.4	6.5	3.1	9.6	1.1	3.3	3.4	1.8	17.6	32.2	4.0	3.9	5.8	4.1	0.8	7.2	13.8	5.5	2.1	6.1	1.6	11.1	3.9	13.3	25.3	9.4	12.1	3.8	7.2	0.0	0.0	9.4	6.5	9.3	15.8	6.1	4.5	4.0	4.2	2.5	4.8	1.7	0.4	6.5	10.2	3.5	5.0	8.7	17.7	3.5	1.8	1.9	10.5	3.7	11.3	0.0	1.4	32.8	5.0	21.8	3.8	13.1	8.0	3.4	24.5	1.9	19.7	5.9	11.6	1.2	1.2	6.6	4.4	9.9	3.6	4.1	4.0	18.4
KLF8	"BKLF3, DXS741, ZNF741"	ENSG00000102349	"Kruppel like factor 8"	O95600	X	56232356-56291531	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 37.6;Peritubular cells: 27.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;hTCEpi: 7.8;RPTEC TERT1: 3.9;RT4: 5.0;SK-BR-3: 5.4;T-47d: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071740			Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA071740: AB_2686440"	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-8)"	"unprognostic (2.96e-1)"	"prognostic favorable (3.32e-4)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.60e-2)"	14.7	2.1	1.1	1.3	1.7	0.6	13.9	1.5	1.4	11.7	0.6	6.4	0.5	10.0	3.7	23.5	9.5	1.7	4.9	1.3	0.8	7.4	0.7	6.1	1.6	0.5	0.6	9.8	2.0	1.1	2.0	3.9	0.6	4.8	1.8	0.6	9.9	2.0	3.8	29.4	5.8	4.9	0.6	5.2	3.7	3.1	0.8	1.2	6.1	1.8	3.0	7.5	17.8	0.9	1.3	0.0	0.0	0.1	1.1	0.4	0.7	0.2	1.5	0.0	0.0	0.0	0.0	0.4	1.9	0.1	0.0	2.9	0.0	0.0	0.0	2.0	3.7	1.0	0.0	0.0	0.1	0.1	0.3	0.0	7.8	0.0	0.6	0.0	0.0	0.3	0.9	0.6	0.2	0.1	0.3	0.1	1.0	0.0	0.0	0.2	0.0	0.2	3.9	5.0	0.0	0.0	2.4	5.4	0.0	3.3	9.5	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	1.2	0.3	0.4	0.6	1.2	0.1	0.0	0.2	1.5	0.0	0.2	0.1	0.1	1.1	1.7	1.5	1.4	1.3	0.8	0.5	0.6	0.6	0.6	0.8	0.9	12.1	0.0	4.1	2.3	11.2	6.9	4.5	3.6	6.2	0.4	8.0	4.1	3.5	0.0	2.2	14.7	2.1	6.3	1.3	1.0	0.0	0.8	0.6	1.9	4.1	11.1	0.0	4.8	14.0	1.0	15.0	6.2	0.0	5.6	1.3	3.5	21.4	0.0	1.2	0.0	5.4	0.7	2.0	1.3	13.9	2.0	37.6	3.2	5.4	8.4	2.1	0.5	5.2	2.5	3.6	0.4	0.3	27.4	5.6	7.5	0.4	7.5	1.5	0.1	19.7	5.2	8.1	0.9	1.1	27.0	11.6	4.5	2.2	3.1	1.2	10.9
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 324.2;skin 1: 239.8;vagina: 186.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 152.1;Club cells: 217.9;Late spermatids: 339.0;Prostatic glandular cells: 234.8;Squamous epithelial cells: 176.4;Suprabasal keratinocytes: 217.1;Urothelial cells: 186.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 53.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;HaCaT: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		1800000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	28.4	0.2	0.0	0.4	0.0	0.0	17.1	0.9	0.1	109.8	44.5	1.9	0.7	7.2	2.6	324.2	34.2	59.3	2.0	1.7	0.0	0.3	0.8	18.9	0.0	0.2	0.1	1.6	89.1	0.0	8.8	0.0	0.3	64.9	0.6	0.7	169.5	4.2	1.9	239.8	1.4	0.3	0.0	0.1	113.3	14.4	0.6	2.5	0.4	0.3	27.2	1.4	186.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.4	0.1	13.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.7	0.0	0.2	0.1	0.3	0.0	0.6	0.0	0.2	86.6	10.4	0.0	0.4	106.9	152.1	131.6	13.1	0.2	33.4	35.3	0.8	88.6	217.9	0.0	0.0	0.0	0.0	0.1	0.0	9.2	111.6	4.7	1.1	3.8	20.3	0.0	0.0	130.2	0.0	9.1	91.3	15.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	10.7	118.0	0.0	11.4	339.0	2.8	1.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	79.4	0.0	0.4	0.5	234.8	0.1	0.0	26.9	1.3	0.0	0.2	7.9	2.1	2.5	176.4	217.1	0.0	1.7	0.0	0.4	186.1
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 118.0;skin 1: 87.1;vagina: 47.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 66.0;Suprabasal keratinocytes: 180.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 88.3;CAPAN-2: 112.2;HaCaT: 83.5"	"Region enriched"	"Detected in all"	5	"hippocampal formation: 36.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		3200000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	5.7	0.0	0.1	0.0	0.0	0.0	8.4	0.8	0.7	24.7	0.2	0.0	0.0	0.9	0.4	118.0	13.2	0.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	17.1	0.1	0.7	87.1	0.0	0.1	0.0	0.2	0.1	1.2	0.2	1.1	0.5	0.0	9.6	0.0	47.2	0.5	88.3	0.0	0.0	0.6	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.7	112.2	0.0	2.2	0.0	0.1	83.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	10.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.7	0.2	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	66.0	0.0	0.4	14.8	0.0	13.0	15.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.7	11.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	5.0	1.8	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	2.8	6.2	21.1	180.1	0.0	0.2	0.0	0.2	0.1
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513745-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 419.1;esophagus: 1156.7;skin 1: 1319.5;vagina: 423.3"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"HaCaT: 1156.8;hTCEpi: 1001.5"	"Region enhanced"	"Detected in single"		"white matter: 1.9"	"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		480000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	4.7	0.3	0.1	0.2	0.0	0.7	419.1	0.0	0.1	148.2	0.2	1.1	1.5	0.3	2.2	1156.7	32.4	2.8	0.7	0.1	0.0	0.3	0.6	4.3	0.0	0.1	0.1	0.4	1.4	0.0	1.2	0.3	0.1	182.8	1.6	0.0	140.0	4.1	0.7	1319.5	2.3	0.1	0.0	0.3	1.6	8.0	0.1	93.7	0.5	0.0	77.6	9.5	423.3	0.1	56.4	7.4	0.0	0.0	0.0	0.0	0.7	5.3	1.3	0.3	0.2	5.9	20.2	0.0	1.8	0.6	14.0	1156.8	0.0	41.8	0.2	0.6	0.0	0.0	7.7	1.9	0.0	0.1	4.7	0.0	1001.5	2.2	6.9	2.7	3.4	0.0	0.3	0.5	0.2	3.5	0.1	0.5	0.0	3.9	6.2	0.0	0.0	104.9	3.3	5.9	2.6	0.1	1.1	15.0	1.2	0.3	20.3	0.0	18.6	0.3	2.8	0.3	2.2	0.1	0.1	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	6.1	12.8	10.3	0.0	2.7	1309.8	2789.9	1190.9	8290.4	0.6	577.7	670.3	0.8	5.7	287.5	1.8	0.0	0.7	16.9	18.3	1.9	8.5	117.6	4.1	0.7	22.9	4.8	0.0	0.1	7.5	7.7	21.7	4.6	8.2	2.5	0.0	0.0	0.0	0.4	0.0	0.1	10.3	189.2	0.0	61.7	44.4	1.5	17.2	320.2	0.0	0.0	0.2	0.0	0.0	0.1	14.1	10.5	0.4	88.7	872.9	8.6	0.1	57.7	0.6	0.0	0.4	32.1	0.6	0.8	4637.9	193.6	1.2	21.6	0.1	7.2	906.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520530	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 5865.0;skin 1: 5885.4;vagina: 2150.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1863.2;head and neck cancer: 3340.4"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	326	"plasmacytoid DC: 32.6"	"Lineage enriched"	"Detected in single"	326	"dendritic cells: 32.6"	"Group enriched"	"Detected in some"	7	"HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8"					"Region enriched"	"Detected in many"	8	"spinal cord: 36.4"	"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	10.0	1.7	0.2	1.8	0.8	4.6	252.5	0.7	0.5	826.2	58.9	1.9	0.0	2.0	97.2	5865.0	12.5	2.0	3.8	1.7	0.0	1.3	3.5	6.4	3.0	0.1	0.0	2.2	4.7	0.1	8.2	2.0	0.1	125.8	0.0	0.0	880.3	100.0	9.9	5885.4	1.8	0.6	0.1	1.7	5.0	2.1	0.6	527.1	3.0	0.3	648.6	93.2	2150.9	0.4	50.6	0.0	0.0	0.0	2.3	0.2	0.8	0.0	0.0	0.0	0.0	1.0	0.3	2.4	0.5	0.2	0.0	3368.0	0.2	5990.5	0.2	0.0	0.0	0.2	0.1	0.0	0.6	1.4	2.8	0.3	13326.8	0.6	1049.7	0.0	0.8	0.0	1.8	4.0	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.2	1.0	1.2	0.8	0.9	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.5	0.2	10.1	1.0	0.9	4.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.1	0.2	0.8	0.7	0.5	1.7	0.0	0.1	0.0	0.1	0.1	0.6	0.4	1.7	0.0	1.1	0.0	0.4	5870.1	1037.6	627.1	1571.3	0.0	43.6	226.2	0.5	0.0	180.7	0.0	0.0	0.0	39.8	0.0	0.0	0.5	0.8	31.3	1.2	26.4	0.0	0.0	0.5	0.0	0.0	29.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	273.6	0.1	0.6	7.3	286.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	22.2	789.7	0.0	0.1	34.8	0.0	0.0	0.2	33.4	0.0	0.0	4370.9	2020.2	0.0	17.8	0.0	0.1	459.8
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201380833-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 362.1;skin 1: 215.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 174.7;Ductal cells: 178.0;monocytes: 248.6;Pancreatic endocrine cells: 227.0;Proximal enterocytes: 214.7;Squamous epithelial cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 159.9;CAPAN-2: 158.5;HaCaT: 220.4;HBEC3-KT: 190.3;hTCEpi: 181.5;MCF7: 218.3;OE19: 246.5;RT4: 164.7;SK-BR-3: 250.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.5	0.1	0.0	15.9	0.1	0.1	15.8	0.0	0.2	65.4	0.0	67.6	75.6	5.0	11.0	362.1	14.7	50.2	8.4	0.2	0.6	38.6	21.6	10.6	2.9	0.0	0.0	0.4	50.7	2.4	0.7	4.1	0.0	15.7	51.0	0.0	51.9	22.6	5.1	215.4	74.5	2.9	0.0	1.4	66.9	0.3	0.0	6.2	3.5	0.2	47.7	71.4	135.2	0.0	159.9	1.3	0.0	0.3	0.0	0.0	57.0	0.0	0.0	0.1	0.1	127.3	158.5	0.0	8.9	0.0	0.0	220.4	0.0	190.3	0.1	0.2	0.0	0.0	0.1	79.3	0.0	0.1	0.2	0.1	181.5	0.1	36.8	0.0	0.1	0.0	0.1	0.7	0.1	218.3	0.2	0.4	3.7	246.5	2.6	0.2	7.4	2.3	126.0	164.7	9.1	0.2	0.1	250.6	3.1	5.4	37.6	0.4	0.0	0.1	0.5	0.5	0.6	0.1	0.4	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	35.4	0.0	0.9	88.5	112.1	47.2	46.7	0.0	15.4	14.1	2.1	110.1	31.3	31.3	0.0	3.8	0.5	174.7	45.0	178.0	1.1	26.2	2.6	1.6	18.1	0.0	0.0	121.9	5.9	2.6	85.1	34.5	0.0	0.0	0.4	9.0	0.5	0.0	0.0	53.8	18.3	0.6	16.0	3.6	0.0	2.6	10.6	0.0	248.6	0.0	0.0	0.0	0.0	227.0	109.6	0.4	2.9	77.1	214.7	71.8	4.8	0.0	0.0	0.0	3.2	0.0	0.3	265.6	152.7	10.4	1.5	0.0	136.2	150.2
LCE3D	"LEP16, SPRL6A, SPRL6B"	ENSG00000163202	"Late cornified envelope 3D"	Q9BYE3	1	152579381-152580516	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 272.5;lymphoid tissue: 84.8;skin 1: 84.1;vagina: 229.7"	"Cell type enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 8.2"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 126.9;melanoma: 47.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 4.3;hTERT-HME1: 3.9"															NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"					"unprognostic (1.34e-1)"				"unprognostic (1.09e-1)"			"unprognostic (2.87e-1)"									0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	272.5	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	84.8	0.0	229.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE3E	LEP17	ENSG00000185966	"Late cornified envelope 3E"	Q5T5B0	1	152565654-152566780	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 96.8;vagina: 49.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"head and neck cancer: 40.7;melanoma: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"hTCEpi: 1.1"															NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"					"unprognostic (1.33e-1)"				"unprognostic (7.76e-2)"			"unprognostic (2.51e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	96.8	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.4	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LIMK2		ENSG00000182541	"LIM domain kinase 2"	P53671	22	31212239-31280080	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 40.0;neutrophil: 96.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 96.9"	"Cell line enhanced"	"Detected in all"		"BEWO: 135.5;hTCEpi: 251.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008183, CAB019313, HPA053882"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.57e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.37e-1)"	20.1	14.4	25.5	39.8	27.3	53.8	30.9	25.8	22.1	26.4	32.6	34.0	21.2	17.0	7.7	71.8	34.2	21.3	14.3	20.8	27.7	27.7	33.0	46.8	23.2	37.8	34.2	21.6	28.8	27.0	21.9	48.0	32.8	36.7	34.7	25.5	50.7	19.1	18.8	71.5	29.3	15.9	32.7	37.5	30.0	19.2	33.6	21.3	42.0	9.2	17.8	25.7	45.3	33.1	26.6	4.4	17.9	10.0	7.6	8.8	135.5	17.2	8.0	16.9	14.2	22.7	12.2	25.8	29.9	26.0	8.1	52.6	20.9	90.3	10.6	19.1	22.8	18.8	21.1	24.7	11.4	35.1	33.1	14.3	251.5	13.7	41.0	114.5	43.6	20.6	10.7	18.2	23.3	20.9	21.5	12.0	16.7	68.3	6.7	28.1	30.0	14.3	19.6	62.3	22.8	20.4	13.0	82.1	35.1	54.8	68.7	13.9	26.6	15.1	23.5	8.3	16.3	10.0	16.2	22.4	9.6	16.4	6.6	5.8	5.1	40.0	3.1	3.5	5.9	2.0	5.7	4.3	1.9	2.4	5.6	4.4	96.9	6.7	1.4	4.4	15.2	4.4	25.5	27.3	25.8	22.1	20.8	27.7	37.8	34.2	32.8	32.7	33.6	33.1	19.5	32.1	17.9	16.3	5.2	35.9	37.7	24.8	59.2	9.4	18.0	23.2	25.1	10.0	32.6	5.5	20.9	69.8	15.3	39.3	3.9	13.0	1.4	49.6	19.2	22.4	13.2	10.3	6.4	45.0	52.4	7.6	48.9	41.6	23.5	8.6	14.3	7.1	18.2	3.3	11.3	42.8	18.3	8.9	8.2	1.6	4.4	13.8	3.6	16.9	5.4	16.6	2.1	2.5	15.5	25.9	21.2	4.5	6.2	27.1	12.0	10.5	36.3	22.8	19.7	7.5	17.2	15.6	18.4	46.1	39.1	115.5	9.3	7.1	51.7	29.9
LPAR6	"P2RY5, P2Y5"	ENSG00000139679	"Lysophosphatidic acid receptor 6"	P43657	13	48389567-48444704	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 266.1;Basal squamous epithelial cells: 327.2;Early spermatids: 334.0;Langerhans cells: 703.7;Late spermatids: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.6;HUVEC TERT2: 35.3;MOLT-4: 20.0"	"Low region specificity"	"Detected in all"							HPA028934	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA028934: AB_2672833"	"unprognostic (1.19e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.82e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.94e-2)"	41.0	26.5	14.5	26.8	14.7	6.1	43.0	15.2	27.1	41.9	18.3	22.1	15.0	28.7	39.5	81.8	22.2	35.5	24.9	14.0	15.8	26.2	23.2	34.6	45.6	19.0	16.4	14.9	8.7	9.7	15.9	77.7	18.0	60.7	27.6	5.8	59.7	32.2	9.0	33.9	21.7	27.1	18.2	40.2	21.6	8.1	16.7	36.4	24.3	20.8	41.1	40.8	75.1	21.0	0.1	2.1	21.6	0.1	7.0	8.6	0.2	4.5	12.7	0.9	2.5	0.0	6.4	0.0	0.1	4.9	0.0	12.7	0.6	7.2	0.4	0.0	4.3	0.2	0.2	15.9	4.6	0.1	0.1	11.5	12.4	0.5	7.0	0.0	35.3	7.0	0.0	0.3	4.2	0.0	20.0	6.3	8.6	0.4	5.9	16.9	0.0	0.2	5.9	13.1	0.0	0.1	0.0	0.1	4.5	13.2	2.2	0.1	9.1	2.4	0.0	0.2	1.1	0.0	0.0	0.0	0.7	1.1	7.8	1.3	71.9	0.3	24.6	112.0	13.6	1.2	70.0	29.4	26.0	0.5	49.3	15.6	5.9	6.9	103.6	1.1	83.9	58.2	14.5	14.7	15.2	27.1	14.0	15.8	19.0	16.4	18.0	18.2	16.7	21.0	266.1	3.2	9.7	4.9	5.8	120.6	196.3	155.7	327.2	1.7	30.5	30.5	5.8	17.2	76.2	5.5	0.0	0.8	22.2	4.9	0.0	10.4	334.0	10.1	20.7	140.1	21.4	8.8	1.8	4.1	0.8	23.6	16.8	12.8	7.6	5.8	136.0	2.9	82.9	0.0	1.8	4.9	42.7	74.0	703.7	321.7	22.7	111.9	49.8	177.1	76.4	11.3	18.6	5.0	2.0	6.7	4.1	15.8	6.3	107.1	3.0	25.5	49.4	1.5	13.1	5.4	13.3	2.5	1.7	182.7	142.9	0.8	52.3	14.0	9.6	143.5
LTB4R	"BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7"	ENSG00000213903	"Leukotriene B4 receptor"	Q15722	14	24311450-24318036	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.1;skin 1: 110.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 45.5;Macrophages: 28.0;Suprabasal keratinocytes: 47.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 100.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 100.3;monocytes: 38.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 20.3;Karpas-707: 17.4"					"Low region specificity"	"Detected in single"			HPA003873	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA003873: AB_1078288"	"unprognostic (4.07e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (2.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.45e-2)"	12.5	12.5	1.3	5.0	1.4	16.0	11.8	1.6	1.4	33.3	1.5	6.2	4.2	6.6	5.3	103.1	10.4	2.2	5.4	1.2	1.3	10.3	18.0	15.4	5.4	1.6	1.4	8.4	7.7	0.5	10.8	2.2	1.6	16.8	1.6	4.2	23.5	2.2	5.8	110.1	12.2	1.6	1.5	40.7	6.0	7.8	1.8	4.0	10.2	0.7	9.2	6.8	51.5	1.6	2.7	5.7	2.0	1.6	1.3	1.3	8.4	1.1	0.8	1.2	1.4	4.2	3.2	4.2	1.9	1.1	2.1	20.3	1.8	3.1	1.7	11.5	6.3	4.0	8.4	2.9	0.6	5.7	5.9	0.7	5.5	2.3	3.0	1.8	2.0	6.8	3.7	17.4	0.5	5.6	2.5	10.1	1.4	0.2	4.3	9.9	1.8	7.4	0.7	4.3	4.3	1.7	5.3	2.9	3.0	3.5	4.9	6.2	1.3	4.3	4.2	4.2	1.5	9.9	2.3	7.1	0.9	14.9	2.8	17.0	38.4	40.5	3.4	4.9	2.4	0.0	2.5	2.7	11.2	0.2	1.2	0.8	100.3	2.1	1.2	1.1	0.6	13.7	1.3	1.4	1.6	1.4	1.2	1.3	1.6	1.4	1.6	1.5	1.8	1.6	10.1	0.0	0.6	3.6	2.5	24.0	10.5	18.5	12.0	3.0	6.3	5.0	1.4	5.7	4.3	0.0	6.2	0.9	14.2	2.2	0.0	2.1	0.3	4.6	1.8	5.6	0.0	1.3	1.5	6.1	0.8	2.5	3.1	4.5	1.3	1.4	7.9	4.1	15.6	0.0	1.3	2.8	8.2	45.5	3.7	1.1	3.4	28.0	3.6	2.8	25.4	1.6	18.6	1.0	1.2	4.6	5.4	1.5	6.2	2.7	5.4	0.9	6.4	10.8	6.6	2.0	1.8	1.5	1.4	22.6	47.0	0.8	13.5	1.3	3.2	2.5
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 46.4"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 18.2;Squamous epithelial cells: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	5.1	5.8	0.4	2.1	0.5	5.4	4.7	0.5	0.4	15.8	0.4	2.7	2.6	3.0	0.8	37.7	4.0	0.9	2.2	0.3	0.3	2.8	4.0	4.7	2.0	1.2	0.4	4.9	4.7	0.2	3.9	1.0	0.5	5.0	0.5	2.1	11.7	1.2	3.0	46.4	5.1	0.5	0.5	13.5	2.7	4.2	0.6	1.7	3.9	0.1	3.2	2.7	21.6	0.8	2.4	3.9	1.6	1.7	0.3	0.5	7.1	0.8	0.4	1.2	0.7	3.1	1.3	2.9	1.4	0.5	1.6	15.0	1.1	2.5	0.8	3.7	4.4	2.0	3.7	1.5	0.4	3.4	3.7	0.5	3.1	1.7	2.0	1.0	0.5	5.3	2.6	3.3	0.5	4.4	1.8	3.5	0.9	0.1	4.7	7.4	1.5	1.7	0.3	2.8	3.1	1.5	1.5	1.8	1.3	1.7	3.4	2.5	1.5	2.3	2.8	3.6	1.3	7.1	2.1	4.7	0.5	5.5	1.8	0.0	0.5	0.3	0.6	0.3	0.3	0.0	0.5	0.5	0.5	0.0	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.4	0.5	0.5	0.4	0.3	0.3	1.2	0.4	0.5	0.5	0.6	0.8	2.3	0.0	0.0	0.0	0.7	0.3	3.4	0.1	18.2	0.4	0.6	1.3	0.0	0.0	0.0	1.8	0.0	0.2	1.2	0.5	0.0	0.2	0.0	1.9	0.2	1.6	1.8	2.1	0.0	1.4	0.1	0.5	1.5	0.4	0.0	0.2	1.1	1.0	0.7	3.3	0.0	0.4	0.0	1.9	0.0	0.0	0.3	1.8	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.4	1.2	0.0	3.0	0.4	1.1	0.3	0.7	0.5	0.0	0.3	0.2	0.9	0.2	15.7	0.1	0.3	2.3	0.3	0.8	0.8
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784882-142786539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2074.3;skin 1: 850.4;vagina: 491.2"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 1171.6;Squamous epithelial cells: 1913.0;Suprabasal keratinocytes: 3866.1"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"A-431: 162.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					NA	NA		210000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	1.7	47.6	0.6	0.2	0.6	0.0	20.4	0.5	1.4	297.4	0.5	0.9	0.0	0.3	0.0	2074.3	1.0	1.4	0.8	0.6	0.5	0.3	0.8	0.5	0.0	0.5	0.5	0.5	1.0	0.0	1.0	2.5	0.5	15.3	0.2	0.0	235.4	0.3	2.6	850.4	0.5	0.0	0.5	0.5	12.4	0.4	0.5	4.6	0.4	0.0	75.6	65.2	491.2	0.7	162.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	6.0	0.0	1.3	0.0	0.2	0.0	0.0	4.0	11.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	1.2	4.0	0.2	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.4	0.6	0.5	0.5	0.5	0.5	0.5	0.5	0.7	0.1	3.2	0.0	0.0	0.0	1171.6	9.4	244.9	138.3	0.0	14.8	14.1	0.2	0.0	154.0	1.8	0.0	0.9	0.1	0.4	1.9	1.1	0.0	0.4	0.1	10.7	0.0	0.0	0.3	0.2	5.7	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	22.4	0.0	137.3	0.0	0.0	0.8	163.7	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	2.5	18.9	0.0	1.2	12.2	0.0	0.0	0.6	16.1	0.0	0.0	1913.0	3866.1	8.2	4.0	0.0	0.4	164.6
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465608	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1066.8;skin 1: 669.3;vagina: 487.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 504.7;Squamous epithelial cells: 811.7;Suprabasal keratinocytes: 2306.1;Syncytiotrophoblasts: 715.8;Urothelial cells: 642.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 158.5;head and neck cancer: 235.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 5.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.6;granulocytes: 2.1;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 99.5;MCF7: 114.2;RT4: 108.2;SK-BR-3: 158.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		7600000	"Cluster 32: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Vesicles"		"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	1.7	3.5	0.7	1.7	0.8	6.6	32.1	0.6	1.0	259.1	1.4	1.1	0.5	7.6	1.8	1066.8	3.5	1.3	1.3	0.7	0.9	2.9	1.2	1.6	2.6	0.7	0.8	8.9	1.3	1.8	2.3	12.3	0.7	11.9	0.7	1.0	183.3	1.3	2.8	669.3	1.6	0.8	0.7	2.1	3.3	1.1	0.8	12.2	1.2	0.2	131.9	55.0	487.0	0.7	38.6	0.6	0.2	0.6	0.3	0.0	15.3	1.5	3.9	1.4	1.9	0.5	42.5	0.4	1.7	1.1	5.6	99.5	0.2	4.4	0.7	0.0	0.3	0.7	4.5	0.8	0.4	0.0	0.9	1.7	37.2	0.2	0.3	1.7	0.0	3.1	0.2	0.1	0.1	114.2	0.9	0.0	0.2	24.3	8.3	0.5	0.0	0.2	1.0	108.2	0.1	0.3	0.5	158.9	1.8	4.7	17.7	0.1	0.0	0.0	0.7	0.5	0.7	0.6	3.0	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.8	0.0	1.1	0.1	2.9	1.1	2.6	0.0	5.5	4.7	2.1	0.0	0.0	0.3	0.9	1.2	0.7	0.8	0.6	1.0	0.7	0.9	0.7	0.8	0.7	0.7	0.8	0.7	0.9	0.0	1.1	0.0	1.3	504.7	102.5	161.2	111.0	0.7	66.6	38.0	0.6	2.8	72.6	14.7	0.0	96.5	2.1	0.9	1.9	1.6	0.1	4.5	4.4	7.5	0.0	0.4	0.0	0.2	87.2	18.1	3.6	24.5	5.7	0.5	0.0	0.3	14.0	3.3	0.1	2.2	24.4	0.3	139.8	0.0	0.6	23.2	147.7	0.0	0.7	4.5	0.0	0.0	0.2	4.7	0.2	0.4	0.0	40.4	0.3	0.7	5.7	0.5	0.0	1.5	10.5	0.1	0.9	811.7	2306.1	715.8	9.6	0.5	1.1	642.9
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27354067-27366961	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	42.9	17.8	17.2	5.5	17.0	0.6	42.6	17.4	20.7	50.2	16.8	25.4	1.8	30.9	4.1	70.0	38.8	4.7	61.8	16.6	17.4	37.3	10.4	54.2	4.7	18.4	17.5	15.6	15.2	5.2	18.0	5.1	17.6	41.3	4.5	1.4	30.3	7.3	15.2	65.7	17.7	12.1	17.3	22.3	23.6	8.3	18.4	2.8	30.3	11.3	7.9	39.8	53.4	16.6	7.2	7.2	6.9	4.4	9.9	12.5	1.4	9.0	5.3	7.2	4.4	2.0	9.4	0.1	8.4	16.4	3.2	10.1	2.0	6.4	3.6	6.5	7.1	0.3	16.0	4.7	2.7	0.5	0.4	10.2	17.6	7.8	2.3	8.8	4.0	0.7	2.0	2.7	10.2	25.1	0.2	9.0	2.2	8.7	8.1	2.3	3.2	1.7	12.9	9.1	2.0	3.0	8.5	7.1	6.3	3.1	4.4	5.0	11.6	13.2	7.2	16.6	5.2	3.5	4.1	0.0	12.1	5.8	4.3	0.9	0.6	3.3	2.8	2.0	3.7	1.5	2.5	3.1	1.3	2.0	1.8	1.6	1.2	0.7	4.5	0.0	3.0	1.2	17.2	17.0	17.4	20.7	16.6	17.4	18.4	17.5	17.6	17.3	18.4	16.6	45.8	19.2	17.8	6.2	3.9	12.5	11.9	8.8	17.1	1.1	8.1	8.9	12.2	5.7	10.3	3.7	0.0	1.2	4.3	8.4	3.9	2.8	0.4	2.3	6.0	27.7	0.0	0.8	1.5	4.4	2.5	10.3	8.6	5.2	2.5	1.2	28.9	0.9	2.8	5.0	1.7	6.1	4.1	8.5	7.1	1.2	16.1	6.4	5.4	5.6	9.3	5.4	8.2	0.0	0.2	12.8	1.9	15.1	3.1	9.5	1.1	1.7	6.2	0.8	6.6	10.8	11.1	13.5	7.7	14.7	14.8	0.1	8.2	0.3	8.8	14.9
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911020	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	11.3	13.8	12.6	21.1	16.1	24.0	16.8	8.1	16.3	18.5	10.8	25.9	26.1	14.6	7.7	51.8	16.6	14.1	20.9	14.9	9.3	13.9	13.1	17.0	21.5	11.8	9.3	12.0	22.4	19.4	19.8	14.9	11.5	20.5	22.4	8.8	27.0	13.1	20.8	40.9	25.1	16.3	7.3	24.1	20.9	10.6	9.5	23.2	19.5	13.7	24.0	19.3	25.0	17.9	52.0	34.1	26.6	28.6	14.6	18.6	35.2	20.8	20.0	29.5	22.3	34.1	49.5	37.8	35.6	20.8	32.0	57.5	26.9	28.7	24.6	26.7	20.9	40.7	23.9	20.3	17.0	45.9	51.4	10.9	36.8	27.0	21.4	13.5	24.7	33.6	35.7	36.5	19.5	64.4	49.3	29.9	31.7	36.0	24.2	39.9	20.4	39.7	19.1	39.8	37.9	25.4	34.7	90.2	24.3	28.9	65.1	26.4	22.7	30.3	19.1	39.6	23.4	24.5	28.8	36.7	20.1	23.2	25.3	1.4	0.7	2.1	1.3	0.7	2.1	0.9	1.0	1.3	1.0	1.6	0.8	0.9	3.6	1.6	1.1	0.9	0.6	0.7	12.6	16.1	8.1	16.3	14.9	9.3	11.8	9.3	11.5	7.3	9.5	17.9	17.3	6.4	6.8	29.7	18.5	25.2	21.1	9.1	19.4	26.8	30.0	18.2	12.8	27.1	11.9	20.2	8.4	26.0	33.4	90.3	1.9	20.2	0.6	29.5	15.8	14.7	29.9	14.7	43.6	21.4	20.6	11.7	27.0	41.0	17.2	21.1	13.6	13.0	17.9	20.2	30.3	39.9	10.2	26.7	18.5	0.9	12.8	25.0	3.6	29.0	17.0	18.8	36.0	31.7	51.8	27.3	39.4	10.9	15.6	30.4	33.4	8.1	14.5	18.1	19.7	19.6	13.1	9.1	18.4	39.9	34.4	65.0	23.6	16.0	33.6	44.3
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654244	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 221.7;Extravillous trophoblasts: 113.7;Pancreatic endocrine cells: 134.9;Syncytiotrophoblasts: 138.7;Urothelial cells: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;HBEC3-KT: 117.2;OE19: 100.0;REH: 315.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 17.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	33.0	4.3	3.9	5.7	4.2	0.2	23.1	4.1	5.8	23.2	4.3	2.5	1.7	5.8	1.2	44.7	10.0	12.8	8.8	3.5	4.3	5.5	1.5	18.6	1.7	8.2	5.8	15.6	3.2	1.6	9.1	11.0	6.3	14.3	0.4	0.1	22.4	2.2	0.9	15.4	3.2	2.5	3.6	0.3	4.6	5.0	4.6	1.5	4.6	1.1	2.5	13.6	27.1	4.2	60.1	0.2	50.4	0.1	0.1	0.0	80.5	0.0	0.0	0.0	0.0	0.0	28.2	0.1	18.2	0.0	0.3	48.4	13.8	117.2	0.0	0.0	0.0	0.4	0.0	2.5	2.2	0.0	0.3	3.6	53.3	0.6	24.6	0.0	38.4	16.1	0.2	0.3	0.0	0.0	41.8	0.4	34.4	100.0	1.6	315.3	29.6	0.5	3.3	9.2	9.4	23.2	0.6	43.1	0.0	34.5	0.2	4.0	40.3	0.1	44.1	0.5	1.7	0.1	0.3	0.1	0.3	2.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.2	4.1	5.8	3.5	4.3	8.2	5.8	6.3	3.6	4.6	4.2	1.8	0.0	0.0	0.0	0.0	24.5	48.6	36.8	12.0	0.5	18.9	16.9	0.9	0.0	8.2	5.5	0.0	221.7	0.2	0.4	0.0	33.8	0.5	0.5	1.7	12.7	0.0	0.0	0.1	51.2	113.7	12.8	0.0	0.7	0.0	10.0	7.9	0.1	19.6	0.0	0.3	1.2	6.1	0.0	4.5	0.5	39.1	0.4	0.0	2.8	0.6	0.0	0.0	4.5	0.2	134.9	0.0	6.0	0.0	55.6	0.0	0.0	3.5	0.0	0.0	19.7	9.1	0.1	7.9	10.7	9.1	138.7	0.6	2.7	0.3	73.5
MEAK7	"KIAA1609, mEAK-7, TLDC1"	ENSG00000140950	"MTOR associated protein, eak-7 homolog"	Q6P9B6	16	84476355-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 40.4;Syncytiotrophoblasts: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	3.0	2.2	3.5	3.6	3.0	1.3	4.7	2.1	2.8	4.6	3.4	4.8	4.1	4.7	5.6	12.8	3.7	4.3	2.4	4.0	2.0	4.5	3.4	4.1	4.5	4.1	1.7	5.1	2.6	6.4	2.0	10.8	4.2	4.7	4.9	6.4	3.8	3.8	3.0	7.2	5.4	4.2	0.3	3.4	4.0	2.2	2.3	4.5	4.9	2.1	6.4	7.2	6.6	4.2	29.1	20.0	17.1	9.2	7.8	13.3	8.1	21.1	18.8	21.2	6.1	11.5	34.2	4.0	11.1	40.8	15.5	31.5	4.9	56.1	27.7	2.2	4.2	3.2	9.7	10.0	9.6	2.5	9.6	9.5	23.9	19.8	25.8	17.1	9.0	11.1	5.3	4.7	14.3	6.8	2.2	2.5	5.2	15.1	7.0	9.0	4.3	1.3	18.7	15.9	5.6	4.0	19.1	13.5	9.4	17.9	19.1	3.9	22.0	14.6	6.7	7.8	8.8	3.7	6.7	10.6	8.8	1.3	5.1	16.9	2.9	4.0	3.3	2.4	3.1	2.8	5.6	4.6	2.5	2.3	6.1	3.8	2.3	2.8	3.2	0.6	8.0	2.5	3.5	3.0	2.1	2.8	4.0	2.0	4.1	1.7	4.2	0.3	2.3	4.2	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	47.1	0.2	0.0	0.0	0.0
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"		2	171317405-171434802	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"	3.6	2.8	2.8	3.2	4.7	3.6	3.7	2.5	3.9	3.4	1.8	5.3	2.2	3.0	2.1	8.6	2.4	2.8	2.5	2.6	1.9	3.1	3.6	2.0	3.5	2.7	2.4	2.2	1.7	2.1	1.2	2.6	2.9	3.9	5.2	1.6	2.1	4.0	3.6	6.8	3.6	6.4	2.0	3.3	2.1	4.2	2.8	2.1	1.8	2.3	3.9	5.2	3.8	4.0	10.3	7.4	5.0	13.0	11.7	14.1	19.1	12.8	9.8	11.1	10.0	13.8	13.5	25.1	9.5	8.1	8.2	10.0	17.7	19.4	13.9	10.8	9.9	15.0	6.5	25.0	11.1	17.0	9.1	12.5	24.7	16.0	28.1	2.6	18.6	10.9	26.7	4.1	9.7	13.5	14.3	4.8	16.9	8.3	8.8	7.0	15.4	21.9	9.1	6.8	12.2	5.1	14.5	11.4	9.2	6.6	9.4	7.0	13.8	11.4	6.1	7.6	7.5	3.6	13.0	15.0	7.2	15.9	11.2	0.5	2.1	0.5	3.4	2.7	4.4	3.4	4.4	3.3	2.1	5.1	1.9	2.1	0.7	3.7	1.6	6.7	4.8	2.5	2.8	4.7	2.5	3.9	2.6	1.9	2.7	2.4	2.9	2.0	2.8	4.0	8.1	6.4	6.1	25.1	72.3	25.5	10.7	18.3	27.9	8.4	10.6	9.1	8.2	14.3	14.1	3.7	2.1	15.5	13.1	8.4	11.7	7.6	13.3	4.0	19.2	8.2	6.7	16.2	28.7	6.2	21.2	14.9	6.1	6.1	6.3	18.5	7.5	10.6	11.8	11.8	33.0	5.7	12.2	9.8	10.2	4.1	14.0	11.9	10.6	17.8	11.4	6.3	7.2	29.1	48.2	8.8	5.3	16.1	24.2	20.4	9.8	18.3	6.4	9.2	6.6	10.8	10.8	11.8	21.3	32.8	26.7	12.9	18.3	23.0	13.7	10.0
MFSD5	"HsMOT2, MGC11308"	ENSG00000182544	"Major facilitator superfamily domain containing 5"	Q6N075	12	53251251-53254406	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039773	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA039773: AB_10793920"	"unprognostic (9.42e-3)"	"unprognostic (9.03e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.43e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.25e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.19e-2)"	18.5	28.8	15.9	12.2	16.9	22.1	16.5	18.1	17.7	19.7	18.8	19.1	13.5	16.6	12.8	61.3	13.3	11.4	21.8	16.0	17.0	19.3	15.8	15.6	14.7	17.4	17.2	9.9	22.1	19.8	11.7	16.1	17.2	15.7	14.6	26.9	26.1	13.3	19.0	60.1	18.5	13.4	17.4	20.4	19.6	10.6	17.7	9.8	12.9	14.0	20.3	18.2	30.6	18.9	23.8	51.1	15.2	27.9	57.7	32.7	17.6	34.7	43.3	36.4	34.1	27.2	43.8	19.4	29.6	50.1	34.4	43.1	24.9	28.7	24.2	25.0	34.7	14.8	18.6	36.2	40.0	28.6	35.8	40.8	39.5	34.5	17.1	39.4	33.7	18.7	27.8	34.4	35.5	89.2	14.0	35.3	26.4	27.3	44.5	17.1	15.3	26.3	26.8	41.1	12.5	18.8	25.0	34.3	28.0	17.8	59.6	26.4	32.2	30.9	20.0	32.0	22.8	20.8	27.3	15.1	41.1	27.4	30.2	58.3	32.3	103.7	26.6	25.9	32.7	50.1	31.4	30.2	38.1	44.6	23.4	22.4	17.5	27.8	17.7	31.9	27.9	23.4	15.9	16.9	18.1	17.7	16.0	17.0	17.4	17.2	17.2	17.4	17.7	18.9	5.5	9.6	10.6	6.2	12.1	13.0	5.8	15.9	14.2	5.4	9.4	7.4	9.5	10.0	18.1	12.9	31.3	38.4	7.8	20.3	5.9	20.4	0.5	5.2	8.0	10.8	2.4	9.9	2.2	26.5	24.5	12.1	9.2	7.7	5.7	7.6	11.4	10.9	28.6	3.3	2.7	10.9	10.2	18.8	13.4	2.0	6.2	11.7	16.0	0.0	17.2	7.8	14.4	3.5	3.4	21.9	13.3	4.9	10.9	8.7	12.0	10.9	10.3	14.3	6.6	7.7	8.4	4.7	14.2	21.3	17.0	33.2	12.1	6.2	8.5	7.9
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MPZL3		ENSG00000160588	"Myelin protein zero like 3"	Q6UWV2	11	118226690-118252365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.3;skin 1: 30.4"	"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 43.8;Suprabasal keratinocytes: 63.9;T-cells: 44.3;Urothelial cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	6	"basophil: 44.3;eosinophil: 99.4;MAIT T-cell: 28.9;neutrophil: 87.8"	"Group enriched"	"Detected in all"	8	"granulocytes: 99.4;T-cells: 28.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.3;HMC-1: 29.0;MCF7: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029116			Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA029116: AB_10610142"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.20e-1)"	3.3	0.5	0.7	4.7	1.0	7.3	8.2	2.8	0.7	11.5	1.7	5.6	5.4	1.5	4.9	33.3	5.4	7.6	1.6	0.7	0.8	3.1	7.5	7.9	4.8	1.0	0.7	0.5	7.2	6.7	3.8	0.8	0.9	5.6	6.1	1.3	11.7	2.7	1.7	30.4	5.3	1.5	0.7	6.0	6.8	1.1	0.8	2.8	6.1	0.9	12.6	4.4	16.8	0.7	5.0	0.6	0.0	0.7	0.0	0.0	0.7	0.6	0.1	0.1	0.1	16.7	26.3	4.9	12.5	0.0	1.9	6.8	1.2	5.6	0.1	0.3	2.0	3.0	1.4	8.1	0.2	4.1	29.0	0.3	13.6	0.0	5.4	0.0	8.8	3.3	3.8	2.7	0.1	17.1	1.9	2.2	2.4	16.5	1.2	0.0	0.0	7.4	10.0	6.2	3.4	0.3	6.6	8.6	0.5	1.3	15.4	2.2	4.3	0.1	1.3	0.1	0.1	0.4	5.1	3.1	0.1	0.1	0.3	44.3	6.0	99.4	7.0	3.7	28.9	1.7	11.3	9.6	8.1	1.9	8.4	6.9	87.8	8.2	2.6	1.1	8.4	5.3	0.7	1.0	2.8	0.7	0.7	0.8	1.0	0.7	0.9	0.7	0.8	0.7	2.4	16.0	26.9	0.0	4.9	35.6	21.7	11.8	9.6	0.3	28.2	14.7	1.7	5.7	15.9	9.2	2.1	0.6	9.6	19.6	0.0	10.5	7.4	32.7	4.1	4.9	12.0	0.4	2.2	8.8	0.7	1.6	18.3	34.0	1.3	0.1	2.2	8.2	1.3	0.0	2.3	5.1	14.2	5.1	18.7	7.7	0.0	5.5	10.6	1.9	3.8	0.3	4.1	0.5	0.3	16.7	9.1	0.4	6.6	30.6	9.3	1.1	43.8	1.7	0.0	0.4	2.3	1.7	0.8	14.3	63.9	1.6	44.3	0.2	8.1	46.4
MROH6	C8orf73	ENSG00000204839	"Maestro heat like repeat family member 6"	A6NGR9	8	143566192-143572772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 23.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.8;Hepatocytes: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 11.6;HaCaT: 13.6;OE19: 14.8;SK-BR-3: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068049	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068049: AB_2685945"	"unprognostic (2.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.04e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.18e-1)"	2.5	3.1	1.1	0.5	1.2	1.7	2.1	1.2	1.4	6.5	1.0	4.5	2.0	2.4	0.1	23.4	2.4	0.7	1.4	1.2	0.9	3.7	7.4	4.0	0.3	1.2	1.2	3.2	1.1	0.2	1.9	0.2	1.1	2.8	0.0	0.1	4.2	0.4	0.9	13.9	5.0	0.1	1.0	4.6	2.9	5.8	1.2	0.3	1.7	0.1	0.7	3.3	8.5	1.0	11.6	2.0	0.2	0.4	0.7	0.7	0.5	0.5	0.4	0.5	0.2	0.4	6.0	1.1	0.6	0.2	0.0	13.6	0.0	2.7	0.0	1.2	1.2	1.3	4.3	0.3	0.6	0.5	1.1	0.7	0.7	0.0	0.0	0.0	0.2	0.4	0.6	0.7	0.0	2.8	0.6	0.3	0.0	14.8	1.1	0.7	0.4	1.1	0.7	1.1	0.2	0.3	0.6	30.0	0.7	0.0	1.3	0.9	0.0	0.4	3.9	0.7	1.2	0.5	0.4	0.3	0.5	6.8	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	1.2	1.2	1.4	1.2	0.9	1.2	1.2	1.1	1.0	1.2	1.0	4.0	0.0	4.7	3.9	1.6	2.8	2.2	1.4	4.0	1.4	7.2	4.3	1.5	7.2	2.7	9.2	0.0	1.0	3.7	13.8	1.9	1.3	0.0	1.5	2.9	2.4	1.8	6.1	1.4	0.7	3.4	3.0	6.6	3.0	1.3	3.6	1.1	13.4	5.2	1.7	1.3	4.5	0.0	8.1	3.7	1.3	4.7	6.0	3.6	0.0	3.3	3.5	4.1	0.5	0.3	7.2	6.0	2.6	3.1	2.1	7.3	2.3	0.9	0.3	0.0	2.8	2.3	0.7	7.6	3.2	2.6	1.0	2.6	2.3	8.2	2.8
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294151-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.4;breast: 5.3;esophagus: 9.6;stomach 1: 6.0"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 199.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 172.8;A549: 83.5;CAPAN-2: 24.3;U-2 OS: 36.1"									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	5.4	0.1	0.0	0.6	0.0	0.1	5.3	0.0	0.0	1.8	0.0	0.5	0.3	0.0	0.7	9.6	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	4.1	0.2	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	3.9	0.0	172.8	83.5	0.0	0.0	0.0	0.0	2.5	0.2	0.1	0.0	0.0	0.5	24.3	0.5	6.3	0.0	0.1	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.4	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.1	8.5	0.0	2.4	0.2	0.1	3.8	0.1	0.1	0.2	3.4	6.8	0.0	0.1	3.5	0.6	0.2	0.0	0.0	0.0	2.4	0.6	0.0	2.9	0.7	1.6	0.1	36.1	0.0	1.4	0.3	1.7	0.2	0.2	0.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.0	0.8	0.8	3.8	0.0	0.0	30.7	37.7	0.4	0.0	17.6	3.7	0.0	0.0	0.9	7.8	0.0	12.6	12.7	1.2	0.1	0.5	0.0	0.0	0.0	9.4	0.4	3.4	23.9	1.5	0.0	0.1	0.0	0.2	2.4	0.0	0.0	1.3	2.0	0.0	0.0	6.9	0.3	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	199.3	22.3	0.0	3.9	1.4	0.0	0.0	1.5	0.0	0.0	0.1	2.9	0.0	0.4	3.4	1.3	0.1	0.4	0.0	2.7	8.5
N4BP1		ENSG00000102921	"NEDD4 binding protein 1"	O75113	16	48538726-48620148	"Predicted intracellular proteins"	"Immunity, Innate immunity"	"Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 134.6;Glandular and luminal cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040849, HPA041080"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040849: AB_10794866, HPA041080: AB_10794186"	"unprognostic (1.07e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.03e-8)"	"unprognostic (9.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.36e-2)"	9.3	6.7	8.0	7.3	7.8	10.3	9.0	9.7	8.0	10.2	7.9	8.8	5.9	8.6	8.3	18.9	8.4	6.3	7.9	7.6	11.0	7.4	7.0	14.7	7.5	8.5	7.8	9.7	7.6	11.4	9.1	7.5	8.2	8.8	6.3	6.9	10.7	6.4	10.5	19.9	9.3	6.3	7.1	10.9	9.2	4.7	10.7	10.3	8.3	7.9	9.0	8.1	11.3	8.4	7.1	11.8	8.3	8.5	11.4	9.0	6.9	6.5	9.9	12.4	6.3	9.3	5.8	7.9	5.9	10.0	5.5	14.4	7.5	10.3	6.8	4.9	6.2	4.1	4.7	8.3	11.1	6.2	10.8	13.0	15.5	4.4	6.4	9.1	6.3	8.1	6.4	8.2	7.5	4.0	7.4	11.2	6.6	7.3	6.7	11.1	13.5	12.4	6.2	11.9	9.3	6.6	5.5	10.0	9.2	8.6	4.2	8.5	9.3	6.3	5.6	3.5	3.9	12.2	7.8	12.0	7.3	4.9	5.6	0.9	1.3	1.8	1.0	1.2	1.3	0.9	1.3	1.6	0.8	0.6	1.1	1.1	8.4	0.4	0.9	1.0	1.0	0.6	8.0	7.8	9.7	8.0	7.6	11.0	8.5	7.8	8.2	7.1	10.7	8.4	41.2	134.6	32.7	28.4	15.3	20.0	21.6	32.4	19.4	24.1	21.3	21.2	15.1	22.8	25.8	7.3	16.7	13.4	53.8	35.4	5.9	8.4	6.4	36.8	35.8	25.7	9.6	6.5	47.5	13.2	10.5	20.1	30.5	113.8	12.6	23.1	24.3	13.4	19.5	26.9	50.1	21.2	6.1	25.9	40.3	3.7	16.1	36.5	5.4	58.1	31.9	15.3	21.6	38.7	54.8	26.7	21.6	20.7	30.2	30.6	16.1	9.4	18.4	23.0	0.0	26.3	17.6	12.6	24.4	26.8	22.7	28.5	36.5	23.8	13.4	47.5
NBEAL2	KIAA0540	ENSG00000160796	"Neurobeachin like 2"	Q6ZNJ1	3	46979666-47009704	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.2"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"HEL: 69.1;SK-BR-3: 64.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051969	Approved					NA	NA		31000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA051969: "	"unprognostic (3.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.99e-3)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.34e-2)"	16.7	16.0	4.0	23.3	3.6	92.1	19.3	3.3	5.7	34.3	4.4	21.5	12.8	10.5	4.6	103.2	14.7	11.0	15.2	3.3	3.4	36.9	11.2	54.0	20.9	4.2	3.8	7.9	40.7	6.7	11.3	4.8	4.5	21.5	8.4	0.8	35.6	8.4	6.5	86.0	31.0	5.6	3.8	70.0	42.5	6.3	4.6	11.2	14.7	2.9	15.8	16.6	56.8	3.7	20.2	22.1	4.0	11.3	2.3	0.8	12.9	2.8	1.7	3.8	2.5	19.4	14.2	17.4	7.7	2.4	3.7	13.0	8.3	9.0	1.9	15.4	12.4	69.1	27.8	12.2	2.2	11.9	48.5	1.9	14.8	3.9	6.0	4.6	34.2	36.2	14.6	26.3	1.9	31.2	20.5	32.7	10.6	31.9	10.0	21.6	0.5	23.0	9.1	41.1	6.1	9.9	2.4	64.4	5.7	4.9	31.5	19.9	25.3	0.3	11.7	5.1	8.9	20.1	20.7	16.3	5.1	55.0	2.9	0.2	0.6	0.4	0.5	0.6	0.1	0.0	0.2	0.5	0.1	0.0	0.1	0.1	4.4	0.4	0.4	0.1	0.2	0.3	4.0	3.6	3.3	5.7	3.3	3.4	4.2	3.8	4.5	3.8	4.6	3.7	15.0	12.8	9.4	7.8	10.0	3.3	5.5	2.4	5.7	1.3	16.3	18.2	4.3	8.6	9.3	33.1	18.8	2.2	30.8	15.1	1.9	22.9	1.4	20.0	4.1	9.8	7.2	10.3	4.0	23.1	1.1	3.0	144.3	23.9	6.3	5.1	11.7	1.2	11.1	0.0	1.5	11.5	4.1	12.9	8.3	1.0	1.2	27.9	0.0	6.5	14.6	1.5	26.8	1.0	1.4	31.4	5.6	0.0	14.2	6.2	3.4	1.3	6.6	1.9	13.1	3.4	3.5	0.5	2.4	33.6	8.0	1.9	26.3	4.5	15.1	21.0
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"NCCRP1, F-box associated domain containing"	Q6ZVX7	19	39196964-39201884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 453.4;skin 1: 273.2;vagina: 181.7"	"Cell type enriched"	"Detected in some"	12	"monocytes: 563.9"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.8;head and neck cancer: 48.5;melanoma: 28.3;urothelial cancer: 33.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 30.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.6"	"Low region specificity"	"Detected in some"			HPA052812	Approved					NA	NA		400000	"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.3	0.2	1.3	2.1	0.9	1.0	6.3	1.9	1.8	97.0	0.0	0.4	2.0	0.6	0.8	453.4	1.1	0.8	0.4	1.0	0.8	2.8	0.2	0.4	2.7	1.0	0.9	0.4	8.8	1.4	0.4	1.1	1.3	1.4	1.9	1.7	54.0	1.2	0.9	273.2	0.7	0.5	0.9	1.4	0.5	0.5	1.0	4.1	0.6	0.0	124.9	5.2	181.7	1.4	0.2	0.2	1.1	0.2	0.1	0.7	2.4	0.1	0.0	0.1	0.2	0.5	0.5	0.7	2.3	0.4	0.2	1.0	1.7	0.7	0.5	0.0	0.4	0.2	0.9	0.1	0.2	0.5	0.3	0.5	0.5	0.1	0.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.2	0.2	0.7	0.2	0.2	0.2	0.4	0.4	0.1	0.6	0.6	1.0	2.9	30.8	0.2	0.9	0.4	0.9	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.6	0.6	0.2	0.5	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	1.3	0.9	1.9	1.8	1.0	0.8	1.0	0.9	1.3	0.9	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	1.6	8.5	0.0	0.3	4.7	2.4	0.3	0.0	30.8	3.7	0.0	0.4	0.2	0.1	0.0	2.7	0.0	0.7	0.4	0.2	0.0	0.0	0.0	2.3	3.1	1.0	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	6.1	0.0	4.7	0.2	0.0	0.7	1.8	0.0	563.9	0.3	0.0	0.0	0.0	4.2	0.7	0.0	1.2	1.1	0.0	0.1	1.6	0.0	0.0	0.1	2.0	0.1	0.5	7.3	7.1	11.1	0.2	0.1	0.0	46.4
NDUFA4L2	"COXFA4L2, FLJ26118, NUOMS"	ENSG00000185633	"NDUFA4 mitochondrial complex associated like 2"	Q9NRX3	12	57234903-57240715	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 304.9"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 627.0;Sertoli cells: 1130.7;Smooth muscle cells: 525.6"	"Cancer enriched"	"Detected in all"	5	"renal cancer: 356.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"AN3-CA: 133.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.23e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.10e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.74e-2)"	85.6	14.0	41.6	6.8	40.1	0.2	55.1	41.4	61.5	109.3	36.8	17.4	5.8	20.7	2.4	304.9	15.5	17.1	180.1	40.3	41.1	47.6	20.9	62.6	5.8	43.0	42.7	14.0	14.5	12.1	30.9	71.7	48.8	27.3	1.9	29.4	55.8	9.8	43.8	206.9	14.2	7.5	38.9	74.1	18.0	8.7	43.5	3.2	54.5	29.2	4.8	27.7	183.5	45.4	0.9	1.3	0.3	133.9	5.4	3.1	0.4	2.1	1.5	0.6	1.3	0.0	1.5	5.5	5.6	2.1	0.1	1.2	0.7	1.0	0.0	3.0	0.2	0.6	0.3	0.1	18.6	4.1	2.0	12.0	2.5	0.2	4.7	0.9	0.0	7.6	0.5	7.2	0.4	2.7	1.1	0.2	0.3	0.6	2.4	2.1	1.0	11.0	0.1	0.1	7.1	2.5	0.2	0.3	4.7	0.1	1.5	14.5	0.6	1.2	0.1	1.1	0.7	10.0	3.5	2.5	4.9	9.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	41.6	40.1	41.4	61.5	40.3	41.1	43.0	42.7	48.8	38.9	43.5	45.4	156.0	0.0	0.5	2.6	2.6	151.2	0.9	89.2	6.8	30.6	2.6	5.8	1.2	0.0	24.8	0.0	18.8	1.0	0.9	0.1	0.0	1.6	1.7	0.4	3.0	91.8	0.0	0.0	2.2	0.0	1.5	21.5	4.6	0.3	8.9	0.1	2.9	1.3	1.9	11.8	3.0	0.2	54.9	0.0	28.9	3.0	3.1	2.0	30.2	18.7	1.0	627.0	0.0	0.5	0.4	4.7	0.0	2.2	1.4	2.0	0.1	0.3	6.2	25.7	1130.7	13.0	525.6	12.3	5.5	20.3	161.4	1.1	1.9	2.5	0.2	1.4
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729200	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 128.8;skin 1: 134.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 12.1;Breast myoepithelial cells: 27.3;Exocrine glandular cells: 12.3;Granulosa cells: 68.7;Pancreatic endocrine cells: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 229.2;hTCEpi: 139.2;RT4: 157.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"	NA	NA		180000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	4.4	4.0	14.8	4.7	25.6	24.3	8.2	17.4	32.3	14.0	0.0	12.4	16.6	3.4	2.3	128.8	4.0	3.4	8.1	30.5	15.3	5.1	4.3	3.4	2.1	23.8	26.5	2.3	18.8	2.7	7.8	7.3	18.4	12.8	12.9	18.5	18.0	6.2	1.9	134.4	12.0	4.5	16.3	3.3	4.6	1.3	26.9	6.7	2.2	1.6	27.9	28.9	36.8	38.8	16.6	13.6	12.6	18.2	6.5	2.1	88.2	6.6	6.1	5.4	3.8	28.8	55.2	21.8	26.1	7.6	10.9	229.2	32.5	117.6	2.4	51.8	4.9	3.0	4.4	13.2	2.6	14.9	35.4	2.0	139.2	17.1	62.5	2.1	16.3	6.2	0.6	113.2	7.2	42.7	0.3	9.0	41.6	55.3	18.7	1.2	75.7	26.3	5.1	157.4	30.6	68.6	22.1	57.4	1.8	18.8	52.3	2.2	9.0	4.8	17.6	39.2	5.9	20.6	28.0	0.2	1.7	11.9	11.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	1.6	0.0	0.0	14.8	25.6	17.4	32.3	30.5	15.3	23.8	26.5	18.4	16.3	26.9	38.8	4.2	0.0	3.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	12.1	27.3	0.0	0.0	4.3	1.8	0.0	4.1	4.1	0.0	0.0	8.7	0.0	4.6	3.2	1.3	0.0	0.0	0.0	12.3	1.3	2.1	0.0	10.9	0.0	68.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.5	0.0	0.0	1.9	0.0	0.0	3.3	1.5	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	8.9	1.3	1.7	0.0	0.0
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070998-161089558	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.9;skin 1: 113.6;vagina: 57.3"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 384.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.4	0.1	0.1	0.5	0.1	0.7	13.7	0.3	0.2	26.5	0.0	1.5	0.7	1.2	6.9	98.9	2.9	3.8	0.1	0.1	0.0	3.1	0.1	3.5	0.1	0.1	0.1	0.0	4.5	0.4	0.6	12.2	0.1	9.4	1.7	0.1	33.6	4.3	0.6	113.6	0.6	0.1	0.0	0.0	8.8	0.6	0.3	0.8	0.2	0.0	14.5	16.8	57.3	0.4	10.9	0.4	0.0	0.1	0.0	0.1	56.5	0.1	0.1	0.1	0.2	0.0	14.6	0.0	0.2	0.0	0.1	37.0	0.0	1.2	0.2	0.0	0.5	0.0	0.8	11.1	0.0	0.1	0.7	0.0	14.6	3.0	3.6	0.1	0.0	0.0	0.0	0.1	0.1	24.0	0.1	0.1	0.1	24.6	0.0	0.0	0.0	0.1	0.0	17.5	0.0	0.2	0.2	47.8	0.0	6.4	31.1	0.0	0.0	0.1	2.4	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.2	6.4	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.6	17.8	0.0	0.0	8.1	16.5	0.0	39.4	0.4	0.0	0.0	41.7	0.0	28.1	2.9	0.6	0.0	0.0	0.0	30.0	67.1	1.2	0.0	43.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	384.2	0.4	0.1	0.0	0.0
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 100.2;skin 1: 38.5;vagina: 30.7"	"Group enriched"	"Detected in many"	4	"Squamous epithelial cells: 212.4;Suprabasal keratinocytes: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 90.2;HaCaT: 382.6;K-562: 311.3;Karpas-707: 135.7"	"Group enriched"	"Detected in some"	8	"hypothalamus: 1.1;pons and medulla: 4.5"	"Low region specificity"	"Detected in some"			HPA025926	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.4	0.7	0.5	9.7	1.5	0.6	1.1	12.3	0.0	1.4	0.8	0.1	0.0	100.2	0.2	0.0	0.2	0.3	2.8	0.2	0.0	0.8	0.5	1.1	2.6	0.1	0.1	0.0	2.3	0.8	0.8	0.2	0.8	0.1	14.3	0.2	0.1	38.5	1.4	0.2	3.0	0.1	4.0	2.2	6.8	1.7	2.5	0.0	7.7	0.1	30.7	0.4	41.3	0.3	22.1	5.6	0.0	0.0	0.0	0.0	0.0	2.9	7.8	0.3	61.5	90.2	8.6	0.0	8.5	382.6	46.1	3.3	2.3	5.6	25.1	0.6	36.0	0.0	0.0	0.0	0.3	0.0	4.2	0.0	3.0	10.0	0.4	6.4	311.3	135.7	0.3	9.9	1.2	0.2	11.7	7.5	11.4	0.2	0.0	0.5	1.9	0.4	19.5	49.0	30.9	0.8	0.1	4.2	20.9	0.1	2.7	0.2	27.5	0.3	54.5	39.1	0.3	0.0	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	1.1	0.3	2.8	1.1	2.6	0.8	3.0	6.8	0.4	0.0	0.0	2.3	0.0	0.6	16.3	0.6	16.2	4.0	0.2	0.9	1.3	0.1	0.0	8.0	0.0	0.0	2.0	0.0	0.6	0.0	0.1	0.4	3.9	0.3	0.7	0.0	14.5	0.2	0.2	0.1	4.4	29.6	5.8	1.3	0.9	0.0	0.1	0.3	0.0	17.2	0.8	20.3	0.0	1.6	0.3	0.0	0.2	3.6	0.0	0.1	2.0	0.0	1.0	0.2	2.4	0.2	0.0	1.2	0.4	0.0	0.0	7.0	0.0	0.0	0.0	1.2	5.8	10.0	212.4	73.6	0.1	0.7	0.2	2.6	12.0
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	1.5	0.5	0.5	5.9	0.2	13.6	1.5	0.2	1.0	5.6	0.7	0.9	1.5	0.6	0.3	11.7	0.9	1.3	0.7	0.2	0.4	0.6	1.7	4.3	2.7	1.0	0.9	0.4	0.3	0.2	0.4	1.2	0.7	0.9	0.9	0.0	4.3	0.4	0.6	14.4	1.3	1.8	0.7	4.4	1.4	0.5	1.4	0.8	0.4	0.3	2.3	1.6	12.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.0	5.8	7.3	0.0	0.0	0.0	0.0	0.0	15.9	7.2	0.0	0.3	0.1	0.0	3.0	23.0	6.0	0.4	13.1	0.7	0.1	1.3	1.4	21.3	0.0	0.1	0.5	10.5	3.4	9.0	1.0	0.9	11.1	0.5	0.2	0.2	1.0	0.2	0.4	1.0	0.9	0.7	0.7	1.4	0.8	0.2	0.0	3.7	0.0	1.9	5.9	0.3	1.2	0.0	0.0	1.4	1.1	0.4	1.5	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	5.6	0.8	0.6	1.2	0.8	0.1	0.0	0.0	0.4	0.0	8.3	1.3	0.5	0.0	0.5	2.5	0.0	0.1	0.0	2.0	9.0	22.5	0.0	0.0	15.2	1.8	1.9	15.6	0.0	1.0	0.0	0.2	0.0	0.0	0.4	4.3	0.4	0.0	0.1	1.0	0.0	0.0	0.1	0.4	0.1	0.4	6.1	15.5	0.3	2.3	0.1	0.1	0.3
OAS3		ENSG00000111331	"2'-5'-oligoadenylate synthetase 3"	Q9Y6K5	12	112938051-112976460	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 15.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 202.5;BJ hTERT+ SV40 Large T+ RasG12V: 224.5;GAMG: 89.8;RT4: 62.6"	"Not detected"	"Not detected"							"HPA041253, HPA041372"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		Yes	No		21000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041253: AB_10794990, HPA041372: AB_10795590"	"unprognostic (8.47e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.06e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.23e-5)"	"unprognostic (4.25e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.93e-2)"	8.1	4.1	3.2	11.5	3.1	20.9	6.0	2.3	2.5	11.0	1.1	7.1	7.1	3.9	1.5	15.8	5.2	11.3	7.0	2.2	2.4	5.6	4.4	12.6	6.0	8.7	3.6	3.8	3.8	3.2	3.5	11.1	6.4	3.4	6.2	0.6	27.7	2.7	3.0	5.4	6.5	9.3	11.8	17.9	11.0	2.3	4.1	16.1	4.1	5.9	6.4	14.4	7.8	3.0	23.2	34.4	0.3	5.5	1.0	4.6	2.1	2.6	25.3	202.5	224.5	24.1	20.5	0.7	7.3	8.1	89.8	15.7	3.3	22.7	11.2	9.7	1.2	15.9	16.3	4.0	3.9	4.5	6.6	0.9	7.2	32.8	1.3	4.0	11.7	3.9	0.5	3.1	2.0	13.3	8.0	2.7	1.4	33.7	22.8	13.5	11.6	0.1	7.0	62.6	0.6	0.1	19.8	5.5	14.8	0.2	25.7	1.1	9.5	4.6	4.0	5.5	6.5	0.8	21.0	0.2	4.9	12.9	16.7	1.0	7.8	0.8	1.4	7.4	1.7	2.3	2.0	2.3	4.1	1.0	1.8	1.7	9.7	2.7	15.3	0.3	2.6	3.5	3.2	3.1	2.3	2.5	2.2	2.4	8.7	3.6	6.4	11.8	4.1	3.0	19.9	3.2	3.9	0.7	3.8	3.4	5.6	13.5	5.2	0.4	3.1	2.7	1.7	0.0	5.1	3.7	0.0	5.4	1.8	14.7	3.9	11.2	5.9	1.8	4.1	20.8	1.8	0.8	0.3	9.8	20.9	5.5	16.3	5.6	1.3	21.9	9.3	1.7	18.7	0.0	0.4	6.8	8.2	5.8	7.0	10.8	10.2	16.7	1.8	5.6	30.2	3.0	8.2	3.5	0.0	21.2	8.2	15.1	1.4	11.8	4.5	2.0	2.3	0.5	0.0	2.5	5.0	0.8	0.7	14.4	4.7	1.9	6.5	9.2	5.4	26.8
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787063-65797214	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 57.2;skin 1: 51.0;testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003984	Uncertain		Approved	Nucleoplasm		Yes	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.1	0.0	0.0	1.0	0.1	0.1	2.8	0.2	0.1	13.6	0.0	10.3	15.5	0.5	0.1	57.2	0.6	0.9	0.0	0.1	0.0	7.4	0.2	0.3	0.0	0.0	0.0	0.0	9.1	15.0	0.1	6.9	0.0	1.4	8.3	0.1	8.8	1.0	0.1	51.0	9.1	0.3	0.0	0.1	1.6	35.5	0.0	0.4	1.3	0.0	5.5	27.4	21.3	0.1	19.0	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.0	0.0	0.0	13.6	5.0	0.0	0.1	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.1	1.4	31.2	0.2	0.1	0.0	24.0	0.2	5.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.3	2.3	26.6	62.6	14.5	54.1	0.0	59.4	25.4	0.5	7.2	13.0	3.7	0.0	19.5	1.3	57.6	0.0	2.5	81.9	76.2	11.7	1.8	31.6	0.0	0.1	3.8	14.0	0.9	0.0	113.2	2.5	0.0	0.0	0.1	2.1	0.0	0.1	54.9	20.3	0.0	1.4	87.2	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	44.5	1.9	3.0	34.1	39.1	6.7	11.3	0.0	0.0	0.0	1.1	83.9	4.8	130.8	57.4	348.9	1.7	0.0	52.0	114.9
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694972-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	13.5	10.3	5.6	7.6	5.7	10.6	12.4	5.7	8.1	9.3	5.5	8.4	4.2	10.3	7.2	16.3	8.4	5.2	9.6	5.7	6.2	9.3	11.3	7.3	7.8	5.7	6.0	8.0	9.6	5.7	6.7	7.0	5.9	37.8	7.3	4.9	9.2	5.7	15.2	8.8	7.1	8.1	5.8	8.2	7.8	5.7	5.9	7.0	7.5	9.7	9.6	11.5	9.9	6.9	35.3	13.7	17.2	29.9	21.3	19.4	24.9	22.4	18.7	33.7	32.9	30.2	15.4	35.6	54.9	19.4	41.4	18.4	35.8	29.2	48.1	20.9	23.3	19.4	12.4	35.2	31.1	54.5	24.3	17.9	25.2	32.6	55.3	11.1	22.9	19.2	60.2	10.0	28.3	21.2	27.4	49.5	37.4	32.7	24.1	27.9	22.4	55.0	24.4	21.0	25.7	22.4	16.8	42.7	51.1	28.9	18.9	19.6	19.6	26.9	19.5	29.2	56.4	23.3	68.7	38.9	11.0	36.3	51.7	2.0	8.1	2.9	9.4	12.4	9.6	10.0	8.3	9.4	11.7	7.2	11.1	13.5	0.4	9.9	10.3	13.7	5.9	6.8	5.6	5.7	5.7	8.1	5.7	6.2	5.7	6.0	5.9	5.8	5.9	6.9	22.6	19.2	12.3	8.8	18.5	66.4	54.2	47.3	30.1	13.2	18.6	28.3	18.6	17.2	35.0	11.0	4.2	24.9	24.8	10.3	19.6	43.3	12.4	26.0	35.0	24.1	5.4	31.1	9.9	26.9	32.0	32.0	14.8	34.3	35.5	16.6	15.0	21.7	36.6	13.5	10.9	12.7	42.7	16.1	12.6	8.4	21.5	18.2	12.4	6.5	22.1	12.0	12.3	9.5	12.5	31.3	7.7	20.7	18.2	56.5	5.1	27.0	17.7	11.8	6.6	40.9	31.4	27.3	44.2	29.3	49.9	17.5	16.3	23.1	24.0	28.6
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 154.7;MCF7: 172.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	11.6	20.0	16.7	8.1	18.2	5.3	22.1	14.2	18.4	27.2	14.0	30.2	27.4	20.6	9.4	43.9	23.4	7.5	15.5	13.9	13.4	37.2	26.2	39.6	4.5	17.1	17.2	24.2	31.8	16.2	30.5	16.3	15.8	40.7	8.0	5.8	42.4	11.0	14.0	40.4	25.1	5.7	12.0	13.8	25.3	35.0	15.7	5.4	29.3	4.3	5.4	20.2	30.4	17.0	62.8	154.7	22.7	34.8	7.1	7.5	68.1	29.3	11.7	19.3	19.4	102.1	51.9	14.3	43.3	18.7	25.2	22.7	12.6	23.2	7.2	38.0	35.4	16.9	27.5	50.4	11.3	17.5	23.6	9.0	10.2	18.1	12.9	12.6	25.5	21.4	34.3	11.0	11.8	172.7	18.6	18.9	41.4	55.2	36.7	18.5	17.9	10.9	19.0	67.9	72.2	49.9	29.8	130.6	33.6	11.7	58.1	28.4	42.8	32.6	55.6	37.8	53.0	12.3	12.9	11.9	39.9	10.3	39.9	0.3	0.7	1.2	0.6	0.3	0.8	0.5	0.7	1.1	0.9	0.6	0.5	0.5	0.5	0.9	0.6	0.8	0.9	0.7	16.7	18.2	14.2	18.4	13.9	13.4	17.1	17.2	15.8	12.0	15.7	17.0	5.1	0.0	1.5	9.4	3.9	14.4	15.9	13.8	9.6	18.8	34.2	21.7	2.0	20.0	9.1	18.4	25.0	42.6	4.4	47.5	31.3	20.5	4.1	19.5	8.5	15.0	44.9	5.0	3.9	19.7	67.4	8.8	23.9	23.3	5.7	21.6	10.0	13.3	9.6	21.9	4.2	33.8	28.5	5.3	4.1	6.4	11.8	3.6	7.2	8.4	11.2	13.6	8.2	9.5	13.5	21.8	44.2	10.5	5.8	21.7	39.5	14.4	13.7	13.4	0.0	8.5	7.5	10.4	24.0	20.1	18.8	65.4	6.0	22.3	33.9	24.3
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853090-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.5;Distal enterocytes: 66.4;Exocrine glandular cells: 46.3;Pancreatic endocrine cells: 65.2;Urothelial cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 86.1;HaCaT: 108.0;HUVEC TERT2: 56.2;OE19: 77.8;RT4: 74.2;TIME: 74.5;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		2500000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	24.0	4.0	11.7	7.7	15.9	1.2	22.8	3.3	15.1	11.6	0.0	23.1	21.4	9.2	6.4	41.7	9.1	6.6	19.3	17.0	2.3	21.3	19.3	27.7	2.0	0.0	0.8	2.5	13.8	3.8	6.5	19.2	0.0	10.8	14.3	3.4	28.8	11.2	8.2	27.4	17.1	7.2	1.1	1.8	23.6	1.1	2.7	1.0	12.6	11.1	9.1	9.8	19.2	5.7	18.9	1.0	7.7	8.5	0.3	0.0	5.5	0.2	0.2	0.1	0.0	4.5	86.1	0.1	43.7	0.6	1.0	108.0	9.9	7.9	0.0	0.1	0.3	0.0	0.4	0.1	6.9	0.0	0.3	0.0	17.8	0.1	1.2	18.1	56.2	0.0	0.1	9.2	0.0	15.1	0.3	0.0	32.5	77.8	14.6	0.3	0.1	13.2	6.3	74.2	0.9	1.8	0.5	23.3	20.0	21.6	18.8	0.4	74.5	0.1	0.7	0.1	6.9	0.0	0.1	0.2	0.5	0.0	52.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	11.7	15.9	3.3	15.1	17.0	2.3	0.0	0.8	0.0	1.1	2.7	5.7	61.5	0.0	5.3	3.6	0.2	1.0	12.0	4.6	0.0	9.6	9.5	4.7	4.4	20.0	8.6	12.9	0.0	0.7	2.0	66.4	3.9	15.3	1.3	10.1	2.1	34.2	7.7	2.7	12.3	46.3	0.3	2.6	21.9	21.3	0.0	0.0	7.5	30.1	0.2	26.9	6.1	21.3	12.2	1.4	2.3	2.5	0.6	0.5	0.0	6.5	0.0	4.8	7.2	5.5	7.2	65.2	30.3	0.4	1.4	25.8	36.4	5.2	7.1	0.5	13.1	0.9	18.5	0.3	0.2	7.4	2.6	20.1	0.9	0.5	18.9	54.5
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"P53 apoptosis effector related to PMP22"	Q96FX8	6	138088505-138107419	"Predicted membrane proteins"	"Apoptosis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 782.9;skin 1: 1115.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 3312.8;Squamous epithelial cells: 3451.4;Suprabasal keratinocytes: 5828.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 555.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 39.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 39.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1024.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022269	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA022269: AB_1855219"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	27.1	9.3	7.0	9.9	7.1	1.5	131.0	7.8	8.6	201.6	13.7	40.9	50.2	23.2	47.9	782.9	61.2	37.9	53.9	6.8	8.1	21.9	93.7	27.0	3.3	9.2	7.8	6.4	33.1	40.6	13.1	38.7	8.6	60.7	38.4	8.7	295.9	46.8	5.7	1115.1	52.0	19.8	7.8	1.4	65.1	3.1	9.3	23.3	24.6	16.3	149.4	60.2	426.4	6.3	81.5	80.3	3.7	11.3	60.0	63.1	172.7	115.5	129.8	17.6	12.9	64.8	143.1	1.5	45.5	37.5	144.0	268.4	15.6	207.6	4.5	126.9	64.6	1.5	70.7	69.8	42.6	1.7	1.0	44.3	1024.8	2.2	111.8	91.7	71.3	5.8	2.4	31.3	3.0	53.4	1.5	4.6	34.4	174.6	47.1	1.5	28.6	0.9	108.2	94.0	29.3	3.7	141.2	68.7	59.6	90.7	36.4	18.4	82.6	29.4	12.1	31.7	2.1	11.1	17.4	1.3	23.0	1.5	65.5	39.8	0.0	0.0	4.3	0.0	7.6	2.0	5.3	3.8	0.0	1.0	0.6	2.3	0.3	0.1	0.0	0.0	8.9	1.3	7.0	7.1	7.8	8.6	6.8	8.1	9.2	7.8	8.6	7.8	9.3	6.3	13.9	211.5	84.2	0.7	8.1	3312.8	1415.8	1383.2	1110.4	3.3	371.4	305.0	137.7	260.2	728.5	154.5	16.7	994.5	17.6	374.8	62.6	588.0	2.1	1013.4	78.1	71.8	147.2	13.9	1.2	305.1	990.1	83.8	197.2	777.1	10.8	0.5	21.4	171.3	82.0	3.3	2.1	185.0	736.5	3.8	259.2	2.7	10.5	12.8	350.4	12.2	10.3	29.1	3.1	2.0	0.5	655.0	316.7	2.6	43.2	789.2	355.0	10.6	743.5	28.3	6.6	15.4	82.6	2.4	1.4	3451.4	5828.3	824.0	67.2	73.5	218.6	1546.6
PHLDA2	"BWR1C, HLDA2, IPL, TSSC3"	ENSG00000181649	"Pleckstrin homology like domain family A member 2"	Q53GA4	11	2928273-2929420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.6;placenta: 79.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 4600.4;Extravillous trophoblasts: 2222.5;Syncytiotrophoblasts: 9959.7;Urothelial cells: 2892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.9;monocytes: 1.2;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 395.9;PC-3: 326.0;SK-MEL-30: 289.9;WM-115: 358.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003994			Uncertain	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoli		"HPA003994: AB_1855311"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.16e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.01e-3)"	"prognostic unfavorable (4.22e-5)"	"unprognostic (1.24e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.59e-1)"	9.3	2.8	1.6	3.6	1.7	1.2	5.3	2.2	2.6	12.6	1.5	14.7	7.3	4.7	0.7	42.6	4.7	3.0	2.9	1.6	2.7	21.8	5.9	7.8	0.3	5.1	3.4	2.4	4.1	0.4	2.8	79.7	4.7	15.4	1.7	0.0	10.2	0.9	0.9	21.4	6.4	0.8	1.9	2.7	17.8	0.8	2.4	0.1	5.6	0.4	1.3	12.7	18.7	2.4	42.2	31.1	1.9	0.5	0.4	9.8	43.4	72.4	21.4	12.9	11.8	15.4	91.8	0.0	41.9	12.1	32.2	51.8	0.1	42.8	2.4	395.9	14.1	0.0	13.9	10.4	32.7	0.1	23.5	13.9	20.2	11.1	12.1	8.8	10.9	0.0	9.2	0.7	6.5	148.9	0.1	6.1	16.5	26.8	326.0	0.0	0.0	29.6	32.2	13.7	4.1	0.3	31.6	25.0	289.9	2.0	7.4	3.3	51.9	31.2	13.6	45.7	32.1	0.6	0.8	0.3	28.2	5.4	358.2	0.0	1.2	0.0	0.3	1.1	0.4	0.0	1.8	0.3	1.9	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.5	1.6	1.7	2.2	2.6	1.6	2.7	5.1	3.4	4.7	1.9	2.4	2.4	27.1	19.2	28.9	1.0	13.0	394.7	1494.1	518.9	116.1	0.0	274.4	221.4	6.0	64.3	328.3	44.1	0.0	4600.4	9.2	506.0	9.8	164.7	2.4	84.9	28.6	37.8	197.3	2.7	2.1	143.7	2222.5	92.0	278.8	175.6	82.6	0.4	15.7	6.2	405.9	0.0	1.0	384.5	258.4	12.9	303.6	0.8	3.7	79.6	103.2	1.9	10.5	0.1	0.0	0.0	0.4	502.3	871.7	3.0	13.2	1318.1	201.9	1.7	133.0	0.4	52.6	10.5	293.5	0.4	3.8	545.6	685.5	9959.7	50.5	0.2	292.8	2892.3
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.0;skin 1: 43.5"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 58.0;Urothelial cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (4.11e-5)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	3.7	9.2	6.3	5.6	5.5	3.5	6.4	3.9	6.4	14.4	8.9	6.1	5.0	5.3	1.1	42.0	8.0	6.1	5.7	5.1	7.8	8.1	13.9	5.6	7.7	4.5	3.8	12.7	8.0	4.2	10.5	3.1	5.8	14.8	1.7	0.8	15.6	3.7	3.7	43.5	6.6	1.9	2.8	6.6	6.3	30.1	4.5	6.2	5.0	1.0	6.8	8.2	22.4	11.3	6.9	7.2	3.0	7.4	2.6	5.3	19.1	4.9	4.3	4.8	3.3	7.3	7.2	4.1	15.2	3.0	3.8	8.0	2.1	8.6	0.9	9.9	6.8	4.6	7.4	8.8	6.5	1.8	8.5	4.5	10.7	5.1	3.1	3.7	4.3	10.2	8.3	6.1	2.4	11.0	7.2	0.4	1.8	16.6	5.8	8.3	3.9	2.8	2.3	23.3	0.1	6.4	6.3	13.5	6.2	1.8	9.7	5.8	5.4	3.1	8.2	3.8	4.7	15.8	18.8	4.7	2.9	3.4	5.3	0.2	2.3	0.3	2.4	1.4	1.8	2.2	2.2	1.8	4.4	2.4	3.2	3.0	0.5	1.8	0.1	5.1	2.3	1.7	6.3	5.5	3.9	6.4	5.1	7.8	4.5	3.8	5.8	2.8	4.5	11.3	2.7	0.0	1.7	2.6	17.1	29.1	27.2	11.6	31.9	1.0	10.0	8.0	1.9	8.6	7.6	9.2	0.0	18.5	7.6	7.1	1.9	5.5	11.3	12.9	9.6	4.6	3.0	1.7	5.1	2.4	4.5	7.3	4.6	9.8	5.7	3.2	4.6	12.6	3.6	0.0	7.0	4.3	8.2	2.8	34.7	8.9	3.7	11.2	5.4	11.2	6.7	4.1	7.2	4.0	2.0	2.1	4.7	3.4	11.6	22.0	10.5	8.5	12.7	1.9	6.6	8.6	10.9	28.2	4.8	37.7	38.4	58.0	14.3	4.6	3.7	45.1
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA006389: AB_2667576, HPA067383: AB_2685828"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	21.9	11.5	11.3	12.8	10.8	4.9	23.3	10.2	12.2	35.2	13.5	24.5	7.6	32.0	7.9	37.3	37.2	12.1	18.1	10.9	12.8	13.7	7.2	17.9	9.1	11.7	12.2	23.4	13.1	14.4	15.4	10.7	11.7	21.6	8.0	9.8	29.2	21.1	25.8	34.4	14.6	23.6	11.3	13.3	21.7	11.1	13.9	13.5	14.9	14.5	17.9	29.1	34.9	10.7	34.6	23.5	23.8	21.1	35.9	67.3	14.5	31.8	43.6	35.5	39.3	19.3	22.2	17.8	33.6	54.8	15.0	35.0	12.4	50.4	29.9	19.4	18.3	8.2	15.9	10.4	35.8	14.7	38.8	55.2	32.3	32.9	18.6	45.6	52.0	15.8	13.2	24.0	74.7	57.6	15.8	7.8	37.0	97.3	37.7	24.6	16.2	11.7	28.2	20.5	8.1	37.9	30.7	16.9	15.5	27.0	78.0	22.1	80.7	47.2	34.8	31.7	20.9	32.6	15.7	11.5	45.8	10.9	23.9	8.9	9.1	10.7	10.6	8.7	11.4	5.4	6.7	11.6	6.8	3.6	6.2	6.0	2.2	15.2	12.5	8.4	8.1	7.0	11.3	10.8	10.2	12.2	10.9	12.8	11.7	12.2	11.7	11.3	13.9	10.7	14.7	22.4	11.5	8.5	8.6	10.7	7.9	15.4	19.4	10.2	16.2	16.5	0.9	4.3	22.8	16.5	12.5	3.7	10.0	2.1	1.9	7.9	2.3	29.4	14.8	12.3	4.2	2.1	4.2	7.7	7.3	11.9	13.3	19.1	10.8	4.9	13.2	3.8	5.2	10.1	3.9	6.2	12.2	4.4	7.0	3.9	14.3	4.1	5.4	7.5	13.1	4.2	8.2	6.6	7.4	12.7	2.0	13.2	4.8	9.2	2.1	1.8	37.6	11.8	26.3	7.0	13.6	4.0	11.4	19.9	16.3	4.0	8.6	6.0	2.8	10.4
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000258724	"PIN2 (TERF1) interacting telomerase inhibitor 1"		8	10725399-10839847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"cervix: 2.9;vagina: 5.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"									HPA009065	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"									"unprognostic (2.57e-1)"					"unprognostic (6.34e-2)"				0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.9	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.2	6.7	12.4	10.4	26.6	20.7	12.0	14.2	5.6	0.0	0.0	0.0	8.6	8.2	3.7	12.5	0.0	4.0	6.9	11.7	0.0	37.0	0.0	0.0	7.3	8.4	6.9	25.0	0.0	0.0	5.3	7.7	0.0	14.0	0.0	12.5	7.0	0.0	3.3	22.4	5.0	8.2	5.4	10.3	32.7	9.3	3.9	7.2	13.1	3.3	9.0	7.2	17.6	15.3	0.0	5.3	6.4	14.0	20.2	6.5	13.3	7.0	22.1	0.0	12.5	5.5	21.5	22.7	12.0	28.6	0.0	8.3	0.0	9.6	8.9
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134807-31140508	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 5.9;esophagus: 13.8;skin 1: 15.4;vagina: 7.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 7.5;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 15.1;AN3-CA: 15.3;NTERA-2: 7.8;SCLC-21H: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021016	Uncertain		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.8	0.2	5.9	0.7	0.1	0.3	0.0	0.0	13.8	0.0	0.0	0.0	0.4	0.1	0.5	0.0	2.5	0.0	1.6	0.1	0.0	0.0	1.0	0.1	0.0	1.7	0.3	0.0	0.0	1.8	0.3	0.2	15.4	0.2	0.0	0.1	0.0	0.6	0.5	0.1	0.1	0.6	0.0	1.7	0.0	7.1	0.2	0.0	0.0	15.1	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.1	1.6	0.1	1.7	0.1	0.1	0.2	0.0	0.0	3.6	1.6	0.0	1.3	0.2	0.2	0.0	0.0	7.5	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	17.8	0.0	0.0	0.0	0.0	0.4
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966482-975865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 54.9;skin 1: 46.0;vagina: 24.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 29.6;Pancreatic endocrine cells: 38.5;Prostatic glandular cells: 37.9;Squamous epithelial cells: 19.2;Urothelial cells: 52.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 15.1;HaCaT: 26.0;SK-BR-3: 16.6"					"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	1.6	0.0	0.7	0.1	0.4	1.7	0.0	0.1	11.5	0.0	0.6	0.9	0.4	0.3	54.9	0.9	0.7	0.2	0.0	0.0	2.1	0.9	1.1	0.3	0.0	0.0	0.1	1.1	0.5	0.3	0.4	0.0	3.6	0.1	0.0	10.2	1.2	2.1	46.0	0.8	0.1	0.0	1.2	2.0	0.4	0.1	0.1	0.7	0.0	1.6	7.5	24.2	0.0	15.1	1.4	0.0	1.0	0.1	0.7	2.5	6.8	1.7	4.1	1.1	2.0	11.3	0.0	3.2	3.0	5.7	26.0	0.2	4.5	0.7	5.0	1.0	0.0	5.6	3.3	0.6	0.3	0.2	0.2	3.8	2.9	1.6	3.7	0.5	0.0	0.3	4.0	0.2	8.3	0.0	0.3	0.5	2.4	11.0	0.1	0.0	5.6	4.3	4.2	0.1	0.1	7.5	16.6	1.0	0.4	3.2	0.0	3.2	5.3	2.3	0.5	4.6	3.2	0.1	0.1	6.8	2.5	3.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.2	1.1	0.0	1.9	4.6	29.6	5.0	1.8	0.5	3.8	1.8	0.9	0.0	6.4	0.0	0.0	7.1	1.0	1.9	0.0	13.8	0.0	3.0	1.1	0.7	0.0	0.0	0.0	14.0	2.0	0.9	3.1	8.2	0.0	0.0	0.7	0.3	1.1	3.3	0.0	0.0	8.2	0.3	1.4	0.0	0.0	0.9	1.8	0.0	1.9	0.2	0.0	0.0	0.0	38.5	3.3	0.0	2.5	37.9	0.0	0.1	5.2	0.2	0.0	0.2	1.0	0.0	0.7	19.2	17.3	9.9	2.8	0.0	0.1	52.9
PLK3	"CNK, FNK, PRK"	ENSG00000173846	"Polo like kinase 3"	Q9H4B4	1	44800377-44805990	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060318	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"			"HPA060318: AB_2684252"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.78e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	13.6	6.4	3.2	10.7	3.6	13.8	8.9	4.0	5.3	8.7	8.1	4.9	3.3	8.1	2.8	19.2	7.4	17.3	6.3	3.6	6.0	5.8	7.1	12.9	9.0	9.3	7.1	6.6	8.9	7.1	7.5	6.7	6.7	5.6	2.9	0.4	6.7	3.3	2.8	16.1	6.5	4.9	5.8	7.7	5.4	2.1	5.4	5.4	7.3	2.4	5.8	18.0	8.7	7.2	7.2	4.1	6.6	3.4	4.7	15.0	12.3	15.7	20.8	5.9	5.8	2.5	9.9	8.1	6.5	12.9	18.7	6.5	3.7	21.4	3.2	13.5	0.7	9.1	2.6	6.2	22.5	2.9	11.7	11.8	12.3	17.4	16.1	20.0	17.8	3.0	4.9	3.6	13.0	4.6	6.2	2.7	4.5	4.0	5.5	7.8	4.3	13.3	20.3	2.4	5.0	3.2	4.5	8.3	17.6	10.1	0.6	2.8	23.3	3.6	9.4	7.5	9.7	9.5	4.7	2.8	8.0	5.2	7.2	0.0	4.0	1.0	1.9	5.9	2.1	1.4	11.6	4.7	5.0	1.2	12.4	5.8	4.7	0.8	6.3	2.0	14.0	4.4	3.2	3.6	4.0	5.3	3.6	6.0	9.3	7.1	6.7	5.8	5.4	7.2	55.7	12.8	35.1	1.3	32.2	44.1	60.5	23.3	32.5	7.1	58.4	33.7	3.4	32.9	15.8	5.5	2.1	19.0	32.2	77.7	0.0	18.3	0.8	41.9	27.6	43.5	53.0	2.7	3.6	13.0	22.9	36.7	109.6	67.5	78.7	12.0	32.5	6.7	36.9	6.7	6.3	53.0	2.0	37.7	60.3	0.7	9.9	72.5	12.4	10.3	9.8	7.4	1.0	1.5	2.0	24.3	116.8	5.3	31.4	25.8	47.3	3.3	14.7	10.2	26.3	58.5	30.5	2.5	4.5	37.2	33.5	59.2	65.2	17.0	46.3	58.9
PLP2	"A4, A4-LSB, MGC126187"	ENSG00000102007	"Proteolipid protein 2"	Q04941	X	49171898-49175235	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 496.5;Exocrine glandular cells: 496.6;Pancreatic endocrine cells: 550.1;Suprabasal keratinocytes: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042415	Approved					NA	NA		250000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA042415: AB_10796907"	"unprognostic (1.40e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.55e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	105.1	195.8	17.3	87.6	17.6	358.6	99.8	19.8	21.3	173.6	27.0	164.1	71.0	162.0	42.7	381.7	124.4	53.2	121.0	17.3	24.4	61.3	36.6	118.6	59.9	22.7	21.9	110.3	250.8	37.5	97.4	60.8	20.4	97.8	130.5	6.2	119.3	104.7	99.0	390.6	96.2	156.6	20.2	79.1	114.6	23.3	21.7	77.9	46.8	53.3	148.0	182.8	264.3	19.7	539.1	312.8	0.4	1.0	131.6	388.9	1.6	278.2	223.5	339.9	255.4	115.2	248.4	193.5	68.1	209.2	340.7	444.1	260.5	517.4	214.5	490.2	104.2	71.4	421.1	3.1	210.0	136.0	304.2	174.7	505.6	443.5	516.5	317.6	260.9	63.0	55.1	239.6	249.2	346.0	14.9	346.2	3.3	263.6	456.2	48.9	300.1	563.8	464.6	355.1	69.4	120.6	394.4	155.6	244.4	2.6	340.6	77.0	293.7	194.4	185.4	344.6	472.4	102.2	100.6	50.9	461.3	359.7	464.4	486.8	287.7	148.7	59.9	99.8	100.7	226.4	214.3	112.8	298.5	144.8	107.8	93.4	320.0	70.5	63.7	694.2	265.8	235.8	17.3	17.6	19.8	21.3	17.3	24.4	22.7	21.9	20.4	20.2	21.7	19.7	49.3	73.7	38.2	1.0	160.8	439.7	306.0	496.5	167.9	0.4	67.8	115.4	33.3	57.2	101.9	80.9	0.0	2.7	232.0	134.6	21.5	379.6	16.4	71.8	27.8	63.7	111.7	43.1	0.6	496.6	27.2	110.4	71.9	51.1	88.7	15.4	55.3	12.8	157.5	0.0	0.7	254.9	138.4	130.3	210.5	20.3	169.9	133.3	224.1	4.7	146.4	18.9	35.0	0.0	0.6	550.1	200.3	60.9	148.5	219.5	141.8	9.4	92.9	1.1	124.9	76.1	128.7	4.2	1.4	401.0	504.9	6.4	162.7	29.6	285.2	334.1
PPDPF	"C20orf149, dJ697K14.9, exdpf"	ENSG00000125534	"Pancreatic progenitor cell differentiation and proliferation factor"	Q9H3Y8	20	63520765-63522206	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2997.4;Paneth cells: 2752.7;Proximal enterocytes: 2849.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 26.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040929			Approved	Nucleoplasm,Nucleoli,Microtubules		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Microtubules"	Nucleoli	"HPA040929: AB_10794155"	"unprognostic (3.75e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.09e-2)"	215.1	72.2	192.7	71.1	203.3	79.6	237.4	194.7	262.1	312.4	108.7	298.3	81.3	217.8	43.8	622.2	185.6	40.8	412.9	164.7	189.8	421.8	134.9	243.4	42.2	220.9	217.1	197.5	197.9	47.1	196.8	30.3	221.9	365.0	60.6	25.6	432.4	93.4	438.3	461.5	167.1	53.4	201.1	117.0	298.8	129.3	202.5	32.1	249.8	64.2	47.3	264.0	410.7	253.9	287.2	87.8	57.9	118.5	65.4	107.9	185.4	169.1	54.1	217.5	85.2	162.8	166.3	60.7	222.8	115.2	83.2	294.3	29.5	196.0	35.5	110.5	58.5	24.8	83.0	31.9	175.3	0.2	124.3	106.5	384.9	55.3	76.4	72.7	86.5	74.9	104.5	138.9	81.1	394.9	288.7	2.7	63.3	228.1	494.5	132.0	132.2	125.7	159.8	117.4	197.1	150.9	170.3	272.6	124.4	39.1	390.7	168.8	147.3	184.1	206.9	245.8	143.5	108.9	93.3	41.1	130.7	70.9	122.6	2.3	3.0	26.0	5.7	3.6	4.7	5.0	5.1	5.4	3.4	5.8	4.3	5.2	1.2	3.0	5.7	4.0	5.7	5.7	192.7	203.3	194.7	262.1	164.7	189.8	220.9	217.1	221.9	201.1	202.5	253.9	328.1	314.1	220.3	15.7	462.8	574.5	714.7	1076.0	375.6	51.8	1282.8	1173.8	70.1	906.5	763.6	960.0	12.5	428.4	422.5	2528.3	2997.4	916.1	222.0	440.1	449.6	294.2	796.4	399.0	15.4	755.9	761.0	430.8	1120.8	520.2	337.8	293.3	376.3	224.2	600.6	50.5	12.5	1549.5	850.4	390.4	755.8	1154.3	371.9	366.4	1191.7	6.5	831.8	236.9	435.6	6.6	67.2	971.0	2752.7	288.5	280.4	1021.9	2849.8	1715.5	542.0	60.0	197.2	216.3	541.5	129.0	261.6	1559.8	932.1	414.1	541.7	158.5	1132.9	1492.7
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537376	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 53.9;vagina: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.5	0.1	0.6	3.6	1.7	0.8	3.8	2.9	1.7	19.8	0.0	26.5	28.9	0.4	0.1	109.4	0.4	3.5	0.2	0.6	0.9	0.8	5.2	2.6	0.6	1.6	1.0	0.3	3.6	0.0	0.2	0.3	1.7	3.1	15.7	0.8	19.1	0.6	0.6	53.9	22.2	0.8	0.6	0.8	26.2	0.3	1.1	0.3	0.2	0.0	6.4	9.8	43.2	5.4	22.1	2.6	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	41.4	0.1	7.2	0.0	0.1	33.9	0.0	0.1	0.0	5.4	0.4	0.0	10.2	0.1	0.1	0.0	6.7	0.0	45.0	0.0	0.2	0.2	0.0	0.1	0.2	2.5	0.2	12.5	0.0	0.2	0.2	57.0	15.5	0.1	1.2	0.5	0.0	26.4	0.3	2.2	2.6	8.1	0.0	0.1	25.2	1.6	0.2	0.3	0.4	0.8	0.3	0.5	0.1	0.1	0.4	0.5	1.1	0.4	0.7	0.1	0.1	0.5	0.5	0.3	0.1	0.0	1.3	0.3	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.6	1.7	2.9	1.7	0.6	0.9	1.6	1.0	1.7	0.6	1.1	5.4	0.3	12.8	25.6	0.3	1.4	5.9	2.6	7.7	5.2	2.2	7.0	4.3	0.4	12.8	14.9	0.0	2.1	0.2	0.2	132.1	0.0	1.4	0.2	0.4	0.5	3.2	5.4	0.0	0.1	1.6	0.2	1.4	59.1	1.3	9.5	0.2	0.4	1.7	0.6	0.0	0.1	42.5	2.0	2.2	2.0	0.0	0.3	2.6	0.0	0.0	1.0	1.6	1.0	0.0	0.8	17.6	97.6	0.0	0.1	1.5	80.2	0.2	8.9	3.7	0.0	2.3	1.1	0.2	0.3	48.0	15.5	0.1	2.0	0.2	32.1	15.9
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, Puf-A, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844095	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 338.4;HEL: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.5	16.7	6.2	22.3	5.9	19.0	24.7	8.1	5.6	13.8	4.9	15.8	12.8	14.7	9.8	24.8	13.5	11.7	12.0	5.5	5.7	21.8	15.2	15.4	23.2	5.0	4.7	18.3	14.8	12.2	10.1	18.0	5.3	12.5	18.7	7.4	16.8	10.6	11.1	16.6	11.7	13.6	4.2	14.7	13.2	15.4	5.2	17.1	11.9	9.4	22.0	30.7	16.0	6.7	78.9	56.7	47.0	48.2	38.6	40.8	53.5	71.7	37.6	72.3	67.3	43.6	36.0	86.4	16.1	49.5	43.2	38.8	85.8	62.0	93.5	338.4	30.7	327.8	59.3	52.9	51.0	146.2	58.7	33.3	26.8	58.8	83.5	33.0	54.3	55.6	35.0	38.1	63.8	36.0	74.6	119.9	120.4	59.9	25.1	86.7	36.8	37.3	48.8	52.7	48.4	46.4	43.2	39.8	40.3	52.0	25.2	78.4	52.1	48.6	40.2	46.8	97.1	17.7	31.0	120.5	36.8	52.4	36.1	7.7	13.7	4.1	18.8	19.9	26.3	23.4	19.3	18.9	18.5	22.4	21.2	20.7	1.9	25.2	17.1	20.8	15.7	11.8	6.2	5.9	8.1	5.6	5.5	5.7	5.0	4.7	5.3	4.2	5.2	6.7	27.7	48.1	41.4	0.0	35.8	0.0	59.6	0.0	62.6	28.0	27.5	26.7	0.0	14.3	41.5	23.9	10.4	34.7	25.5	1.9	46.9	41.2	4.8	36.7	79.1	28.3	8.5	23.8	0.0	26.5	45.4	30.9	35.2	54.9	17.7	39.8	20.0	22.1	21.6	26.9	0.0	9.2	0.0	15.8	0.0	4.9	47.2	20.6	0.0	0.0	29.4	14.2	25.7	0.0	0.0	29.1	8.0	23.0	29.2	57.7	7.6	108.3	32.1	24.0	0.0	50.2	26.8	43.7	45.3	54.3	0.0	35.0	26.5	44.5	12.7	38.2
RAB35	H-ray	ENSG00000111737	"RAB35, member RAS oncogene family"	Q15286	12	120095099-120117502	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054146	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA054146: AB_2682399"	"unprognostic (3.15e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.46e-6)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	27.6	18.4	16.7	27.8	17.6	36.2	23.8	15.3	19.8	26.1	10.8	24.6	21.1	27.0	8.5	39.7	23.9	17.7	22.1	18.2	16.7	19.4	19.1	21.9	28.3	16.3	16.9	20.3	16.1	13.6	16.9	21.5	16.7	19.5	14.8	9.6	21.7	14.5	22.0	36.0	22.9	20.1	14.7	31.3	22.4	10.9	18.0	26.7	15.0	17.6	25.1	25.5	28.4	16.0	52.8	58.8	33.8	34.1	33.6	34.7	44.3	47.0	33.8	46.1	29.7	64.7	26.2	40.2	58.6	60.9	35.2	46.0	45.9	50.0	29.6	66.0	50.7	74.2	33.4	44.2	34.2	52.3	67.3	38.2	38.7	61.7	42.7	42.4	50.3	23.8	62.5	25.4	33.0	54.8	54.6	68.3	38.0	31.4	56.9	42.4	28.3	52.5	28.3	61.2	35.8	41.4	55.9	28.3	34.1	33.0	63.0	45.3	62.2	44.7	47.3	45.5	61.9	51.1	62.7	70.3	45.4	45.6	40.2	3.0	7.3	14.6	6.9	8.2	5.8	3.9	4.6	7.2	6.7	3.9	2.5	3.8	14.1	6.5	11.8	3.8	6.9	6.6	16.7	17.6	15.3	19.8	18.2	16.7	16.3	16.9	16.7	14.7	18.0	16.0	22.1	19.2	17.1	5.9	15.1	29.7	18.9	11.4	8.0	9.3	13.0	8.4	6.6	14.3	10.5	9.2	0.0	28.1	28.6	23.7	37.2	21.6	8.6	11.3	14.9	22.7	12.6	10.5	6.5	18.3	25.7	15.6	22.4	17.2	19.6	9.1	22.5	8.7	36.6	15.2	6.0	19.3	2.0	21.8	28.1	3.4	11.5	21.5	12.4	5.6	24.8	10.8	27.8	1.0	5.9	27.9	20.6	15.4	12.6	20.0	17.1	12.9	10.3	7.1	6.6	9.5	15.3	7.3	8.0	16.0	34.7	48.2	23.5	13.4	15.7	20.2
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113251-88175443	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.6;skin 1: 44.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 18.0"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 18.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	HPA071701			Uncertain	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies, Mitochondria"		"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	2.6	27.8	0.4	1.4	0.4	1.6	8.6	0.3	0.8	11.8	6.3	1.9	2.4	4.7	6.7	48.6	5.6	6.0	1.1	0.7	0.6	4.5	1.8	5.8	1.7	0.5	0.7	3.3	1.6	1.8	2.8	14.7	0.5	2.4	1.3	2.9	7.7	6.4	0.6	44.3	2.3	3.6	0.4	1.6	1.6	2.5	0.8	3.5	7.9	0.4	17.9	8.7	23.5	0.6	10.7	1.4	0.3	0.5	0.4	2.4	0.6	6.5	26.1	10.4	19.0	4.7	4.8	0.5	6.3	6.9	1.2	71.2	5.7	87.7	14.1	1.3	5.1	54.0	6.2	0.0	1.0	0.6	0.6	2.2	308.0	1.4	271.4	13.0	12.3	1.0	0.3	0.9	0.0	0.0	0.7	18.4	8.2	0.7	0.1	0.5	0.1	0.8	20.0	40.6	1.9	1.2	0.3	0.1	175.6	6.2	15.7	4.6	6.7	0.0	4.6	0.0	1.1	1.5	6.5	0.2	1.7	2.2	1.2	0.0	0.8	0.1	1.5	0.6	0.8	0.0	0.4	1.8	1.6	0.0	0.1	0.8	0.6	18.0	1.3	4.4	1.0	0.7	0.4	0.4	0.3	0.8	0.7	0.6	0.5	0.7	0.5	0.4	0.8	0.6	1.0	0.0	6.7	0.7	0.1	46.4	15.9	74.8	21.1	0.1	6.9	9.7	0.2	8.6	25.0	0.0	0.0	94.5	2.7	0.5	3.9	1.7	0.0	2.1	0.9	2.7	0.0	5.5	0.6	1.1	10.5	9.1	3.1	2.3	16.5	5.3	1.1	0.0	17.5	0.0	0.4	0.3	14.2	1.6	21.2	0.1	3.4	3.9	131.6	3.7	6.3	0.6	1.0	2.0	0.1	2.6	2.6	1.2	0.1	9.5	2.1	5.3	7.4	6.4	0.0	0.6	5.3	0.1	5.9	38.1	98.5	54.7	2.7	5.9	2.5	23.3
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 199.1;skin 1: 237.7;vagina: 113.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	6.3	4.4	38.4	6.8	36.1	4.4	9.1	12.1	58.3	48.7	1.8	53.8	48.3	4.6	9.9	199.1	6.6	8.8	6.8	55.1	12.9	3.8	10.5	8.0	2.2	12.0	11.4	3.7	7.9	1.1	14.2	2.3	10.9	17.7	44.5	6.1	27.4	6.9	12.6	237.7	40.6	4.0	8.3	7.3	31.8	10.2	15.2	3.3	4.5	2.8	20.7	21.9	113.2	30.6	5.3	2.6	13.7	10.2	1.5	3.3	6.6	1.9	1.4	2.7	3.2	6.0	7.6	4.2	1.9	2.7	2.4	92.4	2.7	3.3	3.8	7.7	6.9	2.5	3.6	6.0	1.7	5.2	8.5	3.9	45.8	2.8	1.3	4.0	4.1	13.9	1.9	2.8	2.1	14.6	4.9	6.3	4.3	26.1	2.6	8.8	1.6	2.6	1.7	27.6	26.2	5.3	3.3	31.2	1.3	11.5	80.7	3.9	7.9	3.3	6.8	3.5	3.2	4.6	4.7	3.4	7.8	3.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	38.4	36.1	12.1	58.3	55.1	12.9	12.0	11.4	10.9	8.3	15.2	30.6	1.9	0.0	1.1	7.5	1.0	45.5	9.7	14.0	13.1	5.7	2.6	3.7	2.4	11.5	10.9	1.8	6.2	0.2	0.7	87.7	0.0	0.9	2.7	5.9	2.1	2.2	4.9	2.7	47.8	0.8	0.3	1.4	32.6	9.4	5.7	1.7	3.9	4.4	0.5	1.7	32.1	31.9	6.1	1.2	5.2	2.2	3.4	1.9	5.4	1.0	2.4	2.9	1.0	8.0	5.0	1.6	44.6	3.8	0.1	10.9	55.3	0.1	6.5	4.4	0.0	2.1	1.9	12.0	15.0	95.4	97.0	0.7	1.1	1.8	44.1	39.2
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 141.6;skin 1: 121.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 101.0;MCF7: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	17.4	16.2	10.2	5.7	9.7	3.7	19.4	13.0	10.9	55.0	10.8	22.7	2.5	23.3	6.0	141.6	27.2	15.7	17.3	9.7	9.5	12.5	3.2	15.2	5.9	10.3	10.0	20.5	8.5	7.2	8.7	9.5	9.3	26.9	7.8	3.9	30.6	16.2	6.9	121.4	10.4	13.0	10.0	10.2	14.5	4.8	9.5	5.1	22.6	10.6	22.5	26.2	69.3	10.0	22.8	24.7	5.5	50.9	55.0	46.8	1.7	23.2	50.0	29.7	23.3	8.3	101.0	0.5	12.5	93.6	16.2	74.3	18.4	44.6	7.4	5.7	9.4	3.3	18.6	7.4	23.2	0.0	9.1	34.8	63.9	28.5	6.4	74.7	12.7	4.6	0.8	9.8	11.9	110.3	1.3	1.1	16.3	30.4	42.7	7.3	1.9	18.1	8.9	37.1	4.4	22.9	47.0	50.6	32.1	6.8	43.9	1.4	13.8	35.4	16.5	23.6	1.5	4.2	2.6	1.8	43.4	3.8	51.3	1.8	3.1	0.9	7.4	0.9	18.8	2.0	6.5	5.4	6.7	0.6	5.2	4.7	0.0	2.3	0.0	0.6	1.8	4.0	10.2	9.7	13.0	10.9	9.7	9.5	10.3	10.0	9.3	10.0	9.5	10.0	10.7	3.2	7.0	21.2	2.5	34.2	24.1	21.6	42.7	0.5	18.0	15.6	3.7	11.5	11.1	3.7	2.1	7.5	6.2	3.2	0.0	10.5	0.1	3.6	14.4	11.0	1.8	0.8	2.5	5.1	1.2	19.6	13.7	3.4	1.3	0.3	20.3	0.1	2.7	0.0	3.0	2.1	12.2	4.1	13.3	0.5	5.3	4.9	8.8	6.5	1.8	3.6	5.2	7.1	0.7	14.3	4.4	5.3	3.0	19.2	0.2	0.5	3.9	5.2	6.6	9.5	22.0	0.8	5.6	69.9	55.8	1.8	7.2	0.4	5.5	45.7
RASSF10		ENSG00000189431	"Ras association domain family member 10"	A6NK89	11	13009316-13012119	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 6.0;skin 1: 6.6"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Distal tubular cells: 25.4;Gastric mucus-secreting cells: 17.9;Squamous epithelial cells: 60.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 8.9;CAPAN-2: 7.8;HaCaT: 12.6;HMC-1: 6.2;RPTEC TERT1: 11.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040406			Approved	Vesicles,Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles	Cytosol	"HPA040406: AB_2732485"	"unprognostic (6.71e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.41e-3)"	"unprognostic (6.25e-3)"	"prognostic favorable (2.76e-4)"		"unprognostic (3.43e-3)"	"unprognostic (8.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.65e-2)"	0.3	0.0	0.4	0.0	0.8	0.0	1.3	0.2	0.5	0.6	0.3	0.4	1.2	0.1	0.1	6.0	3.0	0.3	0.3	0.2	0.3	3.4	0.0	1.2	0.0	0.7	1.0	0.0	0.0	2.1	0.1	0.0	0.7	0.6	0.4	0.0	4.6	0.2	0.7	6.6	0.5	0.0	1.0	0.0	3.6	0.5	0.1	0.5	0.1	0.2	0.5	1.1	1.5	0.5	0.4	8.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.8	0.0	0.5	0.0	0.3	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	2.2	0.0	1.3	0.0	0.0	11.9	1.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.5	0.2	0.3	0.7	1.0	0.7	1.0	0.1	0.5	2.0	0.0	5.1	0.7	0.1	0.0	6.3	0.0	64.3	0.0	5.8	8.0	0.9	0.0	2.5	1.8	0.0	0.2	0.0	0.9	25.4	0.6	0.0	6.0	1.1	1.4	2.4	0.0	0.0	0.2	0.0	0.2	17.9	11.1	1.3	0.0	3.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.3	0.5	0.0	1.9	0.0	0.9	0.0	0.0	0.0	11.5	1.2	0.0	0.0	1.9	0.0	4.5	7.3	0.0	0.0	0.5	0.3	0.0	0.8	60.0	0.0	0.0	0.2	0.0	5.5	3.5
RCC2	TD-60	ENSG00000179051	"Regulator of chromosome condensation 2"	Q9P258	1	17406760-17439677	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072281	Approved					NA	NA		110000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA072281: AB_2686505"	"unprognostic (2.50e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (9.91e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.42e-8)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.03e-8)"	"unprognostic (6.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.41e-2)"	19.4	18.4	12.3	18.9	12.2	33.3	22.2	12.8	13.2	24.8	11.0	24.0	11.4	18.7	9.9	65.2	16.3	11.8	13.4	12.1	12.5	22.8	15.9	24.2	27.7	14.2	13.6	22.1	21.3	9.4	11.4	16.1	13.1	22.3	17.6	3.1	36.0	7.8	8.4	56.3	27.6	10.2	13.9	39.2	18.3	20.6	15.8	34.2	19.0	4.1	35.2	19.7	31.3	15.3	62.2	34.3	68.4	57.9	25.3	25.4	56.6	24.3	20.9	49.2	40.4	37.0	83.4	133.8	80.4	25.3	14.5	67.4	121.0	70.0	34.1	64.3	61.1	117.6	50.5	36.0	31.8	142.7	79.7	40.5	51.8	55.1	48.7	30.7	53.3	88.7	82.4	188.4	22.0	62.9	117.4	115.9	94.7	76.0	26.0	155.7	68.6	86.5	37.3	29.0	102.9	72.6	61.4	59.5	93.6	56.7	53.2	91.3	41.9	44.8	56.0	18.1	51.1	81.7	72.9	165.8	19.3	158.6	90.9	0.9	1.9	0.7	1.4	2.6	1.2	1.6	1.1	1.4	3.1	1.7	0.8	1.4	0.1	1.7	2.1	2.5	1.0	1.1	12.3	12.2	12.8	13.2	12.1	12.5	14.2	13.6	13.1	13.9	15.8	15.3	22.6	25.6	15.3	16.6	26.4	46.5	14.7	25.3	27.9	6.6	36.5	34.3	0.9	18.6	26.6	22.0	10.4	25.0	32.2	27.5	3.9	24.4	6.8	28.0	38.3	24.9	24.1	28.8	11.0	22.7	48.9	17.4	14.8	37.5	17.7	55.9	17.5	7.3	32.6	6.7	4.9	25.9	24.4	31.4	70.0	21.0	9.3	43.0	16.0	20.6	27.9	15.3	22.6	20.6	15.3	28.8	20.6	6.0	25.9	32.2	7.5	7.0	17.9	5.4	0.0	20.7	16.7	17.6	21.2	42.9	64.5	16.3	19.7	25.6	36.4	19.4
REEP4	"C8orf20, FLJ22246, FLJ22277, PP432, Yip2c"	ENSG00000168476	"Receptor accessory protein 4"	Q9H6H4	8	22138020-22141951	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 89.3;skin 1: 91.0"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042683	Approved		Supported	"Endoplasmic reticulum"		No	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Endoplasmic reticulum"		"HPA042683: AB_2571730"	"unprognostic (2.38e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.65e-2)"	13.0	8.4	7.0	12.5	8.7	28.4	11.6	8.7	9.7	27.9	7.6	23.8	11.0	9.4	2.1	89.3	11.1	5.6	8.0	6.8	8.2	9.2	12.3	18.0	11.2	10.8	8.5	7.4	12.9	5.0	10.9	14.6	10.5	13.6	10.8	2.1	21.8	6.5	4.1	91.0	16.9	5.9	9.0	33.2	18.0	42.7	9.5	9.9	14.8	2.6	10.2	19.6	49.0	11.5	42.2	79.7	24.9	39.7	10.5	10.6	47.9	36.7	19.2	44.6	40.2	46.7	38.8	53.0	46.8	18.4	38.5	100.3	29.6	59.3	21.9	28.2	37.4	57.4	41.2	46.9	11.8	25.8	77.9	9.8	110.3	33.3	27.5	13.9	27.1	58.1	44.5	158.7	22.6	60.6	63.7	88.9	37.4	58.0	53.3	37.0	22.5	101.8	19.9	40.0	21.7	40.1	30.0	31.7	52.7	16.5	64.3	35.9	30.5	29.2	50.1	66.6	50.3	40.0	33.5	34.6	32.6	54.7	59.1	49.8	54.8	64.1	24.3	53.6	19.6	10.5	21.1	21.1	42.7	4.9	9.7	13.1	15.5	26.3	37.0	16.9	15.4	27.6	7.0	8.7	8.7	9.7	6.8	8.2	10.8	8.5	10.5	9.0	9.5	11.5	6.8	3.2	9.2	4.9	7.9	28.0	15.1	45.5	15.4	6.5	5.8	5.7	1.8	7.2	21.9	12.9	2.1	54.0	13.8	27.3	0.0	21.9	16.0	3.8	4.9	9.2	17.4	48.2	0.7	15.0	50.4	8.1	21.9	5.9	10.2	14.0	15.4	6.6	55.4	0.0	0.6	33.0	22.4	38.8	21.5	9.4	9.0	26.1	3.6	10.3	16.5	1.8	10.3	1.0	2.6	25.6	34.7	8.2	19.3	19.0	19.2	1.9	8.1	1.5	13.1	2.3	9.7	61.0	17.9	41.1	39.2	94.1	13.5	8.9	31.1	24.5
RHOV	"ARHV, Chp, WRCH2"	ENSG00000104140	"Ras homolog family member V"	Q96L33	15	40872214-40874234	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 211.8;skin 1: 129.8;vagina: 92.2"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 142.3;Squamous epithelial cells: 375.0;Suprabasal keratinocytes: 283.0;Urothelial cells: 275.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 91.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 328.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053343	Enhanced					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA053343: AB_2682122"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.29e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (3.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.63e-3)"	0.5	0.1	0.9	0.2	0.9	0.2	16.0	1.1	1.8	26.3	0.5	2.8	0.6	0.7	9.5	211.8	2.7	0.5	0.1	1.0	1.1	5.5	0.2	2.3	0.2	2.1	0.8	0.3	16.3	2.2	3.0	3.2	2.4	16.6	2.6	0.0	44.3	2.4	0.2	129.8	0.6	0.1	0.8	0.1	1.2	0.3	1.9	2.6	0.5	0.0	23.3	20.7	92.2	0.9	1.6	9.7	0.1	2.7	0.2	0.0	5.2	0.1	0.8	0.4	0.2	4.0	4.4	0.0	2.4	0.0	0.3	77.9	4.5	0.6	0.2	10.5	12.5	0.5	11.3	0.6	0.0	0.5	0.0	0.3	6.0	0.3	0.1	0.4	0.1	2.3	2.1	0.5	0.0	27.2	0.6	2.3	1.7	19.3	3.7	4.0	0.4	1.8	5.1	34.3	4.0	0.8	8.0	328.9	0.2	0.5	40.9	0.3	0.1	0.0	1.1	0.2	0.3	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.1	1.8	1.0	1.1	2.1	0.8	2.4	0.8	1.9	0.9	0.6	0.0	3.2	0.3	0.5	84.1	42.5	80.9	19.9	0.0	75.2	48.5	0.9	2.8	103.0	29.5	0.0	60.7	1.9	43.1	13.7	107.5	0.0	18.5	1.9	2.5	22.7	0.0	1.5	56.2	6.0	2.0	7.1	25.5	1.3	0.4	0.0	0.0	4.6	0.0	0.5	54.7	67.1	0.0	13.3	0.0	0.0	0.8	32.0	0.0	3.6	0.0	0.0	0.0	0.3	13.8	142.3	0.7	0.1	89.8	1.0	0.9	26.2	0.0	0.0	0.2	7.3	0.0	0.9	375.0	283.0	42.4	1.9	0.0	66.3	275.1
RIN1		ENSG00000174791	"Ras and Rab interactor 1"	Q13671	11	66330241-66336840	"Predicted intracellular proteins, RAS pathway related proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 26.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.7;Basal squamous epithelial cells: 23.3;Squamous epithelial cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 9.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 44.3;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA035491	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA035491: AB_10601608"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.34e-7)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.46e-1)"	4.8	4.3	3.7	2.3	4.9	1.1	4.4	3.3	5.7	8.3	1.5	5.2	2.7	4.4	0.2	20.4	5.6	1.4	3.4	6.3	1.6	4.3	1.3	4.9	0.5	1.0	1.2	3.7	5.2	0.4	7.2	1.4	1.1	7.1	1.0	0.2	5.1	0.8	7.5	26.6	4.3	0.6	0.8	6.1	6.8	3.7	2.0	0.5	2.4	0.5	0.4	5.4	11.3	2.6	2.3	5.7	2.3	5.3	2.8	14.5	1.2	13.7	18.0	14.4	6.8	3.3	9.3	0.5	5.0	13.6	5.2	12.9	0.0	24.3	1.8	1.1	0.0	0.8	4.4	4.1	5.5	0.1	4.2	15.9	44.3	12.4	8.0	17.1	2.8	0.6	0.3	0.1	6.1	0.5	0.3	11.0	0.6	3.9	12.6	0.1	5.4	0.1	3.9	3.0	10.9	2.3	3.2	2.5	20.5	0.6	1.8	1.3	6.5	18.7	7.9	40.7	3.3	0.3	0.9	0.0	26.9	3.5	6.3	0.1	2.7	0.0	0.2	4.7	0.6	0.1	0.4	0.2	1.7	0.0	0.5	0.2	0.0	0.1	9.7	0.0	0.1	1.8	3.7	4.9	3.3	5.7	6.3	1.6	1.0	1.2	1.1	0.8	2.0	2.6	3.9	0.0	0.5	1.3	0.8	13.4	9.3	25.7	23.3	3.8	3.5	4.3	0.8	4.3	4.8	0.0	0.0	0.8	0.5	9.6	0.0	4.1	0.5	2.4	5.1	5.3	3.0	0.0	6.0	6.9	4.8	5.6	5.6	1.8	4.5	0.1	7.9	0.2	4.7	0.0	2.3	4.5	2.0	8.7	6.5	2.0	4.4	6.4	1.8	1.0	8.1	0.7	1.0	0.5	0.5	8.9	7.8	1.9	1.4	4.0	9.1	0.1	3.4	1.2	0.0	4.2	3.4	1.2	0.9	18.6	15.2	0.3	2.2	1.6	9.2	5.8
RNF222		ENSG00000189051	"Ring finger protein 222"	A6NCQ9	17	8390704-8397826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 16.9;skin 1: 6.9;vagina: 5.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.3;NK-cells: 2.1;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 1.4;Syncytiotrophoblasts: 1.2;Urothelial cells: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SK-BR-3: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048916	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA048916: AB_2680555"	"unprognostic (2.49e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.19e-4)"	"unprognostic (2.81e-1)"	"unprognostic (5.30e-2)"		"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-3)"	"unprognostic (5.82e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.97e-2)"	0.0	0.0	0.2	0.1	0.1	1.2	0.3	0.6	0.2	3.3	0.2	0.0	0.0	0.0	0.1	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	1.9	0.0	0.1	6.9	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.2	0.0	5.9	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.8	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.2	0.0	0.3	0.1	0.2	0.1	0.2	0.4	0.2	0.0	1.3	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.7	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.0	0.0	0.4	0.2	0.2	0.1	0.0	1.4	1.2	0.7	0.1	0.0	1.7
RNF225		ENSG00000269855	"Ring finger protein 225"	M0QZC1	19	58396090-58397079	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 2.9;esophagus: 6.6;skin 1: 4.6;vagina: 2.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"													NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"						"unprognostic (3.07e-1)"	"unprognostic (6.94e-2)"				"unprognostic (3.68e-3)"		"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.75e-3)"		"unprognostic (1.40e-1)"		"unprognostic (3.42e-1)"	"unprognostic (9.18e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	2.9	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.1	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RPS6KB2	"KLS, P70-BETA, p70S6Kb, S6Kβ, S6KB, S6Kbeta, STK14B"	ENSG00000175634	"Ribosomal protein S6 kinase B2"	Q9UBS0	11	67428460-67435401	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010010, CAB019404"	Approved		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	"unprognostic (1.38e-1)"	"unprognostic (2.36e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.01e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.66e-1)"	16.2	28.0	9.7	13.8	10.8	28.2	17.0	9.9	12.4	23.5	13.2	22.8	26.5	17.7	6.0	71.9	20.0	10.6	22.1	9.1	9.3	21.3	50.2	19.5	18.4	10.9	10.3	16.2	35.4	17.5	20.6	13.6	10.6	31.6	12.8	4.2	31.5	9.9	37.9	81.6	25.4	10.1	10.2	33.7	35.2	9.6	9.9	24.0	20.1	26.0	20.1	19.3	31.4	11.3	58.2	42.7	22.8	39.0	10.4	20.0	30.0	27.4	33.9	49.7	34.2	67.2	37.5	21.1	46.3	26.9	31.0	41.8	25.9	41.4	19.9	36.9	70.0	34.5	54.2	55.5	35.2	43.7	40.4	25.5	42.8	26.3	26.9	12.5	37.5	54.8	55.8	54.8	25.4	88.5	68.1	68.4	24.9	83.7	54.6	50.0	31.8	100.5	23.0	32.6	34.4	37.1	28.0	76.8	59.8	13.2	90.4	35.7	15.8	25.8	27.6	63.1	31.1	48.8	43.9	34.4	42.4	27.3	33.1	18.8	37.2	28.5	23.8	42.6	24.5	23.4	22.9	23.9	44.1	21.9	16.1	17.9	24.7	29.6	49.9	30.4	34.5	37.3	9.7	10.8	9.9	12.4	9.1	9.3	10.9	10.3	10.6	10.2	9.9	11.3	22.0	9.6	20.5	6.8	48.1	49.8	28.0	48.9	19.9	25.3	32.6	27.8	1.3	28.6	31.2	7.3	10.4	71.8	45.0	66.9	43.0	44.5	14.9	16.0	16.9	17.9	46.2	65.0	7.7	64.8	89.1	21.9	48.9	19.3	27.9	23.2	18.2	57.4	61.3	33.7	7.1	67.7	34.6	45.8	29.1	29.4	20.2	36.9	19.6	3.7	56.6	28.5	73.2	5.0	12.1	46.6	70.4	17.3	82.1	43.7	115.0	42.2	16.0	27.6	19.7	16.7	26.9	15.8	16.0	52.5	63.6	103.6	41.7	27.5	58.3	39.4
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 385.5;skin 1: 302.7"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	3.1	0.1	0.0	0.1	0.1	0.1	19.5	0.1	0.1	69.9	0.0	1.1	0.0	0.1	0.1	385.5	0.3	0.1	0.1	0.0	0.0	0.4	0.1	59.8	0.0	0.1	0.2	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	57.8	0.0	1.5	302.7	0.1	0.0	0.1	0.0	0.6	2.3	0.1	0.5	2.2	0.0	76.8	0.1	121.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribble planar cell polarity protein"	Q14160	8	143790920-143815773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 100.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	18.7	17.1	11.5	7.2	10.8	5.6	23.6	6.0	10.4	45.6	0.0	32.3	9.1	24.7	0.9	100.5	26.0	3.4	24.6	8.7	2.7	27.7	25.4	21.3	4.0	10.7	8.1	23.0	38.8	5.2	24.8	5.0	5.9	28.4	3.4	1.0	40.2	5.2	54.3	68.3	26.5	2.0	4.9	22.9	30.0	26.4	9.0	3.0	24.6	1.7	3.9	27.8	52.6	15.3	55.7	33.1	12.7	20.5	5.1	6.9	33.0	30.9	5.3	11.2	9.1	15.3	29.8	24.2	39.7	7.2	4.6	52.4	7.9	32.9	1.7	30.8	58.5	24.6	30.5	26.1	10.8	13.0	14.8	5.1	29.9	9.4	5.5	5.1	11.5	19.8	42.2	6.4	7.5	93.0	38.1	26.9	15.7	25.0	55.1	44.5	10.6	25.0	5.6	45.5	29.6	27.1	31.4	30.5	33.6	4.5	41.5	28.2	25.7	10.1	64.1	25.2	44.7	31.6	31.0	23.8	13.1	9.5	19.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	10.8	6.0	10.4	8.7	2.7	10.7	8.1	5.9	4.9	9.0	15.3	12.3	0.0	9.9	33.0	4.4	8.5	5.0	10.2	13.6	11.3	16.8	17.0	11.1	11.5	8.3	14.7	14.6	11.0	9.7	28.7	3.9	8.6	1.5	14.0	7.7	7.8	13.8	13.7	5.0	9.4	6.3	7.3	29.6	27.3	0.0	17.9	3.6	8.8	6.5	5.0	6.2	17.8	18.3	6.0	4.1	0.7	9.0	6.6	8.8	6.5	5.0	10.0	5.2	12.1	15.2	11.5	22.8	9.8	5.6	9.3	16.9	4.5	9.9	16.0	13.1	12.0	8.7	9.4	10.0	19.9	10.7	5.1	7.3	8.0	23.2	7.1
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300005-56320776	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.9;lung: 34.4;skin 1: 62.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 155.9;Basal respiratory cells: 325.1;Club cells: 141.9;Ionocytes: 120.1;Pancreatic endocrine cells: 99.5;Respiratory ciliated cells: 82.5;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	35	"memory B-cell: 4.7;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	47	"B-cells: 4.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.8;HaCaT: 10.3;hTCEpi: 16.7;OE19: 24.8;T-47d: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025224	Enhanced					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favorable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	1.7	3.0	1.8	0.0	9.1	1.6	4.4	15.6	0.5	2.2	2.3	0.0	0.0	51.9	0.2	0.4	0.2	2.2	1.5	0.1	0.0	34.4	0.4	4.8	2.0	0.2	0.4	0.0	0.5	0.0	4.9	0.3	3.9	1.1	16.8	0.0	0.3	62.6	15.7	0.2	0.9	0.0	18.1	0.8	2.8	0.3	0.0	0.2	21.9	6.3	24.9	1.8	4.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	10.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	24.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.6	4.4	2.2	1.5	4.8	2.0	4.9	0.9	2.8	1.8	1.7	48.1	155.9	0.0	1.7	51.1	6.2	325.1	4.6	0.3	5.5	2.4	0.2	5.7	141.9	0.0	0.0	0.0	0.0	7.1	0.0	0.7	0.4	0.0	0.1	2.3	0.0	0.0	4.3	1.4	0.0	0.9	10.2	0.1	3.8	0.0	0.0	0.0	0.0	0.0	1.1	19.7	120.1	0.0	3.6	0.4	0.6	0.4	3.6	0.0	0.6	12.3	0.0	0.0	0.3	99.5	3.4	0.0	0.0	9.5	0.3	0.0	82.5	1.6	0.0	0.1	4.9	0.3	5.5	36.6	72.2	0.0	0.6	0.0	5.3	26.0
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.2;Bipolar cells: 23.4;Endothelial cells: 24.4;Hepatic stellate cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 108.1;HUVEC TERT2: 187.0;RT4: 112.3;SK-BR-3: 170.2;TIME: 338.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	NA	NA	1700000	7900000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	33.8	9.0	8.8	8.6	5.7	2.7	31.9	5.1	8.1	28.3	12.0	10.5	13.4	14.5	5.4	100.8	15.6	10.8	22.6	5.0	9.2	49.2	4.8	46.2	3.7	10.2	12.7	3.6	6.7	5.5	11.1	30.4	8.7	32.7	6.3	22.0	24.6	32.5	10.4	75.1	12.5	9.1	6.3	50.7	17.3	2.4	21.8	6.1	27.1	6.1	12.6	27.0	55.4	4.7	13.9	3.1	0.7	14.2	0.2	1.3	3.0	8.0	24.2	6.5	10.2	5.4	6.1	0.5	77.9	1.1	0.7	47.5	6.9	100.7	2.4	0.1	1.8	0.8	108.1	18.5	5.7	1.7	3.2	6.2	55.3	15.1	45.4	90.7	187.0	1.2	2.9	0.1	1.3	12.4	1.5	7.5	8.6	6.2	10.1	11.8	0.0	0.5	7.2	112.3	1.1	2.6	12.8	170.2	0.3	10.4	67.2	7.3	338.6	4.2	31.9	29.7	5.5	0.2	0.0	0.9	0.3	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	5.7	5.1	8.1	5.0	9.2	10.2	12.7	8.7	6.3	21.8	4.7	40.2	0.0	1.1	0.0	0.2	6.8	3.0	9.2	5.7	23.4	10.7	6.0	9.2	1.5	6.6	18.4	10.4	11.2	0.6	5.5	0.0	0.3	0.0	6.5	2.4	24.4	0.0	0.0	0.7	0.8	0.5	1.1	16.3	6.9	0.0	0.2	25.4	0.6	1.4	6.7	1.1	10.7	0.0	0.3	0.8	0.3	0.3	0.2	0.0	3.7	0.0	8.7	0.0	0.0	0.1	6.8	3.8	0.0	0.0	2.5	5.7	0.7	5.4	19.8	0.0	0.5	2.5	0.0	0.4	17.7	8.9	6.3	0.4	0.2	5.2	8.6
SEPTIN10	"FLJ11619, SEPT10"	ENSG00000186522	"Septin 10"	Q9P0V9	2	109542799-109614143	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.4;Cardiomyocytes: 21.8;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 59.4;Fibroblasts: 15.5;Hofbauer cells: 19.6;Smooth muscle cells: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047860, HPA056304, HPA060310"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA047860: AB_2680187, HPA056304: AB_2683094, HPA060310: AB_2684249"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.18e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.12e-2)"	57.0	24.2	16.1	22.6	29.5	0.7	52.9	29.8	20.3	41.5	58.7	52.0	22.3	44.5	21.7	88.4	33.4	41.8	41.7	15.1	24.2	43.4	66.5	60.4	18.4	46.8	29.5	46.7	20.3	26.9	9.5	50.4	41.6	40.6	39.8	13.6	34.7	42.2	28.5	73.4	24.3	58.0	31.9	36.3	30.5	76.9	26.1	19.9	43.3	39.0	22.8	55.1	43.2	44.5	104.7	27.7	99.6	64.1	78.1	145.8	61.1	166.5	290.6	114.8	133.3	52.2	59.0	0.0	82.2	130.4	72.2	47.7	42.8	105.2	151.6	199.4	31.2	0.2	38.5	75.3	58.7	0.2	13.4	91.5	46.9	103.5	135.1	123.9	154.3	0.0	2.7	0.4	141.5	9.9	0.1	10.3	74.4	61.3	53.7	0.1	80.9	17.4	95.7	136.8	29.6	61.8	97.8	2.1	77.0	115.2	26.5	1.2	158.5	120.1	85.1	46.9	69.6	61.4	36.0	0.9	106.7	2.3	148.1	0.0	2.4	0.0	0.1	1.6	0.1	0.8	1.5	0.4	0.6	0.3	0.7	0.2	0.1	0.0	1.0	0.0	3.5	0.8	16.1	29.5	29.8	20.3	15.1	24.2	46.8	29.5	41.6	31.9	26.1	44.5	56.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	59.4	15.5	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0
SERPINB2	"HsT1201, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903888	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Plasminogen activation"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 239.1;lymphoid tissue: 81.2;skin 1: 89.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2243.9;Suprabasal keratinocytes: 1053.6;Syncytiotrophoblasts: 439.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.5"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.3;thalamus: 1.1"	"Immune cell enhanced"	"Detected in some"		"basophil: 22.0;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 282.7;HaCaT: 699.1;U-138 MG: 807.0;U-2197: 1243.9"	"Region enriched"	"Detected in single"	15	"cerebellum: 2.6"	"Not detected"	"Not detected"			"HPA015480, HPA076596, HPA076608"	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"			"HPA015480: AB_1855456, HPA076596: , HPA076608: "	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-6)"	"unprognostic (3.89e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.55e-5)"	21.0	0.3	0.0	8.6	0.0	36.5	8.7	0.0	1.3	21.0	0.0	0.5	0.1	0.7	0.0	239.1	8.4	0.7	1.0	0.0	0.2	0.2	0.3	2.8	0.0	0.0	0.1	0.3	1.1	0.2	0.1	50.1	0.0	0.2	0.0	0.0	31.2	0.0	0.3	89.2	0.1	1.7	0.0	0.3	0.8	0.0	1.1	2.6	0.1	0.2	81.2	6.6	45.4	0.0	1.4	0.0	0.0	0.8	1.3	0.6	0.2	169.2	179.2	6.0	13.1	0.9	0.4	0.2	0.0	6.1	282.7	699.1	0.0	143.7	118.6	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.5	1.5	13.9	81.7	37.0	1.8	0.6	0.0	0.6	0.4	2.8	0.0	0.2	0.4	0.3	0.2	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	1.1	0.0	0.6	0.7	15.7	13.9	807.0	0.4	1243.9	0.0	0.2	0.1	0.0	21.6	1.8	96.7	22.0	4.9	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.5	0.0	0.2	2243.9	4.1	82.1	0.0	0.0	0.6	0.1	0.7	0.0	153.4	0.0	0.0	6.2	0.1	0.0	0.0	92.6	0.0	0.1	0.1	5.5	0.0	0.0	0.0	7.1	1.7	11.0	0.0	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	26.4	2.9	86.4	0.0	0.0	73.1	94.3	0.0	3.9	0.0	0.0	0.0	0.0	167.2	0.0	0.0	1.0	18.9	0.0	0.0	94.5	0.0	0.0	0.3	14.8	0.0	0.0	94.7	1053.6	439.3	2.5	0.0	0.0	52.0
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476958-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 216.6;skin 1: 239.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 964.1;Basal prostatic cells: 358.7;Basal respiratory cells: 272.9;Squamous epithelial cells: 535.4;Suprabasal keratinocytes: 1215.3;Urothelial cells: 564.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1279.3;HBEC3-KT: 425.6;hTCEpi: 875.0;hTERT-HME1: 217.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		770000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.6	0.0	0.0	4.3	0.0	0.2	37.1	0.1	0.1	38.5	0.1	4.8	16.7	0.1	0.1	216.6	1.4	2.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	9.9	4.5	0.0	37.6	1.7	1.4	239.7	22.1	0.2	0.0	0.0	9.7	2.8	0.0	13.9	0.1	0.0	39.9	90.9	78.7	0.1	80.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	73.4	0.1	3.8	0.0	0.1	1279.3	0.0	425.6	0.0	0.0	0.0	0.0	95.8	0.2	0.0	0.0	0.6	0.1	875.0	0.0	217.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	179.9	93.4	0.1	0.0	0.2	0.0	95.1	1.4	0.0	60.2	0.3	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.2	0.9	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	964.1	358.7	272.9	224.3	0.0	5.1	27.3	0.2	0.0	90.0	3.7	0.0	0.3	0.1	14.2	0.0	0.1	9.0	6.2	0.1	5.4	3.5	0.0	0.3	0.0	0.2	5.8	12.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.3	34.6	0.0	57.6	18.6	0.6	1.8	62.2	0.0	0.0	0.0	0.0	0.0	0.1	16.3	51.7	0.0	2.5	85.4	13.5	0.1	85.4	0.0	0.0	0.0	7.1	6.6	2.2	535.4	1215.3	0.1	4.0	0.1	30.6	564.9
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863149-26864456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2461.5;skin 1: 1219.1;vagina: 692.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 7750.0;Basal prostatic cells: 2119.7;Squamous epithelial cells: 3587.1;Suprabasal keratinocytes: 10714.0;Urothelial cells: 2780.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 1510.8;head and neck cancer: 2526.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"A-431: 770.8;HaCaT: 1181.6;HBEC3-KT: 1819.0;hTCEpi: 1196.7"	"Low region specificity"	"Detected in many"							"CAB006268, HPA011105, CAB040552"	Enhanced		Supported	Cytosol	"Secreted in other tissues"	NA	Yes		29000000	"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339"	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	3.1	0.8	1.9	11.6	1.8	2.0	29.1	1.8	9.5	350.2	0.4	95.4	48.8	8.0	0.7	2461.5	2.2	21.4	1.3	1.9	1.6	16.0	3.7	56.1	0.2	9.0	4.4	0.9	2.2	0.1	2.7	1.6	4.3	77.2	32.5	0.6	332.8	3.2	5.0	1219.1	40.8	3.3	1.2	0.9	66.6	0.7	5.2	22.1	2.0	0.1	147.9	167.6	692.0	2.3	770.8	126.9	0.1	1.1	0.3	0.1	37.2	0.5	0.0	0.1	0.3	46.6	393.6	6.7	32.2	0.2	0.6	1181.6	0.3	1819.0	0.0	183.4	5.4	0.9	119.6	138.4	0.1	0.4	1.4	0.4	1196.7	0.6	310.1	0.2	0.2	0.7	1.8	4.5	0.1	163.8	0.7	0.3	2.3	132.6	208.7	0.5	0.4	43.1	281.3	173.9	0.7	0.7	181.2	31.9	1.8	2.9	83.6	1.5	0.5	0.5	337.2	0.3	4.9	1.0	5.8	3.8	1.5	0.7	0.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	1.8	1.8	9.5	1.9	1.6	9.0	4.4	4.3	1.2	5.2	2.3	1.6	179.5	162.2	0.0	5.0	7750.0	2119.7	1374.7	1714.2	0.0	72.6	119.9	0.8	24.3	285.6	16.5	0.0	18.6	0.7	972.0	3.9	48.8	0.0	138.0	20.1	45.3	67.4	0.0	0.0	76.2	59.9	46.2	221.2	251.8	32.3	0.0	0.4	4.5	1.9	0.0	0.1	140.7	114.0	0.6	479.7	0.0	0.0	9.7	533.6	0.0	1.0	0.0	0.0	0.0	0.1	524.8	933.0	0.0	21.2	1030.2	318.5	0.6	158.2	0.0	0.0	0.7	55.2	0.0	0.6	3587.1	10714.0	6.0	23.4	0.1	292.4	2780.0
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780591-153789083	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 318.8;urinary bladder: 306.7"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 806.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	188.2	16.0	4.9	84.6	4.0	0.3	154.9	3.6	6.3	23.2	11.2	72.2	18.4	12.0	22.2	212.7	62.1	318.8	6.2	12.3	13.8	4.5	0.3	62.5	11.8	4.5	3.7	8.3	45.1	7.0	72.5	0.4	4.6	56.5	44.3	2.3	83.4	70.5	6.5	80.5	57.3	89.5	3.8	0.7	34.4	1.5	2.2	9.6	92.3	38.7	3.6	306.7	63.0	12.3	0.0	0.0	229.1	0.2	85.2	15.1	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	140.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	318.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.1	0.1	0.0	8.1	0.2	0.0	0.0	0.4	0.1	0.0	12.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.0	3.6	6.3	12.3	13.8	4.5	3.7	4.6	3.8	2.2	12.3	15.5	3.2	0.6	9.4	0.5	115.5	0.8	0.0	5.7	0.0	3.7	7.9	0.3	0.0	1.9	0.0	0.0	0.1	2.0	0.0	0.0	0.2	0.0	0.1	0.1	11.8	0.0	0.0	0.7	0.0	0.2	806.1	38.7	0.3	1.3	0.0	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.0	175.0	0.5	4.1	5.0	119.2	0.0	0.6	0.0	0.0	0.5	0.1	0.1	0.0	7.2	4.1	0.7	0.0	0.1	2.9	0.0	0.0	6.7	59.4	0.0	0.1	6.9	106.0	0.1	8.6	0.0	0.0	0.9
SH2D3A	NSP1	ENSG00000125731	"SH2 domain containing 3A"	Q9BRG2	19	6752160-6767463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 117.9;Pancreatic endocrine cells: 81.3;Urothelial cells: 87.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 43.2;HaCaT: 34.2;HBEC3-KT: 67.4"					"Not detected"	"Not detected"			"HPA035722, HPA064382"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA035722: AB_10670024, HPA064382: AB_2685251"	"unprognostic (3.32e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.63e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (7.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.81e-3)"	0.9	0.4	0.2	4.6	0.2	3.4	7.5	0.1	0.6	8.0	0.5	12.8	14.3	1.2	1.0	32.5	4.3	3.5	0.6	0.1	0.1	19.6	2.6	10.8	5.2	0.4	0.2	0.8	19.7	5.9	2.8	5.9	0.2	18.1	5.4	0.9	18.7	4.1	1.5	27.6	14.4	0.3	0.2	5.7	14.2	4.4	0.3	3.3	13.0	0.0	4.1	9.1	17.0	0.5	43.2	6.2	0.1	0.2	0.0	0.0	22.6	0.3	0.0	0.0	0.0	20.3	30.8	6.6	19.6	0.0	0.0	34.2	2.3	67.4	0.0	3.6	6.6	0.3	6.9	2.6	0.1	0.6	8.6	0.0	30.3	0.0	5.9	0.8	0.0	14.8	7.3	14.3	0.0	15.3	3.2	0.2	1.6	21.5	12.0	1.2	0.1	24.8	11.5	31.4	0.0	0.2	2.3	31.7	0.1	1.0	22.0	0.4	0.7	0.7	2.2	0.5	0.4	14.1	15.8	9.2	0.2	4.8	0.3	0.1	0.0	0.0	2.6	0.1	4.2	3.6	5.9	5.2	0.1	5.6	7.7	4.2	0.1	1.8	0.1	0.4	3.2	0.9	0.2	0.2	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.2	0.3	0.5	0.7	19.2	14.2	0.3	25.8	30.7	117.9	51.4	25.0	4.1	13.6	11.4	1.9	40.0	43.9	40.5	10.4	23.8	7.7	46.6	1.9	54.1	1.6	15.4	2.9	2.8	12.1	7.8	0.1	37.1	52.8	2.6	50.0	24.9	5.7	0.3	1.8	2.9	3.6	0.0	0.2	37.9	28.5	0.6	10.3	0.8	0.6	2.2	3.6	0.0	4.2	0.8	14.4	0.0	0.1	81.3	69.7	0.0	8.0	58.6	53.9	13.1	27.0	4.6	0.0	2.2	3.5	8.7	11.4	17.6	39.9	10.8	18.0	1.1	32.0	87.9
SH3BP1	ARHGAP43	ENSG00000100092	"SH3 domain binding protein 1"	Q9Y3L3	22	37634654-37656117	"Metabolic proteins, Predicted intracellular proteins"	Phagocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.5;HMC-1: 45.4;NB-4: 44.7"	"Low region specificity"	"Detected in all"							HPA000757	Supported		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA000757: AB_1079951"	"unprognostic (7.81e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.78e-1)"	"prognostic unfavorable (3.48e-7)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.37e-2)"	"unprognostic (8.48e-3)"	4.2	3.6	3.4	14.2	3.4	14.4	3.4	3.7	6.2	12.2	2.7	19.4	18.1	3.2	0.7	37.7	4.0	2.1	2.0	4.1	4.5	3.2	2.6	8.8	12.1	6.0	3.9	3.4	2.8	2.2	2.1	5.1	4.7	7.6	4.5	0.2	9.3	2.0	0.7	27.0	20.9	2.0	4.8	27.0	4.3	5.7	4.7	8.2	2.5	0.5	7.7	10.5	21.1	5.7	20.1	1.0	3.9	3.4	0.9	3.9	28.6	3.8	6.4	6.3	7.0	5.9	2.3	12.6	2.7	2.4	2.0	43.5	2.0	26.0	2.6	36.9	13.7	18.5	0.6	8.6	3.3	25.9	45.4	4.9	6.3	7.9	0.9	5.2	1.0	6.3	6.4	4.8	0.6	12.7	3.0	44.7	7.6	13.7	3.8	15.7	3.2	11.0	0.8	22.2	3.8	10.1	1.0	5.3	17.9	3.9	6.7	22.1	1.3	2.3	10.8	0.5	0.2	29.9	10.2	9.0	3.2	26.4	13.0	1.8	1.4	4.6	1.0	1.8	1.0	0.3	1.1	1.1	0.7	0.1	0.6	1.4	0.9	0.8	3.7	1.2	1.1	0.6	3.4	3.4	3.7	6.2	4.1	4.5	6.0	3.9	4.7	4.8	4.7	5.7	1.2	0.0	7.2	0.7	23.7	19.1	22.2	42.5	23.3	0.3	3.3	4.1	1.2	4.3	8.0	0.0	2.1	47.5	36.1	55.0	0.0	3.0	0.4	0.6	4.3	1.7	4.2	7.8	5.6	4.7	43.9	6.0	11.2	1.3	14.0	3.4	4.2	0.5	48.3	8.4	0.8	29.9	12.2	33.3	19.0	0.1	5.0	45.6	5.4	2.8	36.0	3.0	53.5	5.0	0.9	2.0	46.8	1.9	20.9	29.6	41.9	0.3	11.4	0.5	0.0	0.9	3.6	3.4	6.0	23.6	15.3	37.5	52.7	5.0	23.6	42.0
SH3GL1	"CNSA1, EEN, MGC111371, SH3D2B, SH3P8"	ENSG00000141985	"SH3 domain containing GRB2 like 1, endophilin A2"	Q99961	19	4360370-4400547	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021485	Approved		Enhanced	Cytosol		NA	NA		390000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA021485: AB_1856816"	"unprognostic (1.32e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (6.85e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.36e-8)"	"unprognostic (5.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	61.1	64.7	25.0	29.4	28.8	54.4	50.0	32.8	38.1	69.8	24.2	41.3	40.9	45.1	8.2	175.8	43.9	25.4	37.6	34.4	20.5	39.2	57.4	43.8	22.8	24.8	22.5	49.0	41.8	10.8	46.8	38.9	23.8	48.8	9.2	7.0	51.8	24.0	21.2	119.8	43.7	20.8	21.1	46.8	35.9	28.1	24.7	16.8	37.1	10.1	19.8	53.0	91.6	28.0	111.3	49.2	50.0	66.8	57.4	89.0	92.2	94.2	80.3	82.2	81.1	77.4	56.8	24.9	39.0	94.1	39.8	89.5	35.6	103.7	21.9	33.1	59.8	30.0	66.5	102.7	82.6	27.2	32.6	75.0	70.9	69.4	42.4	40.6	97.8	23.7	78.9	55.1	67.1	92.6	26.5	28.4	126.0	40.4	54.3	20.8	69.8	43.6	65.8	96.4	49.1	75.7	83.3	81.9	59.3	23.5	56.5	42.5	149.3	78.6	57.1	166.7	97.2	34.8	23.2	26.7	112.9	70.0	110.4	0.8	2.3	3.1	2.7	1.1	2.6	3.7	4.0	3.9	3.0	2.7	2.2	2.5	5.6	2.3	3.4	3.8	4.1	2.3	25.0	28.8	32.8	38.1	34.4	20.5	24.8	22.5	23.8	21.1	24.7	28.0	31.6	9.6	21.5	11.8	15.2	60.8	41.0	43.2	19.4	17.1	17.1	15.7	3.6	11.5	25.1	9.2	6.2	41.2	14.7	23.6	13.7	32.1	7.2	17.9	33.8	30.7	10.2	30.7	23.4	29.3	153.7	37.5	19.9	29.5	9.5	23.4	32.9	27.3	51.5	10.1	14.0	18.6	20.3	19.4	51.8	6.7	32.6	22.3	23.2	14.0	14.7	20.3	15.5	12.5	10.3	50.4	17.0	24.0	16.4	38.0	61.6	22.9	15.4	8.7	13.1	17.2	29.3	15.7	11.5	36.8	85.8	44.2	15.1	50.1	19.8	67.1
SHISA5	"hShisa5, SCOTIN"	ENSG00000164054	"Shisa family member 5"	Q8N114	3	48467798-48504826	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 279.7;Extravillous trophoblasts: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042295	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA042295: AB_10794794"	"unprognostic (3.52e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.72e-6)"	"unprognostic (3.82e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-2)"	97.5	71.8	74.2	68.3	71.9	65.0	82.2	58.8	92.2	99.6	113.0	82.1	60.6	91.4	45.3	140.6	94.9	70.6	75.0	72.3	88.9	94.3	115.0	101.7	80.1	76.8	73.6	86.3	58.3	48.0	70.2	138.4	72.0	107.9	39.5	13.7	69.1	69.8	22.8	60.1	74.5	67.1	70.8	114.3	73.5	35.5	87.6	84.4	76.8	31.7	66.9	116.8	98.3	65.2	71.0	141.9	82.4	132.0	153.1	194.7	417.7	115.3	209.0	254.3	187.9	157.4	175.6	97.7	123.2	200.9	240.9	91.7	91.5	148.3	70.7	116.4	63.6	89.2	91.2	128.2	256.7	61.9	164.0	200.9	169.3	205.7	141.7	141.7	193.2	129.0	56.6	115.6	138.2	154.1	70.4	111.1	150.4	101.2	113.0	48.2	36.7	133.4	130.5	446.6	24.6	13.8	74.9	79.1	155.6	136.8	91.5	91.2	153.6	90.5	100.8	155.2	112.0	87.0	76.3	85.8	128.2	118.3	90.2	205.9	301.6	252.5	320.7	267.5	283.4	165.0	264.1	293.8	167.3	222.6	210.9	219.4	910.2	138.7	306.9	126.7	345.7	500.0	74.2	71.9	58.8	92.2	72.3	88.9	76.8	73.6	72.0	70.8	87.6	65.2	69.8	41.7	39.4	12.1	55.8	27.8	73.0	52.2	114.4	22.7	29.6	29.8	17.3	51.5	37.6	64.4	16.7	279.7	56.3	43.0	11.7	79.4	4.2	29.2	49.8	79.4	37.8	22.9	10.8	104.3	229.9	57.4	36.2	31.2	34.8	41.5	66.0	88.0	103.0	6.7	11.0	48.3	14.2	57.5	27.3	5.7	49.0	47.7	46.2	18.7	46.5	30.1	101.0	10.6	10.4	80.2	31.2	39.1	54.5	50.2	64.9	43.3	38.0	5.0	32.9	22.1	43.9	5.1	8.8	85.9	32.1	120.5	74.0	49.9	40.3	50.5
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399336-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	10.6	2.6	3.1	7.3	3.4	1.8	9.3	3.3	4.1	8.2	5.4	14.0	14.2	5.0	3.4	21.4	5.3	4.3	5.0	3.2	3.6	7.7	10.6	10.2	5.5	4.3	3.5	6.0	5.9	6.9	1.9	8.3	3.9	4.6	15.5	0.5	10.8	4.6	1.6	16.3	12.8	8.8	3.5	4.9	8.9	2.1	3.6	3.6	4.2	4.5	11.3	7.9	11.3	3.8	32.4	23.3	1.9	9.2	30.0	44.5	12.2	17.9	21.7	13.8	13.2	12.4	16.0	4.0	10.2	47.4	41.1	23.2	18.2	16.0	12.4	28.5	5.4	11.3	7.4	16.4	19.3	10.6	11.7	18.8	28.3	22.5	19.8	18.9	16.6	6.1	2.3	17.1	15.7	58.9	0.1	15.9	10.3	16.6	35.1	3.2	0.0	4.6	22.3	10.9	1.5	0.0	23.0	47.8	29.1	7.3	8.5	11.0	24.2	22.2	7.1	25.0	28.0	0.4	14.2	8.3	22.3	17.8	19.7	0.0	3.5	0.2	0.9	4.9	1.7	4.4	1.8	2.9	6.0	3.7	0.9	1.8	0.1	6.4	11.2	1.6	1.5	1.6	3.1	3.4	3.3	4.1	3.2	3.6	4.3	3.5	3.9	3.5	3.6	3.8	8.3	6.4	9.7	30.7	8.0	7.8	7.3	8.9	9.6	0.2	6.1	6.6	1.6	2.8	5.6	3.7	0.0	11.9	9.1	21.8	9.8	4.5	0.0	0.9	7.6	6.9	7.3	3.4	10.3	8.9	7.1	11.8	9.7	1.8	8.2	2.1	6.4	5.8	10.3	0.0	6.2	9.6	4.1	7.1	13.6	0.4	8.1	7.5	10.6	1.0	11.9	0.2	9.2	36.7	1.4	13.9	11.4	5.7	2.8	5.4	19.8	9.6	2.0	0.4	0.0	7.8	9.2	0.5	2.3	19.8	13.9	6.8	6.8	1.0	12.2	5.8
SLURP1	"ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740949-142742406	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 1039.2;skin 1: 858.5"	"Group enriched"	"Detected in some"	16	"Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050967	Approved				"Secreted in other tissues"	NA	NA		7700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.9	0.6	0.1	0.0	0.0	0.0	11.3	0.7	0.5	105.0	0.0	0.3	0.0	0.2	0.0	1039.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	70.1	0.0	1.4	858.5	0.3	0.0	0.0	0.2	0.8	0.3	0.1	0.9	0.2	0.0	17.4	0.3	206.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.6	0.0	0.0	1.8	1.5	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.8	65.8	0.0	0.0	0.0	0.0	0.8
SLURP2		ENSG00000283992	"Secreted LY6/PLAUR domain containing 2"	P0DP57	8	142764338-142769828	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 870.8;skin 1: 334.1;vagina: 219.7"	"Cell type enhanced"	"Detected in single"		"Pancreatic endocrine cells: 1.5"					"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 28.5"														"Secreted in other tissues"	NA	NA		3100000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"																					1.1	0.1	0.4	0.0	0.7	0.0	2.0	2.9	2.4	187.1	0.0	19.4	0.3	5.0	0.2	870.8	4.0	0.2	1.2	1.0	0.1	0.2	0.3	0.5	0.0	1.8	0.2	1.0	0.4	0.0	0.2	0.1	1.7	6.5	0.2	0.3	75.2	2.1	0.4	334.1	2.8	0.8	0.2	0.3	5.8	0.3	0.4	1.2	0.6	0.0	22.9	9.9	219.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.1	6.2	0.0	0.0	28.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	2.9	2.4	1.0	0.1	1.8	0.2	1.7	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNX33	"MGC32065, SH3PX3, SH3PXD3C, SNX30"	ENSG00000173548	"Sorting nexin 33"	Q8WV41	15	75647912-75662301	"Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040988	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA040988: AB_10794983"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (5.00e-3)"	"unprognostic (3.00e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	26.2	17.2	11.1	7.1	11.1	0.5	21.3	9.5	9.8	29.3	11.8	19.7	12.1	23.6	8.4	42.5	21.9	14.3	19.6	10.2	9.9	12.5	29.0	19.3	8.2	14.2	10.8	25.6	27.2	11.1	7.0	11.9	10.3	23.5	10.0	1.6	20.6	16.6	5.9	29.6	15.5	14.6	10.1	11.8	18.8	3.5	13.0	7.6	16.7	9.2	10.6	20.2	30.2	9.1	14.9	13.1	12.6	13.5	48.7	31.5	13.9	14.3	29.8	15.6	14.2	8.3	15.3	0.4	10.3	31.7	22.3	35.1	15.7	37.4	8.3	16.4	5.3	4.6	15.5	15.2	32.3	0.4	4.7	32.6	44.5	15.2	21.2	37.4	10.0	1.4	11.0	2.0	18.4	2.9	0.1	9.4	12.1	9.3	7.3	2.3	9.9	0.7	15.9	22.1	1.1	8.6	21.1	22.7	17.4	23.4	13.6	10.5	14.6	22.1	10.4	16.6	7.7	0.3	0.4	0.1	22.3	5.4	6.0	0.0	0.5	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	11.1	11.1	9.5	9.8	10.2	9.9	14.2	10.8	10.3	10.1	13.0	9.1	8.3	6.4	5.6	2.9	0.2	12.1	3.4	9.3	6.2	0.0	6.8	5.7	3.8	2.8	8.2	7.3	2.1	3.1	1.2	13.5	0.0	7.5	0.3	4.8	7.5	5.7	9.1	0.4	0.5	6.5	4.1	13.3	14.3	4.8	1.3	6.8	10.0	12.6	5.1	0.0	0.1	8.1	8.2	2.8	7.8	0.6	13.1	2.9	3.6	2.8	3.0	3.8	0.0	2.5	0.2	15.9	7.6	15.1	1.1	7.5	12.4	3.7	9.5	0.2	19.7	8.5	9.5	0.1	0.6	5.5	11.2	1.4	1.8	2.5	7.3	11.3
SOX7		ENSG00000171056	"SRY-box transcription factor 7"	Q9BT81	8	10723768-10730511	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 42.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8"	"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	22.6	3.8	2.5	1.0	2.3	0.1	11.9	1.9	2.6	27.0	1.4	4.2	0.1	4.3	1.1	26.8	4.5	3.6	18.5	2.1	1.8	5.1	4.3	23.2	1.7	2.6	2.2	1.5	2.6	1.0	5.6	17.3	2.5	5.4	1.1	0.4	10.5	2.7	9.8	20.2	3.6	2.3	2.5	2.4	3.7	0.7	2.7	1.5	7.6	6.4	1.9	4.6	42.4	2.0	5.8	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.6	11.8	3.4	4.2	0.1	0.1	0.4	0.1	0.3	0.1	0.0	0.2	0.2	0.1	21.3	0.0	4.3	0.0	25.2	0.0	0.6	0.3	0.0	0.2	0.2	0.2	1.6	0.9	3.2	1.2	0.0	0.0	0.0	2.1	0.6	3.4	2.2	0.0	0.0	1.4	0.0	0.1	6.8	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	1.9	2.6	2.1	1.8	2.6	2.2	2.5	2.5	2.7	2.0	115.4	0.0	11.5	0.3	1.1	61.2	67.6	24.5	148.5	1.2	5.2	4.7	4.8	1.5	6.3	0.0	4.2	4.3	0.1	0.2	0.0	0.2	0.2	14.9	1.9	115.1	0.0	0.0	4.6	0.2	0.8	4.7	0.0	22.9	3.8	0.5	48.5	4.9	0.7	0.0	2.9	0.2	10.2	1.9	8.7	0.1	0.9	0.9	3.6	10.3	0.3	0.5	0.0	1.5	0.8	0.5	0.0	0.4	1.2	17.8	0.1	0.6	3.2	2.2	0.0	8.5	4.4	2.4	1.6	98.9	40.6	12.4	1.8	1.2	0.4	26.6
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 105.4;Muller glia cells: 165.1;Pancreatic endocrine cells: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.6;TIME: 108.9;U-251 MG: 142.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"olfactory bulb: 5.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	18.9	4.1	4.0	10.5	3.0	17.3	18.0	2.1	3.9	11.0	2.3	7.0	1.9	6.7	3.9	23.8	9.4	11.9	17.5	2.9	3.9	21.4	3.8	24.3	8.1	4.0	4.1	4.3	14.4	4.8	4.9	2.5	4.5	7.3	1.1	8.4	19.9	1.5	3.2	15.6	7.0	3.2	2.3	5.0	6.7	5.8	8.5	3.5	10.6	0.8	4.1	11.3	13.1	3.9	36.9	3.7	15.2	0.8	7.6	7.0	15.8	82.6	54.0	67.8	40.8	19.4	3.9	1.8	7.4	61.0	28.9	7.7	11.7	105.4	16.4	1.6	6.2	0.5	28.3	127.6	16.6	1.3	2.9	13.6	2.1	105.9	41.3	28.8	66.0	3.7	17.3	0.2	13.5	46.6	3.5	0.6	0.9	8.2	29.7	2.5	4.1	2.8	3.7	0.5	2.0	3.6	8.3	0.9	74.4	9.1	3.0	5.1	108.9	105.8	20.8	82.3	142.1	1.7	0.4	1.6	80.5	6.5	16.1	1.5	1.9	0.0	0.7	0.9	0.2	0.0	0.1	0.2	0.5	0.1	0.0	0.1	0.2	0.0	0.2	4.8	0.0	0.8	4.0	3.0	2.1	3.9	2.9	3.9	4.0	4.1	4.5	2.3	8.5	3.9	22.0	0.0	0.0	1.0	2.8	12.6	57.0	18.6	2.8	1.5	31.1	29.1	5.3	47.1	6.6	1.8	0.0	1.2	9.1	1.0	0.0	105.4	0.2	15.3	13.5	51.2	0.0	22.3	0.5	12.7	16.9	27.5	3.1	60.7	7.0	0.4	4.2	0.2	30.1	33.7	1.6	2.4	6.1	8.9	45.4	1.4	3.7	39.9	12.4	1.0	61.5	165.1	3.1	0.0	0.1	101.8	1.2	19.9	3.5	68.9	0.8	2.5	2.0	3.9	0.0	17.3	54.3	0.0	9.5	6.7	10.7	1.4	4.2	0.8	0.4	27.0
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 5.7;lymphoid tissue: 4.9;salivary gland: 6.9;vagina: 10.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Hofbauer cells: 2.8;Oligodendrocyte precursor cells: 1.0;Prostatic glandular cells: 5.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	74	"HeLa: 3708.0;SiHa: 2339.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011039	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	0.6	0.2	0.1	0.0	0.7	0.0	0.2	3.0	1.1	5.7	0.1	1.7	0.0	0.0	1.2	2.4	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.3	6.9	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.4	4.9	0.0	0.1	0.0	0.6	10.1	2.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.5	3708.0	4.0	0.0	0.6	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	2339.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	40.8	0.2	0.1	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	3.0	1.1	0.4	0.1	0.6	0.4	0.9	0.1	0.4	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.8	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.4	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1
SPRR2B		ENSG00000196805	"Small proline rich protein 2B"	P35325	1	153070224-153070840	"Predicted intracellular proteins"	Keratinization			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 50.1;skin 1: 39.0"	"Group enriched"	"Detected in some"	13	"Granulosa cells: 5.8;Leydig cells: 6.2;Theca cells: 3.9"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 77.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 40: Granulosa cells - Unknown function"					"unprognostic (1.52e-1)"				"unprognostic (1.44e-2)"			"unprognostic (3.62e-1)"									0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	15.2	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0
SPRR2E		ENSG00000203785	"Small proline rich protein 2E"	P22531	1	153093135-153106184	"Predicted intracellular proteins"	Keratinization			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1773.2;skin 1: 1179.2"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 26.2;Granulosa cells: 21.2;Squamous epithelial cells: 18.4;Suprabasal keratinocytes: 43.8"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 612.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"hTCEpi: 16.5"															NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"					"unprognostic (2.27e-1)"				"unprognostic (3.86e-2)"		"unprognostic (5.04e-2)"	"unprognostic (3.40e-1)"								"prognostic unfavorable (9.47e-4)"	2.7	0.5	0.0	0.0	0.0	0.3	46.0	0.0	0.0	337.6	0.0	0.4	0.0	0.4	0.0	1773.2	0.3	0.4	0.8	0.0	0.0	0.4	1.0	0.4	0.0	0.0	0.0	2.3	1.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	338.7	0.0	1.2	1179.2	0.4	0.4	0.0	0.3	1.0	0.6	0.0	1.9	0.3	0.0	503.5	0.3	482.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	16.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.2	18.4	43.8	0.0	0.1	0.1	0.0	0.0
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303478-67312607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.6;eosinophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 64.9;MCF7: 64.1;RT4: 111.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	14.4	7.8	8.9	4.0	12.0	9.3	16.2	14.1	11.6	25.9	9.5	19.3	13.3	16.0	7.5	41.9	18.3	11.5	12.5	9.1	10.1	13.1	10.9	12.7	3.1	14.6	10.8	23.5	15.3	9.8	9.7	6.5	13.2	29.9	9.3	1.2	26.2	28.8	6.8	25.2	15.0	6.1	12.3	9.4	20.1	2.3	11.5	1.9	16.3	3.8	4.8	37.4	32.5	14.9	17.3	18.7	0.4	0.6	11.4	11.8	18.8	10.3	13.7	5.6	5.1	21.2	46.8	1.0	32.5	10.5	11.9	64.9	6.0	46.4	2.8	3.6	6.3	4.3	32.2	9.9	8.2	0.9	16.0	12.2	40.5	8.3	8.3	12.9	6.3	0.4	0.1	1.5	6.2	64.1	0.8	7.3	4.2	48.9	13.8	20.6	0.6	3.1	18.2	111.2	3.7	5.8	24.8	41.0	12.8	6.3	57.1	15.3	10.4	4.5	9.8	12.7	2.7	1.5	0.9	0.5	12.7	6.9	4.9	11.6	1.5	11.1	2.0	2.3	1.7	0.2	1.9	1.7	1.7	0.1	0.8	0.8	4.4	1.5	1.1	1.1	1.8	1.1	8.9	12.0	14.1	11.6	9.1	10.1	14.6	10.8	13.2	12.3	11.5	14.9	7.6	3.2	8.7	8.5	0.9	7.0	20.8	25.2	11.4	0.8	21.3	17.3	3.8	20.0	23.4	16.5	0.0	15.1	3.3	28.3	3.9	19.4	0.1	8.3	5.6	4.7	3.6	5.2	4.2	21.6	24.9	8.0	20.9	17.8	3.8	8.1	3.9	5.0	7.7	1.7	5.3	14.4	24.4	6.2	3.1	0.6	13.1	4.8	8.8	2.8	9.2	4.8	7.2	0.0	15.9	20.0	21.0	12.0	0.7	15.4	20.2	7.4	11.6	0.5	0.0	4.9	9.2	0.5	0.4	27.0	10.4	15.7	4.4	5.3	21.4	26.8
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	71.4	32.4	30.9	49.0	32.6	58.0	60.9	34.3	34.4	99.1	49.4	75.1	83.0	53.9	58.4	167.9	50.7	55.8	49.1	34.2	29.0	77.0	32.4	54.1	67.0	29.0	35.5	44.2	48.0	42.4	31.1	57.5	27.2	49.6	72.3	31.7	70.4	51.2	47.1	154.4	94.4	48.2	28.5	51.5	78.3	36.9	41.3	68.2	55.0	38.8	74.1	86.6	113.9	29.2	161.8	49.4	85.6	79.8	128.6	76.4	121.3	73.8	103.0	100.9	97.7	145.7	212.6	114.1	36.6	92.8	63.1	142.1	80.2	162.3	95.5	286.3	41.2	122.0	59.8	84.2	181.0	124.4	82.8	49.8	253.7	79.3	231.6	106.2	88.2	88.0	45.2	76.6	67.0	70.3	93.5	51.1	76.9	217.3	36.6	116.5	52.5	62.3	98.1	143.2	49.8	71.4	46.7	74.2	103.0	129.7	89.6	119.1	120.0	63.8	46.3	52.8	86.5	74.1	41.7	42.5	99.3	74.0	107.4	5.7	12.7	6.3	5.5	10.9	6.6	6.1	10.2	8.0	10.9	7.9	6.9	5.6	10.9	1.5	13.5	7.1	13.7	6.7	30.9	32.6	34.3	34.4	34.2	29.0	29.0	35.5	27.2	28.5	41.3	29.2	36.2	12.8	27.4	27.7	37.4	70.9	83.6	51.2	20.5	20.3	41.5	33.5	3.0	55.8	55.8	68.0	56.3	39.2	36.9	203.8	25.4	35.8	3.5	74.2	48.7	32.5	42.6	41.4	39.2	55.0	45.9	43.2	65.7	99.6	18.4	49.1	25.0	26.6	28.0	10.1	34.2	86.0	24.4	82.2	57.9	5.9	26.8	58.4	56.9	49.6	47.6	25.5	20.6	35.7	11.1	84.4	96.5	30.5	25.5	60.4	111.8	39.2	51.6	11.0	39.5	47.7	41.0	2.9	21.2	61.9	82.1	20.0	45.5	20.4	59.1	153.3
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552172-48599425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 286.0;skin 1: 186.5;vagina: 145.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041724, HPA043539, HPA076510"	Enhanced		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Cytosol	"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.3	0.2	0.5	0.4	0.4	0.1	11.5	0.6	0.8	74.4	0.4	0.8	9.3	0.5	6.8	286.0	1.2	2.7	0.2	0.5	0.5	13.0	0.3	9.4	0.0	0.5	0.7	0.1	0.7	7.9	0.4	1.5	0.5	22.6	0.2	0.0	53.6	3.7	0.4	186.5	18.2	0.1	0.4	0.1	3.5	0.5	0.9	0.4	1.9	0.0	28.3	0.7	145.9	0.5	12.6	15.8	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.9	74.2	0.1	0.1	0.0	0.7	3.9	0.1	0.3	0.0	0.5	0.4	0.0	0.5	0.5	0.0	0.0	7.2	0.2	2.1	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	46.8	0.0	0.5	0.0	122.9	0.0	0.1	0.0	0.1	0.0	3.5	0.2	0.1	0.0	6.2	0.3	0.0	36.7	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.5	0.1	0.0	0.3	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.6	0.8	0.5	0.5	0.5	0.7	0.5	0.4	0.9	0.5	0.4	19.2	0.5	1.0	0.0	24.1	30.5	11.6	0.0	0.0	16.8	12.4	0.6	5.7	40.2	9.2	0.0	3.2	0.0	4.4	0.0	12.2	0.0	15.7	1.4	0.9	4.8	0.0	1.0	1.2	3.1	1.2	2.6	17.5	0.0	0.1	0.0	0.3	0.7	0.0	0.9	12.6	24.4	0.0	4.8	0.9	0.3	0.4	12.4	1.0	0.0	1.6	0.0	0.5	0.8	18.5	7.9	0.0	0.0	62.3	75.9	1.3	6.7	0.6	0.0	0.1	2.2	0.2	11.1	56.0	137.4	1.9	0.6	2.0	9.2	114.6
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2404.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		270000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	401.9	154.7	103.7	356.0	103.2	437.3	355.4	106.3	115.0	266.6	94.9	337.4	314.3	220.5	94.9	494.0	231.9	282.6	351.1	101.1	152.7	307.9	254.4	687.7	321.1	141.7	117.6	170.9	284.7	81.0	100.0	378.2	122.9	208.5	307.9	46.1	388.7	205.2	83.4	418.2	356.3	254.4	125.2	479.7	698.8	127.0	125.9	309.6	210.2	139.6	386.4	436.1	350.0	114.9	1382.3	723.7	22.3	8.3	266.8	646.6	835.4	760.0	872.6	1635.2	799.8	786.6	1049.3	862.0	628.0	954.9	495.0	1054.3	378.1	1039.9	978.8	974.3	355.5	1140.7	651.8	50.0	322.7	808.2	1221.4	667.4	776.9	1030.4	504.3	1134.7	1029.0	260.3	494.8	578.9	586.1	563.0	378.1	601.2	619.3	947.6	1457.7	2.9	391.7	1275.3	376.6	527.7	340.7	325.6	900.7	1435.1	410.3	1190.6	756.5	814.2	1147.3	955.1	1134.4	876.9	2078.0	230.8	110.6	525.0	1238.3	541.3	603.8	1458.4	742.0	3160.6	558.9	449.7	499.9	866.5	620.0	544.6	1177.7	680.2	321.6	360.3	3746.8	817.6	356.9	1966.4	756.1	2257.9	103.7	103.2	106.3	115.0	101.1	152.7	141.7	117.6	122.9	125.2	125.9	114.9	617.1	179.5	130.5	0.3	507.8	549.1	330.6	454.3	307.9	31.6	257.0	201.8	12.8	121.5	221.4	183.9	18.8	497.4	567.6	371.0	74.3	1273.4	54.3	289.4	145.9	509.6	317.8	197.6	0.1	1206.9	2404.5	405.2	545.3	242.7	418.8	32.0	265.2	64.1	443.7	3.3	0.6	445.5	284.8	285.9	952.4	85.9	118.7	651.5	334.4	16.9	911.4	66.3	186.4	0.5	1.6	877.4	263.2	63.9	393.4	337.5	324.2	208.2	275.9	25.6	184.1	358.3	324.3	14.3	20.7	494.1	572.5	230.4	393.6	136.7	271.7	405.9
TAX1BP3	TIP-1	ENSG00000213977	"Tax1 binding protein 3"	O14907	17	3662895-3668679	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 395.9;Ductal cells: 351.0;Exocrine glandular cells: 385.9;Pancreatic endocrine cells: 505.8;Paneth cells: 362.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 164.3;granulocytes: 217.8;monocytes: 78.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046410, HPA063078"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Actin filaments"		NA	NA		120000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli fibrillar center"	"Vesicles, Actin filaments"	"HPA046410: AB_2679656, HPA063078: AB_2684937"	"unprognostic (6.15e-2)"	"unprognostic (6.46e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.80e-2)"	"unprognostic (5.45e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (5.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-1)"	107.3	131.8	62.7	49.2	78.5	16.5	94.4	67.9	67.3	192.9	48.2	108.5	108.8	128.1	33.6	258.5	84.4	90.9	194.8	57.3	58.8	115.0	39.7	94.9	39.3	72.5	73.3	95.9	80.4	23.5	30.9	53.2	69.9	91.7	77.4	3.7	109.7	105.6	28.7	120.4	119.6	70.3	66.2	52.3	136.5	51.2	65.2	44.6	63.6	33.4	49.0	102.8	160.1	80.6	183.1	319.1	68.4	38.5	219.2	175.6	81.3	223.6	184.5	234.0	136.7	135.9	144.5	19.1	159.1	290.8	77.2	282.6	39.1	205.3	90.8	50.7	64.4	25.9	75.8	106.6	191.1	4.3	37.7	267.6	322.5	145.1	68.9	165.3	266.0	50.1	9.6	14.4	280.1	169.4	52.2	15.1	65.9	116.7	112.6	50.0	41.8	16.3	248.6	141.2	14.7	43.2	276.2	116.2	39.4	67.5	125.3	23.2	269.6	195.3	75.2	154.9	230.2	5.7	2.6	5.5	117.4	30.0	190.3	217.8	65.4	120.4	26.9	78.9	22.2	29.2	25.0	26.6	58.7	25.3	17.3	22.7	73.8	20.0	73.6	164.3	36.7	53.3	62.7	78.5	67.9	67.3	57.3	58.8	72.5	73.3	69.9	66.2	65.2	80.6	51.5	60.9	25.8	0.0	19.0	95.3	79.7	229.3	99.6	1.6	51.0	28.2	41.5	92.9	107.6	99.3	0.0	124.7	68.5	395.9	88.0	351.0	16.2	12.8	27.3	77.0	24.6	21.4	0.0	385.9	145.3	72.6	43.8	16.1	26.6	21.2	75.3	11.1	69.8	5.0	0.0	120.0	71.2	35.2	73.2	10.5	174.6	64.0	113.8	0.0	85.5	19.8	26.8	0.0	0.0	505.8	362.8	209.9	5.8	89.0	279.2	185.3	26.8	2.6	39.5	44.1	78.6	8.6	12.8	94.5	76.0	155.6	16.1	92.0	103.0	107.9
TBC1D10A	"AC004997.C22.2, EPI64, TBC1D10"	ENSG00000099992	"TBC1 domain family member 10A"	Q9BXI6	22	30291990-30326947	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007725, HPA008142, HPA076041"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA007725: AB_2667907, HPA008142: AB_1080209, HPA076041: AB_2686772"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.52e-2)"	22.6	17.0	6.9	10.2	8.2	8.2	23.7	5.8	10.2	29.6	9.3	18.3	8.6	14.7	4.6	44.1	14.9	12.7	11.2	7.5	9.3	21.3	17.9	23.7	17.2	7.4	8.1	21.1	10.8	24.5	19.5	17.5	7.0	21.3	5.5	10.8	23.2	12.9	5.6	45.3	17.3	6.8	6.2	24.2	17.3	21.6	9.7	18.4	19.0	6.9	10.4	19.9	39.9	6.4	18.9	7.1	2.9	9.0	8.4	10.8	23.9	10.7	14.9	11.8	18.7	8.4	7.2	9.5	10.2	17.8	16.2	18.3	4.3	9.9	6.2	7.2	12.4	2.6	6.4	6.0	21.9	3.7	12.9	14.0	15.5	23.4	4.0	12.3	5.5	20.5	5.1	8.8	8.9	22.1	26.9	7.9	1.9	33.9	9.5	12.3	12.4	8.8	11.6	17.9	4.9	3.8	11.0	15.7	24.5	7.8	13.8	2.3	10.8	22.9	10.4	13.1	5.8	8.8	4.2	8.3	15.6	5.6	13.1	37.5	14.9	37.9	26.6	30.1	29.3	13.4	30.9	27.2	21.7	20.7	40.7	34.0	10.6	24.3	45.5	37.5	28.8	28.4	6.9	8.2	5.8	10.2	7.5	9.3	7.4	8.1	7.0	6.2	9.7	6.4	27.8	6.4	3.4	24.8	18.2	49.2	40.2	40.3	32.5	7.8	18.4	12.4	2.7	14.3	23.6	5.5	18.8	57.6	19.5	26.8	23.5	20.1	10.7	8.8	5.4	14.4	10.7	3.0	3.0	10.2	80.6	18.3	19.4	16.4	9.5	20.1	11.0	8.6	27.5	1.7	3.5	14.2	18.3	12.9	46.0	6.9	21.8	15.9	26.6	10.3	78.1	28.1	28.8	2.5	1.0	18.7	18.7	9.1	12.3	24.3	14.9	20.5	6.6	39.3	39.5	7.4	17.1	33.2	13.5	27.6	37.1	116.3	28.0	20.2	11.0	28.3
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.2;Hepatocytes: 12.3;Syncytiotrophoblasts: 15.7;T-cells: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.6;HUVEC TERT2: 11.6;TIME: 18.5;U-87 MG: 13.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	2.1	1.9	1.5	4.0	1.5	4.1	5.8	4.6	3.4	4.0	0.0	1.2	1.0	1.7	0.8	9.2	1.9	2.2	1.2	1.5	1.9	2.6	4.5	3.7	4.2	2.2	2.5	2.6	2.0	2.1	2.6	5.2	2.5	2.8	1.1	3.2	3.7	1.2	0.7	4.3	2.4	1.5	0.7	2.8	2.0	1.6	1.7	3.3	1.3	0.7	3.4	2.8	5.9	3.2	5.5	0.3	0.1	0.2	1.0	1.0	2.0	1.5	3.1	0.7	2.2	0.1	0.3	0.2	2.1	1.3	0.5	0.8	0.1	3.0	2.3	10.6	0.5	0.8	0.6	0.1	1.2	0.3	0.4	2.9	1.3	0.3	0.9	2.1	11.6	0.7	3.0	5.1	4.3	0.8	0.6	0.8	0.2	5.0	2.7	0.4	2.1	2.4	0.0	1.9	0.1	0.1	0.5	4.3	0.2	0.8	1.9	0.2	18.5	1.3	0.9	5.5	0.4	7.7	2.6	0.1	13.8	0.4	3.2	5.7	0.2	0.2	2.9	0.2	3.1	1.9	4.8	3.1	0.2	1.8	4.2	3.3	0.9	2.2	0.2	0.7	5.6	1.2	1.5	1.5	4.6	3.4	1.5	1.9	2.2	2.5	2.5	0.7	1.7	3.2	0.5	0.0	1.8	0.0	4.5	0.0	1.3	0.0	3.4	0.7	5.6	3.4	0.4	0.0	1.8	0.0	0.0	16.2	5.6	0.2	0.0	0.9	1.0	0.8	1.4	3.5	0.0	0.4	3.7	0.4	4.9	2.4	2.6	1.3	2.5	0.3	0.7	12.3	2.0	0.0	3.6	0.2	0.0	1.6	0.0	1.1	1.8	1.8	0.0	0.0	0.4	2.1	7.2	1.5	0.1	1.3	0.1	0.7	5.0	2.1	2.1	0.4	0.0	0.1	0.0	2.3	1.1	3.5	2.0	4.9	0.0	15.7	9.1	0.8	0.4	1.1
TENT5B	"FAM46B, MGC16491"	ENSG00000158246	"Terminal nucleotidyltransferase 5B"	Q96A09	1	27005020-27012850	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 111.8;skin 1: 121.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 26.8;Breast myoepithelial cells: 24.8;Distal tubular cells: 23.5;Endometrial ciliated cells: 11.7;Glandular and luminal cells: 10.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 62.0;hTERT-HME1: 31.6;NTERA-2: 32.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"				"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	8.5	0.9	0.5	2.6	0.5	0.0	15.7	1.5	0.8	30.9	0.5	45.9	1.1	24.8	0.8	111.8	16.4	1.8	26.3	0.4	0.7	5.8	0.4	12.8	0.2	2.2	0.5	3.6	1.9	1.9	2.6	3.2	1.3	12.3	1.7	3.0	27.6	15.5	2.1	121.3	10.6	12.2	0.3	0.6	17.4	6.4	0.5	0.6	5.0	1.7	5.5	37.3	47.3	0.5	3.9	0.6	7.6	2.3	0.9	1.2	1.9	5.5	1.8	21.5	8.5	15.3	5.0	0.0	9.1	3.0	4.8	12.4	1.3	20.1	5.8	0.0	1.2	0.2	2.9	2.6	10.6	0.1	0.3	4.8	62.0	6.6	31.6	0.0	0.3	0.0	0.4	0.0	2.8	3.0	0.0	1.2	32.8	2.8	1.5	0.4	0.0	0.2	21.3	0.0	0.9	0.6	10.6	23.4	14.3	15.9	18.6	0.3	0.5	5.2	18.0	0.6	1.1	0.3	0.8	0.0	1.1	0.1	3.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.5	0.8	0.4	0.7	2.2	0.5	1.3	0.3	0.5	0.5	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.8	24.8	0.0	0.0	0.0	0.0	0.0	3.2	0.4	0.0	23.5	1.8	0.0	11.7	1.8	0.5	0.0	0.0	0.0	1.9	3.1	0.5	0.0	10.8	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.0	0.0
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 103.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.0"						"Secreted - unknown location"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	4.8	8.4	9.8	1.6	7.8	0.0	14.7	6.1	8.6	103.7	9.5	7.0	7.9	22.2	7.8	60.3	37.0	10.9	41.6	8.5	7.2	14.2	7.0	10.3	0.9	7.8	9.1	3.1	6.4	0.7	9.7	3.6	7.6	34.0	6.9	1.2	11.4	15.0	3.0	8.5	8.7	10.3	7.0	1.9	12.0	3.1	15.9	1.6	8.8	2.5	2.5	13.3	38.5	5.9	6.0	45.3	0.8	13.0	6.7	40.2	0.2	22.0	53.0	11.2	5.8	0.3	8.7	0.0	17.7	7.8	38.5	17.0	1.8	9.1	6.8	2.0	2.0	0.0	4.4	0.0	4.3	0.0	0.0	3.0	6.7	6.7	26.6	30.5	20.7	0.0	0.0	0.5	9.2	9.1	0.0	0.1	3.9	0.1	7.8	0.0	0.7	0.8	29.5	6.0	0.7	5.5	8.8	10.9	0.0	5.0	43.3	0.1	66.6	0.2	1.0	44.4	11.8	0.0	0.3	0.0	10.4	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	7.8	6.1	8.6	8.5	7.2	7.8	9.1	7.6	7.0	15.9	5.9	1.1	19.2	9.0	6.5	0.0	13.9	106.4	11.3	449.0	3.0	48.7	43.9	60.1	58.6	7.5	5.5	6.2	0.4	0.8	16.2	1.9	18.3	7.5	19.3	13.2	9.8	3.0	0.0	17.1	1.8	0.4	12.5	2.6	31.8	0.0	0.3	6.1	12.3	0.2	0.0	19.1	6.1	0.0	0.0	2.1	16.9	17.4	1.6	8.8	247.3	0.0	0.3	0.0	8.5	6.7	13.6	11.0	74.4	1.2	94.6	29.3	0.5	11.0	0.9	0.0	16.8	6.6	0.9	1.7	141.5	10.9	0.8	3.1	42.2	13.2	29.7
TMEM109	MGC5508	ENSG00000110108	"Transmembrane protein 109"	Q9BVC6	11	60914158-60923443	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011785	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA011785: AB_1858075"	"unprognostic (5.23e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (2.68e-4)"	83.0	46.4	22.2	44.4	23.2	27.0	71.9	23.3	25.5	85.4	42.1	75.1	26.2	97.7	26.7	93.8	73.7	35.7	84.0	19.8	23.2	47.3	32.1	71.8	48.0	26.7	24.5	81.5	46.1	67.3	41.1	46.8	25.4	52.4	27.0	14.3	81.8	60.8	99.4	69.7	47.8	70.0	25.9	58.1	58.2	14.4	25.5	41.4	57.3	77.0	50.3	70.4	79.9	24.7	111.5	103.5	63.3	102.1	169.4	77.7	51.5	107.3	100.4	118.5	99.8	94.5	115.7	131.5	190.4	130.1	69.9	143.5	73.2	48.8	72.5	102.5	97.0	96.2	44.3	21.1	50.2	188.4	77.0	54.1	61.6	92.9	46.8	41.9	148.1	104.8	48.4	330.4	85.4	217.2	139.9	80.8	104.6	62.8	111.4	132.3	123.9	183.0	56.6	63.6	25.3	44.4	86.2	196.8	102.7	44.8	110.4	35.8	143.7	136.9	65.9	174.4	95.8	108.7	89.5	69.9	121.2	82.0	159.7	39.0	76.0	56.4	188.7	69.5	193.3	116.5	108.4	161.4	227.4	140.4	97.4	124.8	8.2	121.1	52.4	470.0	91.1	139.4	22.2	23.2	23.3	25.5	19.8	23.2	26.7	24.5	25.4	25.9	25.5	24.7	118.2	70.5	23.2	5.5	60.2	50.7	43.8	30.9	63.7	13.4	39.5	45.3	34.6	25.8	23.9	25.8	0.0	120.7	83.4	6.8	25.4	76.6	20.7	18.7	25.9	91.2	7.2	33.0	5.3	80.2	116.4	75.9	10.7	27.9	50.7	22.2	71.0	18.9	66.8	30.3	3.8	10.1	22.4	21.3	69.1	11.1	89.5	43.4	51.6	11.2	45.4	30.2	68.0	3.5	5.1	53.1	14.7	97.4	38.4	36.5	10.6	17.1	18.7	34.8	39.5	45.0	67.6	5.9	7.2	55.1	50.6	53.2	52.7	25.8	16.8	33.9
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618628-152680012	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.3;skin 1: 58.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.6;Basal keratinocytes: 74.2;Glandular and luminal cells: 75.0;granulocytes: 101.2;monocytes: 82.1;Squamous epithelial cells: 119.2;Suprabasal keratinocytes: 194.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 6.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basophil: 403.7;eosinophil: 305.7;neutrophil: 477.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 477.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.0;HMC-1: 71.1;Karpas-707: 55.6;U-266/70: 69.7;U-937: 56.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	3.1	0.5	0.3	17.2	0.7	18.6	4.3	0.6	1.7	5.7	0.5	3.1	2.6	1.6	0.7	58.3	1.4	5.1	0.8	0.4	0.7	0.6	5.9	5.1	14.3	0.8	0.6	0.2	1.0	0.3	0.8	3.8	1.1	2.0	2.6	0.2	6.9	2.3	0.4	58.5	3.6	1.8	0.7	12.4	5.9	0.2	1.0	6.2	3.6	1.9	26.4	11.6	7.9	1.0	32.1	0.1	0.3	0.1	0.5	8.7	14.1	8.0	29.1	8.5	16.2	0.4	4.2	32.5	3.3	7.6	9.3	22.8	0.0	63.0	15.5	0.1	0.1	1.8	0.5	0.0	8.9	25.7	71.1	8.3	29.7	27.1	23.4	0.0	21.4	19.7	0.1	55.6	0.7	2.3	10.1	8.0	1.6	0.1	7.8	1.2	0.1	0.2	47.5	19.4	0.1	1.2	2.2	6.2	1.0	8.4	1.0	17.8	8.6	1.2	5.1	0.7	11.1	69.7	26.0	18.1	11.7	56.6	6.6	403.7	37.8	305.7	4.9	38.2	9.2	51.6	10.9	7.9	19.6	45.1	10.7	7.4	477.5	0.8	43.7	2.5	22.5	17.2	0.3	0.7	0.6	1.7	0.4	0.7	0.8	0.6	1.1	0.7	1.0	1.0	6.5	12.8	19.3	0.0	108.6	74.2	9.0	23.6	20.5	0.1	8.8	4.8	1.7	0.0	20.9	22.0	2.1	25.0	9.8	0.9	0.0	6.4	0.1	31.9	13.4	6.7	1.2	6.6	0.5	3.7	14.5	5.2	8.2	75.0	101.2	0.1	0.7	4.6	4.5	3.3	0.3	0.7	14.2	9.8	15.7	0.2	0.6	28.2	5.4	15.9	82.1	0.1	5.2	3.5	0.1	21.5	7.1	0.0	45.7	5.4	0.0	0.3	60.5	0.7	0.0	3.0	3.6	0.1	0.5	119.2	194.4	25.9	28.6	0.5	2.6	27.2
TMEM265		ENSG00000281991	"Transmembrane protein 265"	A0A087WTH1	16	30740642-30745196	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.6;Astrocytes: 9.8;Club cells: 6.2;Excitatory neurons: 5.6;Inhibitory neurons: 6.1;Microglial cells: 5.6;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 5.9;Respiratory ciliated cells: 5.1"					"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 47.3;HaCaT: 12.8;HBEC3-KT: 16.2;hTCEpi: 24.2;RT4: 14.4;SK-BR-3: 16.7;T-47d: 19.8"															NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"																					4.3	3.6	0.6	0.0	0.6	0.1	8.2	0.7	1.8	10.6	0.5	11.8	0.0	2.9	0.0	31.3	5.6	0.9	9.7	0.6	0.5	23.4	12.3	18.1	0.0	0.6	0.6	6.5	10.6	2.4	12.9	0.2	0.6	13.6	0.0	0.0	19.2	0.1	8.0	31.7	10.1	0.1	0.6	17.1	12.1	3.5	0.6	0.0	17.8	0.0	0.0	8.7	19.3	0.7	10.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	12.8	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	24.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	9.0	14.4	0.0	0.0	0.0	16.7	0.1	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.3	0.3	0.6	0.5	0.6	0.0	0.6	0.3	0.7	0.9	1.7	0.3	0.0	0.4	0.1	0.6	0.6	0.7	1.8	0.6	0.5	0.6	0.6	0.6	0.6	0.6	0.7	0.0	9.6	4.6	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.6	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	2.5	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 132.4;skin 1: 89.9;vagina: 59.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 24.1;Squamous epithelial cells: 59.9;Suprabasal keratinocytes: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.2;SK-BR-3: 26.7;T-47d: 28.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoli fibrillar center"		"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	2.1	2.8	5.5	1.5	6.3	2.9	4.5	6.2	7.5	34.5	5.1	2.4	2.6	2.4	2.6	132.4	2.5	1.8	1.8	5.2	5.7	2.4	3.6	1.9	2.9	6.2	6.2	2.4	2.1	6.0	3.7	1.6	6.0	28.4	1.3	1.7	23.5	2.6	2.9	89.9	2.7	1.2	5.8	3.8	2.9	2.0	6.1	3.6	2.2	0.7	10.9	6.9	59.4	7.8	12.5	7.2	2.4	4.7	1.8	1.8	5.9	3.5	1.4	6.2	2.4	8.5	3.4	2.2	7.6	0.9	2.2	10.8	2.8	5.1	2.7	8.3	3.9	2.3	3.3	2.5	3.3	2.6	3.3	1.7	30.2	4.6	4.7	4.4	1.4	8.2	10.5	14.8	2.9	14.1	7.3	4.0	3.6	9.0	5.7	8.5	2.3	5.0	1.3	3.0	4.3	4.7	4.3	26.7	7.0	2.9	28.3	7.4	3.4	11.5	3.8	4.2	9.5	11.3	13.0	5.2	8.0	6.0	8.8	0.0	2.0	3.0	1.7	0.7	1.8	1.7	1.5	1.8	1.6	2.2	2.0	2.4	3.7	1.7	1.3	2.0	2.1	1.7	5.5	6.3	6.2	7.5	5.2	5.7	6.2	6.2	6.0	5.8	6.1	7.8	1.8	3.2	1.5	8.8	3.9	13.3	1.4	24.1	9.1	3.0	10.0	6.5	1.2	2.8	14.3	1.8	2.1	7.7	3.6	2.4	1.9	2.5	0.1	3.7	2.4	2.0	3.0	0.8	1.8	3.3	1.8	2.1	1.5	6.7	0.0	3.1	2.2	2.4	3.4	8.4	2.2	2.9	10.2	2.5	1.8	0.3	1.5	1.4	5.4	3.7	4.4	1.5	1.0	2.5	5.8	4.5	2.1	0.7	1.6	10.7	4.3	1.6	4.2	2.2	0.0	1.0	1.9	1.3	2.1	59.9	33.1	7.4	3.2	2.9	3.1	6.4
TMPRSS11F	"FLJ16046, HATL4"	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129869	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.2;skin 1: 9.3;vagina: 4.8"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 6.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"K-562: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026911	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.1	1.0	0.0	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	4.1	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.1	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	6.9	0.0	0.3	0.0	0.1	0.0	0.5
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103121476-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 277.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 48.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 785.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	119.9	76.8	9.0	103.6	11.5	106.8	78.4	6.7	12.2	53.8	12.1	39.8	38.0	50.9	6.6	88.3	57.1	102.2	48.3	8.0	9.7	67.7	61.6	142.4	87.4	17.1	10.4	16.9	33.6	66.8	16.6	48.4	16.2	73.6	26.8	1.6	84.0	14.9	35.0	53.3	52.5	24.8	13.6	147.9	37.4	37.1	21.4	39.5	36.8	32.5	80.3	277.5	74.6	16.1	34.7	156.3	1.1	0.6	10.1	45.9	54.5	9.7	43.2	26.4	8.9	1.6	148.7	0.3	120.3	48.5	142.5	104.2	11.6	0.0	11.9	6.1	0.6	15.4	120.0	0.7	19.2	7.7	20.0	17.8	1.6	8.4	0.1	10.5	14.2	7.7	15.5	35.3	3.6	3.4	0.4	11.6	9.7	19.6	13.4	6.8	18.9	24.9	80.8	785.1	1.3	2.3	150.2	52.4	1.9	5.6	83.8	50.4	28.4	5.1	13.5	30.3	31.5	31.4	2.4	0.9	38.1	34.0	16.1	5.9	16.8	9.0	0.1	18.6	0.1	0.1	0.1	0.0	9.4	0.2	0.1	0.1	48.4	0.2	15.0	0.5	0.0	4.5	9.0	11.5	6.7	12.2	8.0	9.7	17.1	10.4	16.2	13.6	21.4	16.1	45.8	0.0	25.1	2.3	8.2	28.3	41.8	295.5	6.8	1.1	24.2	11.4	14.1	51.5	126.1	27.6	0.0	1.2	1.3	1.0	0.0	160.9	36.8	92.4	122.2	47.1	17.3	1.7	2.5	44.7	61.2	123.3	5.6	172.8	33.7	4.5	18.9	8.0	54.1	0.0	5.7	0.3	85.5	151.2	198.7	48.8	8.4	163.3	30.2	25.3	351.9	5.9	5.2	1.0	0.9	122.1	18.3	2.2	11.7	186.0	0.7	14.4	121.5	0.7	19.7	104.9	39.7	2.1	4.6	20.7	33.4	4.8	8.3	1.1	1.9	138.6
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225102	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050958: AB_2681290, HPA054475: AB_2682500"	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	5.7	2.3	2.6	9.9	2.5	9.3	5.7	2.2	2.7	4.3	2.2	7.0	6.2	2.9	1.1	8.4	4.1	8.2	3.0	2.0	2.4	3.8	5.3	6.6	13.4	3.4	2.8	0.8	2.4	2.7	0.8	7.1	3.1	2.9	7.1	0.2	4.8	2.5	1.5	4.9	6.5	3.9	2.8	6.8	6.5	0.5	3.4	6.4	3.0	2.8	14.0	10.8	5.8	2.8	18.7	33.0	1.7	0.1	1.2	6.4	0.1	3.8	2.3	1.9	5.2	25.4	31.8	42.9	41.9	2.4	9.1	34.6	29.5	47.2	3.1	10.7	0.2	22.7	20.4	14.7	16.2	12.3	20.7	11.0	38.2	41.1	35.0	5.5	21.9	1.4	35.7	14.9	8.9	14.5	0.4	7.8	22.6	33.0	20.0	0.3	0.0	31.2	24.4	39.5	0.9	1.1	9.3	23.0	0.0	6.9	12.3	9.3	31.3	0.1	0.2	1.8	0.1	17.4	26.7	32.7	0.2	3.9	0.5	2.8	6.1	5.7	5.0	2.6	13.8	15.3	16.1	10.2	6.3	19.1	15.7	9.2	0.6	6.1	2.6	0.0	20.8	6.5	2.6	2.5	2.2	2.7	2.0	2.4	3.4	2.8	3.1	2.8	3.4	2.8	21.5	3.2	8.7	0.7	22.3	23.6	20.7	9.1	21.6	0.2	8.2	7.1	1.1	7.2	15.5	11.0	0.0	0.1	3.1	10.1	0.0	10.1	0.1	8.6	1.9	16.6	2.4	1.3	0.4	4.0	0.4	2.2	10.2	23.9	7.6	0.7	2.9	5.1	3.1	0.0	0.4	7.0	8.2	2.2	12.7	0.0	0.0	8.5	3.6	9.4	4.2	0.0	2.1	1.0	0.5	20.3	7.3	0.0	14.0	11.7	4.5	2.9	5.7	0.0	0.0	0.9	1.1	0.0	0.5	25.6	27.4	0.0	12.8	0.1	9.1	27.4
TPBG	"5T4, 5T4-AG"	ENSG00000146242	"Trophoblast glycoprotein"	Q13641	6	82363206-82367420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.6;hTCEpi: 115.2;hTEC/SVTERT24-B: 98.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010554	Enhanced		Approved	Nucleoplasm		NA	NA		310000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA010554: AB_1858206"	"unprognostic (3.03e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.55e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.57e-2)"	19.9	2.5	1.6	3.3	20.6	0.5	17.3	0.4	5.7	24.2	0.6	8.5	3.5	15.8	2.6	26.3	14.9	6.9	9.1	0.2	4.2	10.7	1.5	7.5	1.9	8.2	11.4	6.0	8.3	4.2	14.2	6.2	9.3	15.3	3.0	0.2	20.1	7.0	2.9	15.9	8.0	6.7	3.1	9.9	9.0	3.6	3.6	4.2	15.7	1.9	3.0	35.1	20.2	3.6	17.1	27.6	8.7	21.2	35.2	40.4	17.6	84.9	94.6	16.7	22.0	3.9	26.9	0.0	9.6	39.5	51.9	37.3	10.3	44.6	13.9	0.0	14.5	11.9	13.1	0.8	29.1	0.9	9.2	25.8	115.2	98.5	34.1	12.9	4.5	0.7	2.3	0.2	3.9	37.8	0.0	0.0	12.5	8.8	22.3	0.0	19.4	0.2	24.4	25.8	4.4	16.9	20.9	28.3	0.0	16.2	49.4	3.5	10.8	15.1	15.8	33.5	19.2	0.1	0.0	0.0	71.3	1.3	17.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	20.6	0.4	5.7	0.2	4.2	8.2	11.4	9.3	3.1	3.6	3.6	16.4	12.8	6.5	2.3	0.2	67.9	78.2	120.3	68.3	1.1	44.6	24.0	2.1	21.5	62.4	55.2	0.0	42.7	0.4	9.0	0.0	35.8	8.6	29.2	38.7	25.4	1.2	0.0	21.3	45.4	82.5	48.0	14.8	68.0	0.0	3.8	11.0	0.2	3.6	1.7	0.9	20.2	75.3	0.6	11.5	6.5	12.8	2.3	17.8	7.5	0.1	2.1	0.0	2.0	3.2	38.2	17.8	6.0	0.0	51.9	1.9	0.7	29.9	0.3	32.9	55.6	47.0	13.7	11.8	25.2	31.3	65.9	3.5	9.7	10.8	78.8
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103002	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1297.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 2111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		370000000	"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	324.1	109.9	24.7	186.3	26.3	33.8	269.0	42.1	40.4	342.4	23.4	255.0	64.6	455.0	10.6	401.8	310.0	144.8	189.6	23.2	27.0	168.1	54.1	374.1	78.2	30.7	28.7	293.8	77.9	23.6	93.4	170.7	31.9	212.1	39.2	3.6	267.2	140.4	50.3	241.4	153.8	190.4	29.1	244.1	201.4	66.2	36.6	32.4	119.4	19.3	68.5	287.5	333.8	27.8	614.5	275.2	194.7	190.9	701.3	728.2	725.6	1082.9	470.3	356.4	357.7	325.5	473.5	31.1	724.2	492.9	383.9	331.6	72.9	386.7	141.6	503.8	138.8	305.4	270.2	232.3	357.0	52.3	728.3	715.2	94.0	327.6	331.1	353.2	427.2	115.7	46.2	217.9	360.8	290.2	152.4	233.0	227.1	461.2	380.4	201.4	413.2	143.4	87.3	387.9	75.3	315.3	670.4	155.5	298.8	90.6	5.3	60.8	1237.2	954.1	166.8	2111.0	875.3	82.4	167.3	142.5	651.4	144.5	337.0	130.8	81.4	5.9	96.0	93.9	71.4	59.6	69.0	84.3	96.6	53.0	18.6	47.2	82.1	75.2	50.4	76.8	151.0	158.4	24.7	26.3	42.1	40.4	23.2	27.0	30.7	28.7	31.9	29.1	36.6	27.8	389.4	400.6	156.6	9.4	148.6	431.1	1297.2	175.2	273.8	45.9	194.3	189.4	49.1	120.1	297.0	242.8	10.4	263.5	205.6	298.4	13.7	717.1	67.3	159.0	506.6	425.5	94.0	33.4	23.8	571.6	852.9	345.1	303.7	305.0	249.6	170.8	288.8	4.2	336.8	5.0	19.0	215.8	101.7	112.0	368.8	54.8	173.1	433.2	142.3	26.2	249.5	7.5	132.8	13.6	48.5	1017.2	258.8	547.2	310.9	900.2	61.2	29.0	133.1	11.7	335.2	170.0	516.6	29.5	10.1	328.2	343.8	568.9	192.0	222.3	162.7	1025.0
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 50.6;vagina: 32.3"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 199.7"	"Cancer enriched"	"Detected in many"	4	"breast cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	10.6	1.9	0.5	1.8	0.6	0.0	23.3	0.6	0.7	23.3	3.5	0.5	0.3	3.0	2.8	50.6	8.4	2.9	2.0	0.4	0.7	0.4	9.0	4.4	0.9	2.2	0.7	2.2	0.6	0.1	0.2	1.2	1.0	1.2	0.3	0.4	6.1	1.3	9.1	25.1	0.7	3.0	0.6	0.7	0.5	4.8	3.6	1.5	1.3	0.4	9.0	1.0	32.3	2.0	0.9	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.1	0.1	1.1	2.2	1.3	3.4	0.1	0.6	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.7	0.2	0.4	0.0	0.0	0.6	23.4	0.3	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.2	0.5	0.0	0.7	4.1	0.6	0.0	0.1	0.3	0.0	0.3	4.3	3.7	0.4	0.1	0.0	0.1	0.0	1.5	0.0	3.8	1.2	0.5	0.1	3.0	4.0	0.4	0.0	0.6	1.5	0.7	0.0	1.1	0.0	3.8	0.9	0.5	0.6	0.6	0.7	0.4	0.7	2.2	0.7	1.0	0.6	3.6	2.0	0.9	38.5	1.7	3.6	0.9	5.6	19.9	10.5	13.6	1.3	9.8	31.1	0.8	0.0	6.4	0.0	0.0	0.4	5.3	0.2	0.0	0.3	199.7	1.2	1.1	1.0	0.0	2.7	2.8	0.6	0.2	5.5	0.5	0.2	1.3	0.3	0.0	8.4	4.8	0.0	7.9	0.3	2.0	3.5	2.7	24.4	7.2	2.5	0.0	3.7	0.6	0.2	2.1	9.5	2.1	4.5	0.1	3.0	5.6	1.7	0.2	0.2	1.0	0.2	0.0	30.7	5.3	5.1	1.1	4.3	5.8	0.3	14.4	1.2	0.2	5.7
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111286-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 600.1;skin 1: 551.2;vagina: 269.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 4.0"	"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	2.5	1.0	0.1	0.4	0.2	0.4	41.7	0.0	0.4	133.8	1.6	3.0	1.7	2.6	4.8	600.1	17.4	3.5	0.4	0.3	0.0	1.7	1.8	3.7	0.0	1.8	0.6	0.4	1.0	0.0	8.1	30.7	1.8	31.4	2.6	0.3	131.5	23.7	2.2	551.2	1.0	1.5	2.6	0.3	1.4	2.7	0.0	19.9	0.4	0.2	107.2	55.8	269.1	0.6	34.4	2.5	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.2	0.1	0.8	25.6	0.2	3.9	0.2	0.5	399.9	0.0	107.5	0.0	0.1	0.0	0.2	25.4	0.4	0.0	0.2	0.5	0.0	476.0	0.0	2.6	0.0	0.0	0.0	0.2	0.7	0.0	4.4	0.0	0.0	0.1	11.4	0.1	0.0	0.3	0.0	0.3	190.5	1.3	5.9	268.3	35.2	0.1	0.2	1.9	0.0	0.4	0.1	2.1	0.2	0.1	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.0	1.8	0.6	1.8	2.6	0.0	0.6	0.5	0.0	1.5	3.3	0.2	272.0	106.1	76.4	250.4	0.0	9.5	58.8	1.2	1.5	39.2	0.0	0.0	41.0	0.2	11.3	0.0	5.0	28.1	8.7	0.8	3.4	2.4	0.0	0.5	4.3	7.1	5.6	1.1	3.6	1.3	0.0	0.0	0.4	5.0	0.0	0.1	2.1	12.2	0.0	30.3	150.3	0.6	1.4	23.2	1.0	0.0	0.0	0.0	0.0	0.1	57.1	11.3	0.0	0.0	66.0	0.2	0.6	64.6	0.0	0.0	0.1	4.9	0.8	2.6	552.9	460.6	24.8	2.4	0.1	3.7	159.3
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533124	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 156.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 276.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	97.9	20.7	29.1	43.1	24.2	57.2	80.1	25.1	29.7	63.1	19.4	33.4	30.9	38.4	44.1	92.1	47.1	32.9	51.2	26.2	21.4	45.7	21.1	70.8	54.2	31.7	32.2	47.2	33.1	35.7	15.7	81.9	29.7	34.8	27.1	7.9	47.7	34.1	24.9	74.3	34.8	33.3	31.2	48.5	24.7	23.2	32.8	40.1	46.5	42.1	44.6	55.0	56.1	31.4	96.2	135.6	128.3	44.5	186.6	59.3	59.6	49.3	91.8	51.1	38.0	134.8	54.6	31.5	93.2	26.4	18.9	97.0	35.9	88.5	41.4	55.9	13.9	88.9	15.8	118.2	63.5	31.8	20.3	58.8	77.2	52.8	92.1	94.8	191.5	31.8	48.8	23.0	15.0	83.3	50.0	23.3	29.5	61.2	0.1	167.9	14.9	5.3	203.9	131.9	27.5	42.3	19.7	133.7	149.5	43.7	54.1	79.8	276.3	13.0	52.8	12.4	35.1	10.7	42.0	11.8	42.2	65.4	57.5	16.2	51.5	56.3	92.1	102.1	41.3	13.8	70.7	81.1	33.9	13.7	82.3	79.3	54.7	95.2	172.8	13.6	61.8	84.3	29.1	24.2	25.1	29.7	26.2	21.4	31.7	32.2	29.7	31.2	32.8	31.4	141.9	16.0	55.1	13.1	18.5	34.9	40.3	54.6	35.3	2.1	29.5	23.2	11.3	25.8	39.0	33.1	77.2	7.8	38.4	32.8	7.9	43.8	2.4	44.7	38.9	95.3	64.2	35.6	12.9	24.8	74.4	18.8	18.3	75.1	7.6	41.2	156.7	21.1	50.5	3.3	7.4	37.0	34.6	129.3	12.9	4.1	39.1	66.5	14.2	35.6	51.8	23.7	89.6	4.5	13.5	64.2	21.6	41.0	18.4	55.7	23.4	8.0	29.6	7.1	98.6	10.2	43.1	5.0	19.0	80.2	36.4	7.7	55.7	10.4	30.6	69.7
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151547-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 690.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1429.2;Pancreatic endocrine cells: 1442.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 516.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	249.3	164.5	42.3	65.3	46.3	488.7	204.3	50.9	61.1	217.3	45.8	189.7	73.6	91.8	8.7	690.1	108.5	39.4	174.7	39.9	51.0	120.5	81.9	181.5	44.3	61.9	48.8	72.3	93.4	22.4	50.8	30.5	57.4	126.6	33.9	4.2	244.9	28.9	84.0	388.0	116.9	26.6	58.0	206.9	216.9	21.4	59.5	22.2	77.4	27.5	39.9	135.7	355.5	69.0	300.0	143.3	10.2	134.4	54.7	175.3	10.8	216.6	107.0	109.4	115.7	28.8	222.4	0.3	147.8	175.7	52.2	242.2	27.9	171.7	13.9	49.5	111.4	28.9	150.4	10.1	193.4	66.4	145.0	137.5	276.4	65.9	58.2	125.8	262.9	0.2	24.0	53.6	114.2	244.5	1.1	188.5	11.6	154.0	355.7	67.0	0.0	516.2	139.3	173.8	14.0	65.4	103.9	200.4	263.5	0.1	76.3	256.6	269.7	132.6	96.9	135.5	92.9	21.7	4.1	2.7	170.0	218.3	171.4	656.8	1678.5	931.0	314.7	1051.6	247.7	199.2	429.9	309.2	1170.2	266.9	325.9	264.3	1052.3	365.0	713.1	209.0	539.5	1585.6	42.3	46.3	50.9	61.1	39.9	51.0	61.9	48.8	57.4	58.0	59.5	69.0	225.5	160.3	140.0	3.6	88.9	366.8	392.3	1429.2	554.3	2.8	269.3	360.2	92.1	323.1	555.7	206.0	2.1	10.0	140.3	680.7	369.8	578.5	2.4	170.8	143.6	220.4	194.9	239.9	0.3	586.4	284.9	205.1	440.9	309.5	268.6	124.3	187.1	110.5	758.5	3.3	0.8	636.8	478.1	644.7	524.7	11.7	82.6	611.6	723.9	10.3	776.9	180.5	207.0	6.0	20.1	1442.1	705.9	157.6	76.3	526.2	471.9	180.7	283.2	19.4	105.2	108.2	197.8	2.8	4.5	1067.4	536.0	20.0	180.0	30.5	664.1	786.1
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 43.2;urinary bladder: 205.7;vagina: 52.4"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 29.1"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049879	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.8	0.0	0.2	0.1	0.3	0.1	0.3	0.5	0.4	31.8	0.2	0.1	0.0	0.0	0.0	43.2	0.5	0.2	0.1	0.3	0.3	0.5	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.2	6.8	0.0	0.1	4.2	0.2	0.1	20.7	0.1	0.0	0.1	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.3	205.7	52.4	0.2	0.0	0.4	0.2	0.2	0.4	0.1	0.4	0.0	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	3.8	0.3	0.0	0.2	0.2	0.2	0.1	0.5	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.5	8.1	0.0	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.2	0.5	0.2	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.3	0.2	0.3	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.2	0.0	0.0	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.4	1.3	0.0	0.4	0.1	0.1	0.0	0.0	29.1
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510525-76516522	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 120.6;esophagus: 64.8;lung: 50.0;urinary bladder: 42.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 121.8"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1"	"Not detected"	"Not detected"							HPA010506	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	120.6	0.7	0.1	0.1	0.4	0.1	1.4	0.0	0.4	8.0	1.0	1.2	0.0	0.7	0.2	64.8	10.0	0.1	10.6	0.0	0.2	0.6	1.0	50.0	0.1	0.1	0.2	6.9	1.3	0.0	1.7	0.0	0.2	2.7	0.0	0.2	8.3	0.0	0.5	4.1	0.9	0.0	0.0	2.1	2.9	4.2	0.7	0.0	1.4	0.0	1.8	42.2	12.1	0.1	1.1	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.2	0.0	0.4	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.3	3.9	0.0	0.1	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.1	0.2	0.2	0.0	0.7	0.1	0.3	121.8	3.3	0.0	0.3	1.7	0.4	18.3	4.6	0.4	0.2	0.0	0.3	20.0	20.4	3.7	4.2	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.9	1.1	0.5	1.3	0.1	0.7	0.1	0.1	1.7	0.0	0.0	6.1	0.3	2.5	0.0	12.2	0.3	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	11.1	0.2	0.0	0.0	1.1	0.0	0.1	2.1	2.8	0.1	0.4	0.0	0.2	14.2
XXYLT1	"C3orf21, FLJ35155"	ENSG00000173950	"Xyloside xylosyltransferase 1"	Q8NBI6	3	195068284-195271159	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.39e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.29e-3)"	"unprognostic (5.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.13e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.07e-2)"	6.8	4.4	5.3	6.9	4.9	5.8	5.5	4.4	5.7	8.3	5.5	6.2	4.4	9.2	3.7	11.3	5.8	5.4	4.4	4.5	6.5	5.1	1.9	5.1	6.2	6.2	4.7	4.3	2.9	5.8	5.8	10.4	6.3	5.3	4.7	2.7	4.6	5.5	1.9	9.2	4.4	8.6	4.2	5.3	4.2	2.5	6.6	5.2	4.4	1.7	5.0	6.2	8.1	4.7	16.1	13.5	39.7	65.2	22.1	19.2	14.1	24.9	17.0	24.1	20.8	14.3	11.0	18.9	26.1	19.7	18.5	18.8	16.8	14.7	12.7	10.7	26.6	18.9	10.7	15.5	10.2	23.9	29.2	13.8	19.0	8.6	9.4	13.4	51.3	12.4	23.5	5.4	8.3	40.0	16.0	30.6	30.7	15.1	23.5	27.0	16.2	20.5	17.8	5.3	36.4	33.6	15.5	12.1	15.5	21.0	36.6	13.2	34.2	14.0	3.5	13.7	25.8	4.6	14.8	45.9	9.1	30.4	15.2	0.9	3.8	1.8	1.5	2.6	1.2	1.4	1.3	1.4	2.6	2.2	1.3	1.3	1.2	1.5	2.3	10.0	0.7	1.2	5.3	4.9	4.4	5.7	4.5	6.5	6.2	4.7	6.3	4.2	6.6	4.7	11.8	3.2	4.4	15.0	4.0	4.2	4.8	5.6	4.0	6.8	4.1	6.2	3.9	2.8	5.8	7.3	4.2	10.9	7.8	2.2	3.9	10.3	0.3	4.2	11.6	10.8	8.4	9.7	25.1	5.3	13.9	11.9	3.1	4.5	2.5	15.9	11.7	1.6	8.3	0.0	30.9	4.0	8.2	13.8	3.2	1.9	6.5	11.8	0.0	26.2	9.9	4.4	10.3	20.6	17.4	8.4	0.5	10.5	2.6	6.6	1.4	5.3	4.8	3.2	6.6	5.0	8.6	1.0	6.1	13.0	7.1	4.8	4.4	10.3	4.3	4.9
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076587	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;Basal squamous epithelial cells: 94.4;Plasma cells: 48.2;Squamous epithelial cells: 107.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;SK-BR-3: 15.6;U-698: 28.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	0.6	1.1	1.4	2.2	1.2	5.3	1.7	3.3	1.9	1.3	0.4	2.5	3.0	0.5	0.1	9.2	1.4	0.2	0.4	1.4	1.0	1.5	0.7	1.3	2.8	1.2	1.1	0.7	0.7	0.1	3.3	0.1	1.2	2.4	0.3	0.5	5.1	0.4	0.5	6.0	4.2	0.1	1.1	5.9	2.7	2.3	1.0	0.4	1.2	0.1	1.4	1.5	3.2	0.9	4.6	2.9	0.1	0.6	0.0	0.2	2.5	0.6	0.0	0.3	0.2	4.7	1.6	24.0	2.7	0.1	0.0	8.3	1.2	1.8	0.0	5.2	6.3	7.2	1.4	4.8	1.2	3.9	7.2	0.9	0.9	0.9	0.0	0.1	0.7	0.4	5.2	8.0	0.0	6.5	0.3	6.8	2.7	2.8	6.3	13.5	0.0	14.8	0.5	1.6	4.4	0.4	3.0	15.6	0.1	0.4	3.4	8.1	1.5	0.0	2.4	0.1	0.0	8.6	9.3	28.7	0.2	5.0	0.1	59.7	10.7	17.2	8.3	18.3	9.7	82.6	4.3	9.3	26.0	62.8	1.8	4.7	5.1	45.9	18.5	78.5	4.4	8.7	1.4	1.2	3.3	1.9	1.4	1.0	1.2	1.1	1.2	1.1	1.0	0.9	2.4	0.0	0.6	2.3	53.3	12.1	13.9	1.5	94.4	1.4	20.5	13.3	1.2	0.0	2.6	3.7	4.2	0.4	31.9	18.5	0.0	1.8	0.5	6.1	1.0	2.0	5.3	3.0	0.4	0.9	3.6	1.3	21.9	4.5	8.9	0.5	1.4	0.2	3.5	0.0	0.3	32.1	6.1	2.9	19.1	0.5	0.0	7.6	3.6	0.0	24.9	0.4	12.3	0.0	0.5	1.2	36.1	1.2	48.2	6.4	23.4	0.2	3.9	1.6	0.0	0.8	3.2	1.1	14.2	107.3	10.1	0.8	18.5	0.2	28.9	6.2
ZNF436	"KIAA1710, Zfp46"	ENSG00000125945	"Zinc finger protein 436"	Q9C0F3	1	23359448-23369836	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.8;HSkMC: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043817	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"HPA043817: AB_10794774"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.51e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.75e-3)"	10.0	14.8	4.8	2.3	5.2	1.4	9.8	5.5	5.4	9.8	4.5	8.5	3.1	9.9	8.0	16.5	6.9	5.5	8.3	5.5	5.3	4.0	3.7	4.2	2.7	6.3	5.2	15.4	6.9	5.3	4.4	4.2	5.6	9.5	3.1	4.6	14.6	5.1	6.5	12.6	5.6	6.2	5.6	7.0	6.1	7.9	5.4	3.5	9.0	6.2	3.6	10.4	10.2	5.9	3.8	2.4	8.6	4.5	9.1	18.8	4.1	3.4	4.6	4.3	5.0	1.4	3.3	2.6	3.8	4.9	2.8	4.8	15.0	5.7	4.6	3.2	3.3	2.8	5.3	2.2	3.6	1.2	1.9	34.9	8.0	3.6	4.1	7.8	6.2	3.1	3.4	1.8	4.5	1.8	2.9	2.1	0.3	1.7	3.8	3.8	3.6	2.5	3.4	9.5	3.9	4.9	9.6	4.7	3.7	2.9	2.6	1.4	5.0	3.7	2.7	2.9	1.9	2.8	3.6	2.1	2.9	2.3	2.9	0.0	0.7	0.7	0.7	0.8	0.7	0.4	0.5	0.8	1.1	0.5	0.8	0.7	0.5	2.6	0.8	0.1	0.9	0.6	4.8	5.2	5.5	5.4	5.5	5.3	6.3	5.2	5.6	5.6	5.4	5.9	7.8	0.0	0.5	2.6	2.0	5.2	1.6	1.9	22.2	4.1	6.9	5.0	6.4	1.5	1.6	5.5	6.2	3.8	2.6	3.5	0.0	2.9	2.3	5.0	8.5	14.0	3.6	1.7	4.2	4.9	1.8	9.6	2.0	7.8	0.0	9.4	3.3	3.1	2.1	10.1	3.3	4.6	2.0	1.9	3.8	1.5	9.9	2.1	5.4	0.0	4.5	9.3	2.1	2.5	3.1	3.6	5.9	11.7	2.1	3.3	4.0	2.8	2.4	2.4	0.0	4.5	4.5	5.5	6.9	22.1	9.7	2.9	2.4	7.9	3.1	2.0
ZNF562	FLJ20079	ENSG00000171466	"Zinc finger protein 562"	Q6V9R5	19	9641807-9675100	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA055332: AB_2682786, HPA062397: AB_2684751"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (4.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.13e-3)"	5.9	4.6	6.1	6.4	6.7	7.5	11.6	12.6	6.3	6.1	5.2	8.3	5.0	7.9	4.3	14.0	5.4	6.4	5.6	4.5	6.3	5.5	6.9	5.7	5.9	5.9	5.3	6.1	6.0	5.8	4.7	6.2	5.6	6.3	7.5	5.7	6.7	6.4	3.0	6.0	5.3	8.0	5.5	7.2	5.8	3.5	6.7	5.4	5.9	5.2	7.4	9.0	7.1	10.2	12.7	10.5	15.2	29.0	7.9	7.3	0.7	13.6	9.4	14.1	15.4	8.2	7.2	12.9	13.1	10.4	11.4	10.1	19.7	15.2	17.5	14.4	12.1	46.3	10.9	8.2	9.2	16.6	33.1	12.9	10.5	17.5	28.1	7.8	15.4	10.3	22.8	22.0	14.0	6.2	16.7	4.1	19.8	8.9	6.8	6.5	17.5	6.3	6.6	34.8	16.0	10.0	20.1	7.7	9.3	12.0	11.3	13.6	13.5	24.9	9.7	11.4	17.7	17.7	45.3	21.1	3.5	1.1	13.2	3.3	2.7	3.1	2.4	3.9	3.6	3.1	2.1	1.7	3.5	2.3	2.4	3.0	1.2	3.0	4.5	2.1	2.3	1.3	6.1	6.7	12.6	6.3	4.5	6.3	5.9	5.3	5.6	5.5	6.7	10.2	14.7	9.6	18.5	8.5	11.3	6.4	40.0	11.6	12.0	30.6	23.9	14.4	9.4	30.0	17.7	25.8	73.0	14.9	11.9	32.2	19.6	19.6	7.5	20.1	17.6	18.1	23.9	23.8	19.4	8.6	18.5	12.7	19.4	29.7	12.7	22.1	23.2	13.6	11.9	28.6	18.0	16.9	12.2	31.5	8.9	12.2	12.2	16.7	7.2	18.7	21.3	12.4	20.6	24.6	22.2	24.7	20.9	13.5	6.1	45.1	9.6	9.1	15.6	31.2	0.0	17.4	12.8	13.5	11.4	14.6	10.1	19.4	11.9	13.7	18.1	67.1
ZNF750	"FLJ13841, Zfp750"	ENSG00000141579	"Zinc finger protein 750"	Q32MQ0	17	82829434-82840022	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 96.1;skin 1: 139.0;vagina: 51.7"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 33.3;Squamous epithelial cells: 156.8;Suprabasal keratinocytes: 41.1;Syncytiotrophoblasts: 68.1;Urothelial cells: 51.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 20.5;head and neck cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.3;hTCEpi: 7.2;MCF7: 5.4;SK-BR-3: 14.0"	"Not detected"	"Not detected"							"HPA021573, HPA023012"	Enhanced					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA021573: AB_1859438, HPA023012: AB_1859439"	"unprognostic (3.46e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.33e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.30e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.25e-2)"	0.5	0.1	0.8	0.0	1.2	0.1	5.1	0.5	0.9	25.0	0.0	0.1	0.1	0.2	4.1	96.1	0.6	0.2	0.6	0.6	0.2	0.4	0.1	2.0	0.0	1.0	0.3	0.1	0.2	2.2	2.9	3.9	1.0	3.3	0.0	0.0	33.6	2.7	12.0	139.0	0.1	0.0	0.2	0.1	0.2	0.4	0.6	5.1	3.5	0.0	14.7	4.9	51.7	2.3	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	1.2	1.0	0.0	14.0	0.0	1.7	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.5	0.9	0.6	0.2	1.0	0.3	1.0	0.2	0.6	2.3	0.6	0.0	8.2	0.0	0.0	5.2	14.3	19.6	9.1	0.0	7.4	5.0	0.4	0.0	21.2	0.0	0.0	23.1	0.0	0.0	0.0	0.0	2.4	27.1	3.3	0.9	0.0	0.0	0.4	0.0	1.9	0.3	0.0	33.3	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	10.2	0.0	0.3	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	7.6	0.0	0.1	14.2	0.0	0.0	0.1	1.5	0.0	0.2	156.8	41.1	68.1	0.2	0.0	0.0	51.3